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1. 
PSEUDOMONAS AVR AND HOP PROTEINS, 
THEIR ENCODING NUCLEIC ACIDS, AND 
USE THEREOF 
This application claims benefit of U.S. Provisional Patent 
Application Ser. Nos. 60/356,408, filed Feb. 12, 2002, and 
60/380,185, filed May 10, 2002, each of which is hereby 
incorporated by reference in its entirety. 
This work was supported by National Science Foundation 
Grant Nos. MCB-9982646 and IBN-0096348, National Sci 
ence Foundation Plant Genome Research Program Coop 
erative Agreement DBI-0077622, and National Research 
Initiative Competitive Grants Program, U.S. Department of 
Agriculture, Grant No. 01-35319-10019. The U.S. Govern 
ment may have certain rights in this invention. 
FIELD OF THE INVENTION 
The present invention relates to isolated DNA molecules 
corresponding to the open reading frames of Pseudomonas 
syringae pv. tomato DC3000, the isolated avirulence effector 
proteins and hrp-dependent outer proteins encoded thereby, 
as well as their various uses. 
BACKGROUND OF THE INVENTION 
The plant pathogenic bacterium Pseudomonas Syringae is 
noted for its diverse and host-specific interactions with 
plants. A specific strain may be assigned to one of at least 40 
pathovars based on its host range among different plant 
species and then further assigned to a race based on differ 
ential interactions among cultivars of the host. In host plants 
the bacteria typically grow to high population levels in leaf 
intercellular spaces and then produce necrotic lesions. In 
nonhost plants or in host plants with race-specific resistance, 
the bacteria elicit the hypersensitive response (HR), a rapid, 
defense-associated programmed death of plant cells in con 
tact with the pathogen (Alfano & Collmer, J. Bacteriol. 
179:5655–5662 (1997)). The ability to produce either of 
these reactions in plants appears to be directed by hrp (HR 
and pathogenicity) and hrc (HR and conserved) genes that 
encode a type III protein secretion pathway and by avr (avi 
rulence) and hop (Hrp-dependent outer protein) genes that 
encode effector proteins injected into plant cells by the 
pathway (Alfano & Collmer, J. Bacteriol. 179:5655–5662 
(1997)). These effectors may also betray the parasite to the 
HR-triggering R-gene Surveillance system of potential hosts 
(hence the avr designation), and plant breeding for resistance 
based on Such gene-for-gene (avr-R) interactions may pro 
duce complex combinations of races and differential culti 
vars (Keen, Annu. Rev. Genet. 24:447 463 (1990)). hrp/hrc 
genes are probably universal among necrosis-causing gram 
negative plant pathogens, and they have been sequenced in 
P. syringae pv. Syringae (Psy) 61, Erwinia amylovora 
Ea321, Xanthomonas Campestris pv. vesicatoria (Xcv) 
85-10, and Ralstonia Solanacearum GMI1000 (Alfano & 
Collmer, J. Bacteriol. 179:5655–5662 (1997)). Based on 
their distinct gene arrangements and regulatory components, 
the hrp/hrc gene clusters of these four bacteria can be 
divided into two groups: I (Pseudomonas and Erwinia) and 
II (Xanthomonas and Ralstonia). The discrepancy between 
the distribution of these groups and the phylogeny of the 
bacteria provides some evidence that hrpf.hrc gene clusters 
have been horizontally acquired and, therefore, may repre 
sent pathogenicity islands (Pais) (Alfano & Collmer, J. 
Bacteriol. 179:5655–5662 (1997)). 
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Virulence effector proteins delivered to or into host cells 
by type III secretion systems are key factors in the patho 
genicity of many bacteria, including animal pathogens in the 
genera Salmonella, Yersinia, Shigella, and Escherichia, and 
plant pathogens in the genera Pseudomonas, Erwinia, Xan 
thomonas, Ralstonia, and Pantoea (Galán & Collmer, Sci 
ence 284:1322–1328 (1999)). In plant pathogens, the type 
III secretion machinery is referred to as the hypersensitive 
response and pathogenicity (Hrp) system because secretion 
mutants typically lose their ability to elicit the defense 
associated hyperSensitive response in nonhost plants and to 
grow parasitically or be pathogenic in host plants (Alfano & 
Collmer, J. Bacteriol. 179:5655–5662 (1997)). These phe 
notypes demonstrate the importance of the Hrp system in 
bacterium-plant interactions, and global identification of 
effectors will be important for understanding the pathogen 
esis of bacteria that use type III secretion systems. Unfor 
tunately, several factors have hindered searches for type III 
effector genes. These factors include: (i) effectors are often 
redundant with mutants having only Subtle phenotypes; (ii) 
with few exceptions (see e.g., Miao & Miller, Proc. Natl. 
Acad. Sci. USA 97:7539–7544 (2000)) motifs that can 
identify proteins as substrates for type III secretion have not 
been recognized (Lloyd et al., Mol. Microbiol. 39:520–523) 
(2001); (iii) many effectors show no similarity to known 
proteins; and (iv) some pathogens have multiple type III 
secretion systems which deliver different sets of effectors 
(Cornelis & Van Gijsegem, Annu. Rev. Microbiol. 
54:735–774 (2000)). Thus, a complete inventory of type III 
effector genes is lacking for any pathogen, although it seems 
that pathogens such as Salmonella may have many such 
genes (Worley et al., Mol. Microbiol. 36:749 761 (2000)). 
Plant pathogen type III effector proteins are mostly des 
ignated AVr or Hop, depending on whether their primary 
phenotype involves plant reaction or secretion behavior. 
Many effectors were initially discovered through their abil 
ity to betray the pathogen to the host R (resistance) gene 
Surveillance system, thereby rendering the pathogen aviru 
lent on a test plant (Keen, Annu. Rev. Genet. 24:447 463 
(1990)). Over 25 effector genes have been identified by Avr 
or Hop phenotypes in various P. syringae pathovars and 
races (Vivian & Arnold, J. Plant Pathol. 82:163–178 (2000); 
Alfano et al., Proc. Natl. Acad. Sci. USA 97:4856–4861 
(2000)). The encoded effectors seem to determine both basic 
pathogenicity and host range, but the number of Such 
proteins produced by any single strain has not been system 
atically investigated. P. S. tomato DC3000 is known to carry 
at least three avr genes, avrPto (Ronald et al., J. Bacteriol. 
174:1604–1611 (1992)), avrPtoB (Kim et al., Cell 109: 
589–598 (2002)), and avrE (Lorang & Keen, Mol. Plant 
Microbe Interact. 8:49–57 (1995)), with the latter being in 
the Hrp pathogenicity island along with five other candidate 
effector genes (Alfano et al., Proc. Natl. Acad. Sci. USA 
97:4856–486 (2000); Lorang & Keen, Mol. Plant-Microbe 
Interact. 8:49–57 (1995)). 
The present invention is a further advance in the effort to 
identify, clone, and sequence AVr and Hop proteins or 
polypeptides from plant pathogens. 
SUMMARY OF THE INVENTION 
One aspect of the present invention relates to an isolated 
nucleic acid molecule that includes a nucleotide sequence 
which (i) encodes a protein or polypeptide having the amino 
acid sequence of SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID 
NO: 6, SEQ ID NO: 8, SEQ ID NO: 10, SEQ ID NO: 12, 
SEQID NO: 14, SEQID NO: 16, SEQID NO: 18, SEQ ID 
US 7,220,583 B2 
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NO: 20, SEQID NO: 22, SEQID NO: 24, SEQID NO:26, 
SEQID NO: 28, SEQ ID NO:30, SEQID NO:32, SEQ ID 
NO:34, SEQID NO:36, SEQID NO:38, SEQID NO:40, 
SEQID NO:42, SEQID NO: 44, SEQID NO:46, SEQ ID 
NO:48, SEQID NO:50, SEQID NO:52, SEQID NO:54, 
SEQID NO:56, SEQ ID NO:58, SEQID NO: 60, SEQ ID 
NO: 62, SEQID NO: 64, SEQID NO: 66, SEQID NO: 68, 
SEQID NO: 70, SEQ ID NO: 72, SEQID NO: 74, SEQ ID 
NO: 76, SEQID NO: 78, SEQID NO:80, SEQID NO: 82, 
SEQID NO: 84, SEQ ID NO: 86, SEQID NO: 88, SEQ ID 
NO:90, SEQID NO: 92, SEQID NO: 94, SEQID NO: 96, 
SEQ ID NO: 98, SEQ ID NO: 100, SEQ ID NO: 102, SEQ 
ID NO: 104, SEQ ID NO: 106, SEQ ID NO: 108, SEQ ID 
NO: 110, SEQID NO: 112, SEQ ID NO: 114, SEQID NO: 
116, SEQ ID NO: 118, SEQID NO: 120, SEQID NO: 122, 
SEQ ID NO: 124, SEQ ID NO: 126, or SEQ ID NO: 209; 
or (ii) hybridizes, under stringency conditions comprising a 
hybridization medium which includes 0.9xSSC at a tem 
perature of 42°C., to a DNA molecule complementary to 
SEQID NO: 1, SEQID NO:3, SEQID NO:5, SEQID NO: 
7, SEQ ID NO:9, SEQ ID NO: 11, SEQ ID NO: 13, SEQ 
ID NO: 15, SEQ ID NO: 17, SEQID NO: 19, SEQID NO: 
21, OR SEQ ID NO. 23, SEQ ID NO: 25, SEQ ID NO: 27, 
SEQID NO: 29, SEQ ID NO:31, SEQID NO:33, SEQ ID 
NO:35, SEQID NO:37, SEQID NO:39, SEQID NO:41, 
SEQID NO:43, SEQ ID NO:45, SEQID NO:47, SEQ ID 
NO:49, SEQID NO:51, SEQID NO:53, SEQID NO:55, 
SEQID NO:57, SEQ ID NO. 59, SEQID NO: 61, SEQ ID 
NO: 63, SEQID NO: 65, SEQID NO: 67, SEQID NO: 69, 
SEQID NO: 71, SEQ ID NO: 73, SEQID NO: 75, SEQ ID 
NO: 77, SEQID NO: 79, SEQID NO: 81, SEQID NO: 83, 
SEQID NO: 85, SEQID NO: 87, SEQID NO: 89, SEQID 
NO: 91, SEQID NO: 93, SEQID NO:95, SEQID NO: 97, 
SEQ ID NO: 99, SEQ ID NO: 101, SEQ ID NO: 103, SEQ 
ID NO: 105, SEQ ID NO: 107, SEQ ID NO: 109, SEQ ID 
NO: 111, SEQID NO: 113, SEQID NO: 115, SEQ ID NO: 
117, SEQID NO: 119, SEQID NO: 121, SEQID NO: 123, 
or SEQID NO. 208; or (iii) is complementary to the nucleic 
acid molecules of (i) and (ii). Expression vectors, host cells, 
and transgenic plants which include the DNA molecules of 
the present invention are also disclosed. Methods of making 
Such host cells and transgenic plant are disclosed. 
A further aspect of the present invention relates to isolated 
effector proteins or polypeptides encoded by the nucleic acid 
molecules of the present invention. Compositions which 
contain the proteins or polypeptides are also disclosed. 
Yet another aspect of the present invention relates to 
methods of imparting disease resistance to a plant. Accord 
ing to one approach, this method is carried out by trans 
forming a plant cell with a heterologous DNA molecule of 
the present invention and regenerating a transgenic plant 
from the transformed plant cell, wherein the transgenic plant 
expresses the heterologous DNA molecule under conditions 
effective to impart disease resistance. According to another 
approach, this method is carried out by treating a plant with 
a protein or polypeptide of the present invention under 
conditions effective to impart disease resistance to the 
treated plant. 
A further aspect of the present invention relates to a 
method of causing eukaryotic cell death which includes: 
introducing into a eukaryotic cell a cytotoxic Pseudomonas 
protein of the present invention, said introducing being 
performed under conditions effective to cause cell death. 
A still further aspect of the present invention relates to a 
method of treating a cancerous condition which includes 
introducing a cytotoxic Pseudomonas protein of the present 
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invention into cancer cells of a patient under conditions 
effective to cause death of cancer cells, thereby treating the 
cancerous condition. 
Yet another aspect of the present invention relates to a 
method of inhibiting programmed cell death which includes 
introducing into a eukaryotic cell Susceptible to programmed 
cell death, a protein of the present invention that is a 
hypersensitive response Suppressor, said introducing being 
performed under conditions effective to inhibit programmed 
cell death of the eukaryotic cell. 
Yet another aspect of the present invention relates to a 
method of modifying a metabolic pathway in a cell which 
includes: introducing into a cell a protein or polypeptide of 
the present invention which interacts with a native cellular 
protein involved in a metabolic pathway, wherein the protein 
or polypeptide modifies the metabolic pathway through its 
interaction with the native cellular protein. 
It is believed that bacteria have evolved effector proteins 
to make exquisite alterations in host metabolism. While 
plant disease resistance, Suppression of programmed cell 
death, and cancer cell toxicity are important uses, as men 
tioned above, it is believed that these effector proteins can be 
used to modify or effect metabolic targets in eukaryotes, 
including both yeasts and higher order species, such as 
plants and animals. It is noteworthy that several of the 
effector proteins disclosed herein have homologs in other 
phytopathogenic bacteria. Thus, these proteins appear to 
represent a set of effectors that are conserved among 
Pseudomonas, Erwinia, Xanthomonas, and Ralstonia spp. 
By disrupting or augmenting the function of these effectors 
through, for example, transgenic expression thereof in a host 
plant, it is believed that use of these effectors may lead to 
widely applicable means for controlling diseases of plants. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIGS. 1A–C illustrate assays for Hrp system-dependent 
secretion in culture or translocation in planta of candidate 
effector proteins. P. S. tomato DC3000 and a Hrp secretion 
mutant derivative were used for tests of newly identified 
candidate effectors (1A–B). DC3000 or a DC3000 hrcC 
mutant (Yuan & He, J. Bacteriol. 178:6399–6402 (1996), 
which is hereby incorporated by reference in its entirety) 
carrying test ORFs (i.e., candidate effectors) fused to either 
the FLAG (F) or hemagglutinin (HA) epitopes were grown 
in Hrp-inducing media, and cultures were separated into cell 
(lanes 1-3) and Supernatant (lanes 4 and 5) fractions and 
analyzed by SDS/PAGE and immunobloting. Lanes 1 and 4. 
wild-type DC3000; lanes 2 and5, wild-type DC3000 (pTest 
ORF); lanes 3 and 6, DC3000 hrcC mutant (pTestORF). As 
an additional control against leakage, pCPP2318 was 
included in all strains, which encodes the mature form of 
B-lactamase (B-lac). The presence of an epitope-tagged 
protein in the supernatant fraction of the wild type (lane 5), 
but absence in the hrcC secretion mutant (lane 6), indicated 
that the test ORF encoded a secreted product. In FIG. 1C, an 
AvrRpt2 translocation assay was performed with DC3000 
HopPtoG. Test strains were infiltrated into A. thaliana Col-0 
(RPS2) and Col-0 rps2-201 (rps2) plants. Plant responses 
were scored 18 h after inoculation for hypersensitive 
response (HR) or no visible response (N). 
FIGS. 2A–C illustrate pHIR11-dependent HR is sup 
pressed by HopPtoE, and a P. S. tomato DC3000 hopPtoE 
mutant exhibits an enhanced HR. FIG. 2A is a schematic 
representation of the pHIR11-based suppression assay in P. 
fluorescens (Pf)55. When DC3000 effectors are individually 
expressed in trans in Pf(pHIR 11), they can potentially 
US 7,220,583 B2 
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suppress the HopPsyA-dependent HR. FIG. 2B shows N. 
tabacum cv. xanthi leaves that were infiltrated with 
Pf(pHIR11) (left panel) or Pf(pHIR11, phopPtoE)(right 
panel). N denotes no HR. FIG. 2C shows quantitative 
differences in the ability of DC3000 wild-type (WT), hopP 
toE mutant UNL139, and complemented mutant UNL 139 
(phopPtoE) to elicit the HR in N. tabacum cv. xanthi leaves. 
Different dilutions of bacterial cells/ml (1, 10 cells/ml; 2. 
107 cells/ml: 3, 10° cells/ml; and 4, 10 cells/ml) were 
infiltrated into leaves, then leaves were photographed after 
24 hr. 
FIGS. 3A-C illustrate that HR suppression is not due to 
blocking TTSS, and the TTSS is functional. FIG. 3A is an 
image of an immunoblot showing that AvrPto is type III 
secreted from DC3000 (WT), but not from a secretionde 
fective DC3000 hrcC mutant (hrcC). B-Lactamase (B-Lac) 
was used as a lysis control. C. cell pellet fractions; S. 
Supernatant fractions. FIG. 3B is an image showing that the 
HR elicited in N. tabacum cv. xanthi by DC3000 is inhibited 
when hopPtoE is expressed in trans. FIG. 3C shows the 
results of Pfluorescens(pHIR11) mixing experiments in N. 
tabacum cv. Xanthi, demonstrating that HR Suppression can 
occur when HopPtoE and HopPsyA are TTSS-delivered by 
different bacteria. pl. N18 is a pHIR11 derivative that lacks 
hopPsyA, but encodes a functional TTSS. pCPP2089 
(Huang et al., Mol. Plant-Microbe Interact. 4:469-476 
(1991), which is hereby incorporated by reference in its 
entirety) is a pHIR11 derivative encoding a defective TTSS. 
FIGS. 4A-C identify P. S. tomato DC3000 effectors that 
suppress the HR on tobacco and Arabidopsis. FIG. 4A lists 
DC3000 effectors that were tested in the pHIR11 assay. A y 
indicates that the effector inhibited the HR, an ‘n’ indicates 
that it did not, and a y indicates that it partially suppressed 
the HR. Refer to the Materials and Methods for information 
regarding effector constructs. The nucleic acid and amino 
acid sequences of AvrPphE, AvrPpiB1, HopPtoB, 
HopPtoC, HopPtoD1, HopPtoD2, HopPtoF (previously des 
ignated AvrPphF ORF2), HopPtol, and HopPtoK are 
disclosed in U.S. patent application Ser. No. 09/825,414 to 
Collmer et al., filed Apr. 2, 2002, which is hereby incorpo 
rated by reference in its entirety. The nucleic acid and amino 
acid sequence of AVrPto is reported at Genbank Accession 
L20425; Salmeron & Staskawicz, Mol. Gen. Genet. 239: 
6–16 (1993), each of which is hereby incorporated by 
reference in its entirety. The nucleic acid and amino acid 
sequence of AvrPtoB is reported at Genbank Accession 
AY074795 and Kim et al., Cell 109:589–598 (2002), each of 
which is hereby incorporated by reference in its entirety. 
AvrPtoB was independently shown to suppress the pro 
grammed cell death elicited by AvrPto or by heterologously 
expressed BAX in Nicotiana benthamiana (Abramovitch et 
al., EMBO.J. 22:60–69 (2003), which is hereby incorporated 
by reference in its entirety). FIG. 4B is an image of N. 
tabacum cv. xanthi leaves that were infiltrated with P. 
fluorescens(pHIR11) with different effector constructs 
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(noted above each picture). Complete suppression of the HR 
is denoted with N. FIG. 4C is an image of the same strains 
(as illustrated in FIG. 4B) infiltrated into Arabidopsis WS-0. 
producing identical results. 
FIGS. 5A-B illustrate that the HR elicited by HopPsyA 
can be suppressed via Agrobacterium transient expression of 
effectors. In FIG. 5A, N. tabacum cv. xanthi leaves were 
co-infiltrated with A. tumefaciens C58C1 carrying 
phopPsyA and another strain carrying each candidate Sup 
pressor. All of the suppressive effectors identified in the 
pHIR11 screen also suppressed the HR elicited by HopPsyA 
in this test. In FIG. 5B, an immunoblot of plant tissues with 
different agroinfiltrations shows that each HA epitope 
tagged effector was made in planta. The asterisks indicates 
a protein of the predicted size of the effector in that lane. 
FIG. 6 is an image showing that Pseudomonas syringae 
pv. tomato DC3000 suppressor mutants display an enhanced 
ability to elicit the HR. N. tabacum cv. xanthi leaves were 
infiltrated with P. syringae strains that were 10-fold serially 
diluted from 10 cells/ml. The last dilution (10 cells/ml) that 
resulted in an HR is shown. In all cases, the mutants exhibit 
more HR at this dilution than the wild type, and this 
phenotype was complemented when the Suppressors were 
provided in trans. The following strains were infiltrated: 
DC3000 wild type, WT: avrPphEPto mutant, UNL113: 
avrPpiB1Pto mutant, UNL114; avrPtoB mutant, UNL127: 
hopPtoF mutant, UNL109; hopPtoG mutant, UNL124. HR 
was scored for each sample: spotty HR (HR-); strong HR 
(HR+); or no HR. 
FIGS. 7A-B illustrate that Pseudomonas Syringae pv. 
tomato DC3000 HR suppressors inhibit the PCD initiated by 
Bax in plants and yeast. In FIG. 7A, Agrobacterium C58C1 
strains carrying binary vectors that encode Bax or a specific 
effector were co-infiltrated into N. benthamiana leaves. 
Leaves were photographed after 7 days. N* indicates that the 
HR was nearly absent. Effector constructs were the same as 
in FIG. 4. In FIG. 7B, yeast strain EGY48 carrying plasmids 
that encoded for Bax (p.G4-5-Bax) and a specific effector 
were spotted on plates at 5-fold dilutions. Expression of Bax 
was induced by galactose, whereas effector expression was 
constitutive. Only AVrPpiB1 was unable to suppress Bax 
induced killing. Bcl-XL (pGilda-Bcl-XL), an animal protein 
known to inhibit Bax-induced PCD, was used as a positive 
control. 
DETAILED DESCRIPTION OF THE 
INVENTION 
One aspect of the present invention relates to Pseudomo 
nas Syringae pv. Syringae DC 3000 nucleic acid molecules 
which encode Avr or Hop effector proteins. 
A first nucleic acid molecule encodes HopPtol (ORF1) 
and has a nucleotide sequence according to SEQ ID NO: 1 
as follows: 
atgcttatcggg cacagottgcatcacatgc gacccactgctgtggattotagoctaccaact tcc.gca 
actagoc agacitatcago: aataccaaaagtcggctggat.ccgcatcgtgtc.cgtgaacttacattcatc 
ggagtgggtag tagtgttgcctacct act caatgagcttaatgg to gotttgcc.gatagoggggtaa.ca 
acgcc gtttittaggaaaagttcagtattgtaggcaaggacgactcittgggcc.gagaatgttcgtgggaaa 
ggittatattalaccaccagacitgaaattataagccaatgg gaccaac aggttccaaaatatgatcc taac 
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HopPtol has been shown to be a protein that is secreted by 
DC3OOO. 
A second nucleic acid molecule encodes HopPtoH 
(ORF2) and has a nucleotide sequence according to SEQID 
NO:3 as follows: 
atgatcactc.cgtotcg at atcCaggcatctatato gocc cccitcagtaac galaccgacago agcticac 
acatttaaagaacaagcagaggaag cacttgaccatat cagogcc.gcacccitctgg.cgataagctattg 
cgaaaaat atcc actottgc.cagtcaaaaagatagaaaagttcacgctaaaagagattgaaataaataac 
cagtgttataccgaagctgttctgagcagraggcaactggaaaagtacgaaccagaaaactittaac gag 
aaccgg cacattgcatcacagot atcacgaaagggg acctttaccalaaggtgaaggaa.gcaacg.cgatt 
attggctggtoaccagacaaagcaa.gcatacgcttaaatcagaatggct caccgttacaccittggaatg 
gataacgacgacaaaatcacg accotagotcatcagctic gttcatgctogacatgtgttaggtogcago 
to cittagoggatgg.cggagat.cgctataatccacgtacgg gatctggcaaagaggaacttagg gcc gtt 
ggattagataagtaccgctatto acttacaaaaaaaccgtcagagaacticcatcc.gagctgaac acggc 
citgc citctg.cgcatcaagtacaggg cacatcaatag 
25 
The HopPtoH protein encoded by this nucleic acid molecule 
has an amino acid sequence according to SEQID NO. 4 as 
follows: 
MITPSRYPGIYIAPLSNEPTAAHTFKEQAEEALDHISAAPSGDKLLRKISTLASQKDRKVTLKEIEINN 
QCYTEAWLSRRQLEKYEPENFNENRHIASQLSRKGTFTKGEGSNAIIGWSPDKASIRLNQNGSPLHLGM 
DNDDKITTLAHELWHARHWLGGSSLADGGDRYNPRTGSGKEELRAWGLDKYRYSLTKKPSENSIRAEHG 
LPLRMKYRAHQ 
HopPtoH has been shown to be a protein that is secreted by CAC16702, each of which is hereby incorporated by refer 
DC3000. HopPtoH has significant homology (1e-114), as "ence in its entirety. 
detected by BLAST search, to ORF3 from Pseudomonas A third nucleic acid molecule encodes HopPtoE (ORF3) 
syringae pv. pisi avrPpiC2 locus (Arnold et al., Microbiol- and has a nucleotide sequence according to SEQ ID NO: 5 
ogy 147:1171–1182 (2001); GenBank Accession No. as follows: 
atgaatagagtttcc.ggtag citcgtoag.cgacittggcaggcagt caac gatcttgttggagcaagtaagc 
gag agaaccacgttgtctacgacaggittatcagacggcaatgggcc.gcttgaacaaaccggaaaaatca 
gatgcggatgcgctgatgacitatgaggaggg.cgcaa.cagtacacggatagogcgaag.cgaacttatatt 
toggaaacgct gatgaatctgg cagatttgcagoaaaggaaaatctatogcacca acagogggaacttg 
cgtgg.cgcgattgagatgacgccitacgcaactcacagattgcgtacagaagit gcc.gc galagaggggttc 
to caattgttgacatacaggcgctdgaaatcggcttgcaccitt.cgacataagttaggaatctoagatttic 
accatctacagoa accgtaagttaa.gc.catalactatotgg to atccaccc.ca.gcaatgcatttcc gaaa 
ggagc gattgtag act cittggacgggacagggcgtggtggagctgg acttcaag acco gattgaaattic 
aag caccgggaag agaactacgcagtgaacgc.caatatgcacgagtggat.cgagagatacggccaag.cg 
catgtgattgactga 
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The HopPtoE protein encoded by this nucleic acid molecule 
has an amino acid sequence according to SEQID NO: 6 as 
follows: 
MNRWSGSSSATWQAVNDLVEQVSERTTLSTTGYOTAMGRLNKPEKSDADALMTMRRAQQYTDSAKRTYI 
SETLMNLADLQQRKIYRTNSGNLRGAIEMTPTOLTDCVOKCREEGFSNCDIQALEIGLHLRHKLGISDF 
TIYSNRKLSHNYWWIHPSNAFPKGAIVDSWTGQGWWELDFKTRLKFKHREENYAVNANMHEWIERYGQA 
HWID 
HopPtoE has been shown to be a protein that is secreted by 
DC3000 as well as translocated in planta. 15 
A fourth nucleic acid molecule encodes HopPtoG (ORF4) 
and has a nucleotide sequence according to SEQ ID NO: 7 
as follows: 
atgcaaataaagaacagtcatctotattoagcttcaagaatggtgcagaatacttittaatgc citcgc.ct 
aagatggaagtaactaatgcaatagoaaaaaataatgaacct gctg.cgctgag cqctacgcaaactgca 
aag acacacgaaggcgattcaaaaggccaatccago: aataactictaaattgcc citt.ccgc.gc.catgagg 
tacgctgcataccttgcaggcag cqcctacctctacgataaaactg.ccaataattitttittctittctacc 
acttct citgcatgatggcaaaggtogttttaccago gatgccaggcttaac gatgcacaagataaag.cg 
cgaaag.cgctaccaaaacaac catagoagc actottgaaaataaaaacticgcttittaa.gc.ccgcttagg 
citttgcggagagaatcagttcttaacgatgattgattatcgtgcagdaactaagatttacct citcc gac 
citagttgacacggagcaa.gc.gcacacatcaattctgaagaatattatgtgcctgaaaggtgagcttacc 
aatgaagaggcaataaaaaaactica accoggaaaaaacaccaaaagacitat gaccttacaaatago gaa 
gcctatataagcaagaacaaatattotttgaccggc gttaaaaatgaggagacgggat.ct acto gttat 
acatctogttctato acaaagcc atttgttggaaaaaggcc toaaacactittataaaag.cgacitcatggc 
gaaaaagctotcacgcc caag cagtgitatggaaact cittgata acttactt.cgaaaaagtat cacgcto 
aacagtgatticc caattic.gcago aggc.caggc acttittggttittcagacaggtotato.cgggtogalagac 
gcttggggggatgcggaacgggtoatattgaaaag.ccattataatcggggc actogtactic caagatgaa 
gctgataaaatagalactaagtagg.ccgttctgaga.gcaagatttagcaaagaacatgtttaa gaggaat 
accago attgcagg gcc agtgct citaccacgcatatatttatatacaagaaaaaatcttcaagctaccc 
cc.cgacaaaatagaagatttgaaacataaatcaatggcag acttgaaaaacct gcc tittgacticatgtt 
aagcttagcaattic.cggtgtgggatttgaagacgc.citcagggittaggagacitcgtttacagotcitcaac 
gc gacgtoctotgttaatcacgcaagaataatgagtggtogagcct cocittgtcaaaagatgatgttgttg 
attctgataggttgcct caacgc.cgtatacgacaattic gag.cggaataagg cattctotcc.gc.gaaatt 
gcac gagggtgctttgttgggtgctggttttacgg to caggacggtgacg acttctacaaacagatctgc 
aaaaacgc.ctictaag cagttttacaacggctaa 
The HopPtoG protein encoded by this nucleic acid molecule 
has an amino acid sequence according to SEQ ID NO: 8 as 
follows: 
MQIKNSHLYSASRMVONTFNASPKMEWTNAIAKNNEPAALSATOTAKTHEGDSKGOSSNNSKLPFRAMR 
YAAYLAGSAYLYDKTANNFFLSTTSLHDGKGGFTSDARLNDAQDKARKRYONNHSSTLENKNSLLSPLR 
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LCGENQFLTMIDYRAATKIYLSDLVDTEQAHTSILKNIMCLKGELTNEEAIKKLNPEKTPKDYDLTNSE 
AYISKNKYSLTGVKNEETGSTGYTSRSITKPFWEKGLKHFIKATHGEKALTPKQCMETLDNLLRKSITL 
NSDSQFAAGOALLVFRQWYAGEDAWGDAERVILKSHYNRGTVLQDEADKIELSRPFSEQDLAKNMFKRN 
TSIAGPWLYHAYIYIQEKIFKLPPDKIEDLKHKSMADLKNLPLTHWKLSNSGWGFEDASGLGDSFTALN 
ATSCVNHARIMSGEPPLSKDDWWILIGCLNAVYDNSSGIRHSLREIARGCFVGAGFTVQDGDDFYKQIC 
KNASKOFYNG 
HopPtoG has been shown to be a protein that is secreted by 
DC3000 as well as translocated in planta by recombinant 
Pseudomonas syringae pv. pisi. Thus, HopPtoG appears to 
be a Hrp-injected effector protein. HopPtoG has significant 
homology, as detected by BLAST search (1e-137), to a 
hypothetical protein of Ralstonia Solanacearum (see Gen 
Bank Accession No. NP 521884, which is hereby incorpo 
rated by reference in its entirety). 
A fifth nucleic acid molecule encodes HopPtoS1 (ORF5) 
and has a nucleotide sequence according to SEQ ID NO: 9 
as follows: 
15 
Chem. 269:27451–27457 (1994); GenBank Accession No. 
P55807, each of which is hereby incorporated by reference 
in its entirety), as well as significant homology to a type 
III-secreted ADP-ribosyltransferase from P. aeruginosa 
(Yahr et al., Mol. Microbiol. 22:991–1003 (1996), which is 
hereby incorporated by reference in its entirety). Further 
confirming its similarity to ADP-ribosyltransferases, HopP 
toS1 has been determined to possess an ART domain 
(pfam1129). 
atgggtaatatttgtgg tactitctggctocaatcatgtgtatagt cogcct attagcc citcaiacatgca 
totggttcgtccacaccagtgcc cagtgcttctgggacgatgctttctotcagtcatgaacaaatatta 
agcc agaactatoctagoaatataaaggggaaat atc.gcacga accoccgaaaaggaccatctoctagg 
citttctgatacgct gatgaag caggcgctgtc.ttcagtgatcacaca agagaaaaag.cgacittaaaagt 
caac caaagttcaatagoccaagatattoagccitccaaacagoatgatcaaaaatgcacttgatgaaaaa 
gacago cacccttittggtgattgcttittcagacgatgaatttcttgc gatcCatctotatacgagttgt 
citttacagaccgatcaiaccatcatctg.cgg tatgcc.ccgaaaaatgatgtc.gc.gc.ctdttgttggaggca 
atgaatagoggtttggccaaacttgct caataccct gattatcaggtgtctggtoagctgcatagaggc 
atcaa.gcaaaagatggatgatggtgaagttatgagtc.gcttcaag.ccgggtaatacittatcgtgatgac 
gc gttcatgageac atcgacitagaatggatgttacagaagaatttactitcc gatgtcacgttacatctg 
cagticcitcatcago.cgtcaatataggtoccittittcaaaaaaccoatacgaggacgaag.cgct catc.ccg. 
cc cctoacgc.ctttcaaagta accq gttctgcacaag caggacgataggtgg cacgtcc acttgaac gag 
atc.gcagaga.gctotgacgagtga 
The HopPtoS1 protein encoded by this nucleic acid mol 
ecule has an amino acid sequence according to SEQID NO: 
10 as follows: 
A sixth nucleic acid molecule encodes ORF6 and has a 
nucleotide sequence according to SEQ ID NO: 11 as fol 
lows: 
MGNICGTSGSNHWYSPPISPQHASGSSTPWPSASGTMLSLSHEQILSONYASNIKGKYRTNPRKGPSPR 
LSDTLMKQALSSWITQEKKRLKSQPKSIAQDIQPPNSMIKNALDEKDSHPFGDCFSDDEFLAIHLYTSC 
LYRPINHHLRYAPKNDWAPVVEAMNSGLAKLAQYPDYQVSGQLHRGIKQKMDDGEVMSRFKPGNTYRDD 
AFMSTSTRMDWTEEFTSDWTLHLQSSSAVNIGPFSKNPYEDEALIPPLTPFKVTGLHKQDDRWHVHLNE 
IAESSDE 
HopPtoS1 has been shown to be a protein that is secreted by 
DC3000 as well as translocated in planta. HopPtoS1 has 
significant homology, as detected by BLAST search (1e-5), 
to a chicken ADP-ribosyltransferases (Tsuchiya, J. Biol. 
65 
atgagcttatc.gc.cgacgctgcaaaagctaactaatatattgggc.ccgac 
aaaaaatgccaagcctdtcacagaggctatocagtggcaggaagg catgg 
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atataacgctgcatotoag.cggcgacagocttacct tactagotaaaatc 
atagaactg.cgtacagaccctaaagacgacattittattgcgcaa.gctgct 
tacccatacgtttc.cgggcctg.cgtctg.cgcc.gtgg.cgc.gcttaccatca 
accotgatggaagtg.ccctggittittctottatgaacacgattittcaccitt 
citggacaaag.ccc.gttittgagag cctoctogcca actittgctdaaacggc 
gcaggagctt.cgagacacagogacacatttitcgttitta actoga 
The protein encoded by this nucleic acid molecule has an 
amino acid sequence according to SEQ ID NO: 12 as 
follows: 
MSLSPTLQKLTNILGPTKNAKPWTEAIQWQEGMDITLHVSGDSLTLLAKI 
IELRTDPKDDILLRKLLTHTFPGLRLRRGALTINPDESALWFSYEHDFHL 
LDKARFEsLLANFAETAQELRDTATHFRFN 
Although the protein of SEQ ID NO: 12 possesses N-ter 
minal Hop features and features shared by type III chaper 
ones, this protein was shown not to be secreted by DC3000. 
Because ORF6 is located directly upstream of ORF17 
(described infra), it is believed that the protein of SEQ ID 
NO: 12 is a type III chaperone for the protein encoded by 
ORF17. 
A seventh nucleic acid molecule encodes ORF7 and has 
a nucleotide sequence according to SEQ ID NO: 13 as 
follows: 
atgaaacaac gag.cgacagtcatctgcaaacgtgacggcc aggtgctitta 
cgitacgcaaaccaaaatcc.cgctgggctttgc.caggtggcaagattgaag 
10 
15 
25 
30 
35 
16 
-continued 
cc.ggggaaacgc.cittitcCaggctg.ccgtgcgc gagctttgc gaagaalacc 
ggtotggaaaatcto gatctgttgtacctggcggtgtacgagaaaggtoga 
gg to acgcactacgtgttcaccactcaggttcct gcctacago gagc citt 
cgc.cccagaacgagatttctgcctgcaaatggcttgc.gc.ccaaaaatctt 
ggcg accitta aggccagoagcgc gacca aggctatogtoaagtcgitatgg 
cc.gc.caggctgaagacggtttacticagogctaac tag 
The protein encoded by this nucleic acid molecule has an 
amino acid sequence according to SEQ ID NO: 14 as 
follows: 
MKQRATWICKRDGQWLYWRKPKSRWALPGGKIEAGETPFOAAVRELCEET 
GLENLDLLYLAVYEKGEWTHYWFTTOWPAYSEPSPONEISACKWLAPKNL 
GDLKASSATKAIWKSYGRQAEDGLLSAN 
This protein shares significant homology, as detected by 
BLAST analysis (3e-7), to MutT mutator of Mesorhizobium 
loti (Genbank Accession No. NP 104556, which is hereby 
incorporated by reference in its entirety). The protein of 
SEQ ID NO: 12 was shown not to be secreted by DC3000. 
Although this protein is not secreted, it may still be an 
effector protein, because AvrB similarly is not secreted in 
culture although it is translocated in planta (see Van Dijk et 
al., J. Bacteriol. 181:4790 4797 (1999); Gopalan et al., 
Plant Cell 8:1095-1105 (1996), each of which is hereby 
incorporated by reference in its entirety). 
An eighth nucleic acid molecule encodes ORF8 and has 
a nucleotide sequence according to SEQ ID NO: 15 as 
follows: 
gtgctic gottttgcatacgt.ca.gc.ct gattagaga.gcagaaattggacatcaaaaaacgttggcc titcc 
agtgagcaggagttggtagaagtc.cgacggtttaacaaaaccotc.gc.ccggctg.ccg.cgtttcCaggitt 
cgcaatcgcct cacgc.ccc.gcttgattcdgg.cgctgctg.cggg.cggcticagattggtogc.gc.gttgaaa 
ccggtoaaacatgacctg.cggattgaaacaaccatcgtoagcaccggtaacgtocct gtttcagtgcga 
atcataaggcc caaaggcaaac coaaaggcgtggtgtttgatatto acgg.cggcggttgggtgatcggc 
aacgc.ccagatgaacgatgaccitcaatat cqgt atcgittaacgc.gtgcaacgtgg.cggtogtgtc.cgtt 
gattacagattggctittatc gaccc.ccg.tc.gaagggctgatggatgactgcttittctgcc.gcatgctgg 
citgctgggtag cqact gtaaggagtttgc.cggcctg.ccggittattgtcgtcggtgagtcc.gcggg.cggg 
catcttgcc.gcagocactittgctoaaattgaaag.ccaggc.ccgacittgctcaag.cgc.gtag togg cacg 
gttctgt attacggcgtgtacgacct gaccgggacaaaaag.cgttcgtaccgcaggc.ccggaaacgctg 
gtgctic gacggcc.cgggcatcgtoggcgcaatgcgcttgctogcc.ccggacagaaccgacgagaag.cgc 
cgc gagcc.gc.cgittatc.gc.ccttgtatgg.cg acct cacggatctgcc.gc.ccgc.cctgatgtttgtcggc 
gaacticga.ccc.gctgctggacgacacgctggaaatggcc gag.cgatggaaaaacticggcagacgttgaa 
atgcatcttctg.ccc.gag to tccacatgg gttcatcc actitc.ccgact gccittgg.cgc.gcaagg tactt 
gcgc.gcago Cacgagtggataaacgc gaggatggaaggacggCCttaa 
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The protein encoded by this nucleic acid molecule has an 
amino acid sequence according to SEQ ID NO: 16 as 
follows: 
WLAFAYWSLIREQKLDIKKRWPSSEQELVEVRRFNKTLARLPRFQWRNRL 
TPRLIQALLRAAQIGRALKPWKHDLRIETTIVSTGNWPWSWRIIRPKGKP 
KGVWFDIHGGGWWIGNAQMNDDLNIGIVNACNVAWWSWDYRLALSTPVEG 
LMDDCESAAcWLLGSDCKEFAGLPWIWWGESAGGHLAAATLLKLKARPDL 
LKRWWGTWLYYGWYDLTGTKSWRTAGPETLWLDGPGMWGAMRLLAPDRTD 
EKRREPPLSPLYGDLTDLPPALMFWGELDPLLDDTLEMAERWKNSADWEM 
HILLPESPHGFIHFPTALARKWLARSHEWINARMEGRP 
10 
15 
18 
This protein shares significant homology, as detected by 
BLAST analysis (1e-12), to a putative esterase/lipase of 
Mesorhizobium loti (Genbank Accession No. NP 105776, 
which is hereby incorporated by reference in its entirety). 
The protein of SEQID NO: 16 was shown not to be secreted 
by DC3000. Although this protein is not secreted, it may still 
be an effector protein, because AvrB similarly is not secreted 
in culture although it is translocated in planta (see Van Dijk 
et al., J. Bacteriol. 181:4790 4797 (1999); Gopalan et al., 
Plant Cell 8:1095-1105 (1996), each of which is hereby 
incorporated by reference in its entirety). 
A ninth nucleic acid molecule encodes ORF9 and has a 
nucleotide sequence according to SEQ ID NO: 17 as fol 
lows: 
atgcaaaccitatatacccitatccaaaaaaccotcc caccgttggtacagttctgctgactitcc tatggc 
to attc.gcc catgaaaacgagatacctaaatcttgtgctg.ccgacgctittaagagtaggcaaagagctic 
gct gatggtttcgatggc gaggttcatcatctagg.cgctctgatgctgatgattitcc.gactitt.ccagoa 
gag.ccgctgctgaaag catctgctgctaagaaaggttctittgctagga attactitc.gcttggctaccta 
ttatccitatggat.ctactggtgaaaaag.cgaag.cgaatcatcgaag caggttgtgg tatttittct cqtc 
agagtgagtggtgatattgaaaac cotaaag caaaaattgaagtttatagotcittggtotgaataccag 
aagttcc ttgaac coattittgaag acaggtoacttittatccagtgaaaacg.tc.gtcgttitt.ccgaataa 
The protein encoded by this nucleic acid molecule has an 
amino acid sequence according to SEQ ID NO: 18 as 
follows: 
35 
MQTYIPYPKNPPTVGTVLLTSYGSFAHENETPKSCAADALRVGKELADGF 
DGEWHHL.GAL.MLMISDFPAEPLLKASAAKKGSLLGITSLGYLLSYGSTGE 
40 
KAKRIIEAGCGIFLWRVSGDIENPKAKIEWYSSWSEYQKELEPILKTGDF 
YPWKTSSFSE 
45 This protein shares significant homology, as detected by 
50 
BLAST analysis (3e-50), to ORF4 of Pseudomonas seri 
Oboryae (Genbank Accession No. BAA87063, which is 
hereby incorporated by reference in its entirety). 
A tenth nucleic acid molecule encodes ORF10 and has a 
nucleotide sequence according to SEQ ID NO: 19 as fol 
lows: 
atgat caacct cacco acattgcgtottcattggcgcgggcagogctdag cq attcgacaaag.ccgaag 
atggagc.gc.gc gataaacgt.cgc.gagccacatcgctggcaaagtc.gc.gttgcagg to accagotcatta 
citggagcagaaaggtotgcttaac gag.cgtcagoagaaagggct citcgatgattotgaaggccittgagc 
ggcaaggagcc.ggtgaacaatgtc.gaga.cgcacga agggggaggc.cgattcaatctggc gC gag.ccgCC 
titcgacgtggc.ca.gc.gttgttctgggagcgcgacaagtic gatgcatalacgtgatgagctttctggg.cgtc 
agogacagoaagggcaagatgttgttctotctgggcaagaagctgg.cggatgcaatggccaa.gc.ctdag 
cctggcaaggacaa.ca.gtgaggccacaaatgcgc.gc.catgcc tatttcto cagoa acttgaaactgaac 
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cgc.cacagtCct cqc.gcggaCaggtotgcCaagggacgacctggcc.gagaggagaggalacgggg Caagg 
ttcaatgccaa.gcaaacaaag.ccgacagaggctgaagccitacggtgatcatcagacaccolaatcct gat 
ttgcacaggcaaaaagaga cagotcaacgc gttgctgaaagcatcaa.cago atgc.gagag cago: aaaat 
ggaatgcaacgc.gc.cga-agggcttctoragagccaaagaag.cgttgcaa.gctcgggaagcc.gc.gc.gcaag 
cagottctggacgtgctic gaggc catcCaggctdgcc.gtgaagacitccaccgacaagaagat cagogcc 
actgaaaagaacgc.cacgggcatcaactaccagtga 
15 
The protein encoded by this nucleic acid molecule has an 
amino acid sequence according to SEQ ID NO: 22 as 
follows: 
MNITPLTSAAGKGSSAQGTDKISIPNSTRMINAASIKWLNKVRSAISDHIRTSIEKGKLFELASLGSNM 
FGWPALSARPSTLQPWLAFEADPNHDLNLVRVYMODSAGKLTPWDPTPNAVTTTSNPSEPDAQSDTASS 
SLPRRPPAGSWLSLLGIALDHAQRHSPRADRSAKGRPGREERNGARFNAKQTKPTEAEAYGDHQTPNPD 
LHRQKETAQRVAESINSMREQQNGMQRAEGLLRAKEALQAREAARKQLLDWLEAIQAGREDSTDKKISA 
TEKNATGINYQ 
This protein possesses N-terminal Hop features (see U.S. AAB00126.1, which is hereby incorporated by reference in 
patent application Ser. No. 10/341,180 to Collmer et al., filed its entirety). 
Jan. 13, 2003, which is hereby incorporated by reference in 35 
its entirety), Suggesting that it is likely to be secreted, and A twelfth nucleic acid molecule encodes ORF13 and has 
has significant homology, as detected by BLAST analysis a nucleotide sequence according to SEQ ID NO: 23 as 
(5e-7), to a HrpA-like protein (Genbank Accession No. follows: 
atgcgcacatc.cgittaatggtotgcttgagcacagoctogaag accotgggctittgatactitcggcattg 
caggccttgcgcgacgacggittatttact.gtggcaaggcaaggataagcaa.gc.ca.gtc.ttctggttcc c 
totactgacgg.cgacgc.gctttitcgctatotgtaccttgagcc.gtgtc gatc.ccgag cacgacggacgt. 
citgctgg.cgcttgcattgcacctgaacctgtcticcitgtccacac gatgag cqcatgtatagodicttgat 
gtoga.gcaaaacacgttgttgtc.ttc.gctacacccatgaccttgg.cgggaacgggg cagataccctgttg 
cittgcgctogaaaacgcc caag.cgcttgctgaacagatcaag caggtaatcgaaaactittagg cacgat 
Cagggacgc.cgatag 
The protein encoded by this nucleic acid molecule has an 
amino acid sequence according to SEQ ID NO: 24 as 
follows: 
MRTSVNGLLEHSLKTLGFDTSALQALRDDGYLLWQGKDKQASLLWPSTDGDALEAICTLSRVDPEHDGR 
LLALALHLNLSPWHTMSACIALDWEQNTLCLRYTHDLGGNGADTLLLALENAQALAEQIKQVIENFRHD 
22 
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Because ORF13 shares features common to type III chap 
erones and is located directly upstream of hopPtoS1 
(ORF5), it is believed that the protein of SEQID NO: 24 is 
a type III chaperone for HopPtoS1. 
A thirteenth nucleic acid molecule encodes ORF14 and 5 
has a nucleotide sequence according to SEQ ID NO: 25 as 
follows: 
atgatcgc gttcgcaa.ccggactgctagaacacagoctdaaacggcttggatacgacgcc.gcagatttg 
caatcc ctitcgg gatgaaggg tatttgctgtggcacgggaaaaacgg to acaccagotctgttggtgccc 
gctgctgg.cgggatgcgcttitttgtcatcago accotgagctacatc gatcctgaacaggacggg.cgg 
citgctggcgcttgcgctgcatttgaacttgtc.gc.ca.gc.ccacactctggg.cgc.cagtatcgc.gctggat 
atcgagcaaaataccttgtgcctg.cgttacacgcac gaccitcactgggcacgg cacagacaatttgtc.c 
cgc.gc.gcttgaaag cactcaggc acttgcc gag cagatcaagcaggtoatcgaaactt.ccgcagtgaa 
titcggacgc.ccgc.caatgc.ccgc.ccacacagoccgacggccagatgcc.ctggcgctittag 
2O 
The protein encoded by this nucleic acid molecule has an 
amino acid sequence according to SEQ ID NO: 26 as 
follows: 
MIAFATGLLEHSLKRLGYDAADLQSLRDEGYLLWHGKNGHTSLLWPAAGGDALFWISTLSYIDPEQDGR 
LLALALHLNLSPAHTLGASIALDIEQNTLCLRYTHDLTGHGTDNLSRALESTQALAEQIKQVIETFRSE 
FGRPPMPAHTARRPDAWAL 
30 
ORF14 shares features common to type III chaperones and 
shares weak similarity with ORF8 of the DC3000 Conserved 
Effector Locus (“CEL) (U.S. patent application Ser. No. 
09/825,414 to Collmer et al., filed Apr. 3, 2001, which is 
hereby incorporated by reference in its entirety), which is a 35 
candidate chaperone for the protein encoded by CEL ORF7. 
Thus, the protein of SEQID NO: 26 is likely a chaperone for 
the protein of SEQ ID NO: 28. 
A fourteenth nucleic acid molecule encodes ORF15 and 
has a nucleotide sequence according to SEQ ID NO: 27 as 
follows: 
gtgaaaaagttctgg.cgctggaactcaa.gc.ctato.cgttgttc.gc.citctg.cgacgggaagctogtogaag 
ggcgttctaagtaccattgcc aggcaccitgacgg gatgttittgcacccaacaag acto cqcttcattca 
gcaa.cago.cgtttcgitatgagctattgcc.gggcaattattotgtc.gcc.gc.cagtgtgcatggcttgtcg 
gttgat caccgc.ca.gc.cgg.cgctgacacgactgagtaacgtgctgttcaatcaggcactggcgctggac 
citggag cqttittgacgaggg.cgc.gc.ca.gc.cgacgaaatgttcaggccitt cactgaaacgc galacgtgcc 
catcc.ccgattggc.cgact cactgggtggc gagcaactggctdtgcaaaccatggaga agggccittaaa 
cggctggcagaggatcc to cqcagtcc tittgcgc gatgcc attcatttittttaccc gatcagtagt gat 
accactitcaccitcaagcatcactitcattctgtgg.cgagct catctggctga 
The protein encoded by this nucleic acid molecule has an 
amino acid sequence according to SEQ ID NO: 28 as 
follows: 
WKKSGAGTQAYALFASATGSSSKGVLSTIARHLTGCFAPNKTALHSATAWSYELLPGNYSWAASWHGLS 
WDHRQPALTRLSNWLFNQALALDLERFDEGAPADEMFRPSLKREGAHPRLADSLGGEQLAWQTMEKGLK 
RLAEDPAQSFARCHSFFYPISSDTTSPQASLHSVASSSG 
24 
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This protein possesses N-terminal Hop features (see U.S. 
patent application Ser. No. 10/341,180 to Collmer et al., filed 
Jan. 13, 2003, which is hereby incorporated by reference in 
its entirety), Suggesting that it is likely to be secreted, and 
has significant homology, as detected by BLAST analysis 
(2e-92), to a putative protein of Ralstonia Solacearum (Gen 
bank Accession No. NP 518366, which is hereby incorpo 
rated by reference in its entirety). Furthermore, the protein 
of SEQ ID NO: 36 has been shown to be translocated by 
DC3000 in planta. 
A nineteenth nucleic acid molecule encodes ORF20 and 
has a nucleotide sequence according to SEQ ID NO:37 as 
follows: 
5 
10 
32 
WKINLPALRTTSSRVQICLTAVLLCTPLLFSAHAQAAGTASEQANVEVMI 
RQLNALEAVAQRSWDLPQDPAQRYHLDYPRLVSDIARIRQGLQDYLSPSR 
AQPRDPVELSGHYNWSGDHTP 
This protein possesses N-terminal Hop features (see U.S. 
patent application Ser. No. 10/341,180 to Collmer et al., filed 
Jan. 13, 2003, which is hereby incorporated by reference in 
its entirety), Suggesting that it is likely to be secreted. 
A twentieth nucleic acid molecule encodes ORF21 and 
has a nucleotide sequence according to SEQ ID NO: 39 as 
follows: 
atgc gttcCagg gttatalactacatcgctggtag to attatgctotcatgtgcatcago.cgcto cagot 
tgcttcto cqcaga catgacitcc cagogtgtcgaac gaga.gcacgtoggaggcggattitt cagdaatgg 
citggct acttitcc.gcagdaatgcaactactaagggcatcgacacago cacactic gatcttgcttitccala 
aa.catcacgcttgaccc.gactgtgcaccagttggatatgg.cgcaaccagagttcacgacggc catctgg 
gattatttgttctgaacgtctgacitc.cgaagaatato cago aaggg caggagcttctgcaaaaagagcca 
gttctgaacgaggtagagcgtcactacggtgtggatgc galagattatc.gcggc catctggtgtattgaa 
agcggctacggtaaggatattgg tagt cqc gatgtgatto gttcc ttggcc acgcttgcttaca agggc 
cggcggatggattacggggctacacagttgatggcc.gc.ccttcat atcgtgcaaaacaaaga catcgcc 
cgtgcgcaattgattggctic gtgggctggcgc gatggggcagacgcaattcatcc.cgacg accitat citc 
gacitat gcagttgattittalaccacgacaatcggcgc gacgtttggagttcc.cggg.ccgatgcgctggcc 
to cact gcct cittatttacaacgcagogcttggaactc.gc.gc.gtotcittggggacaggaggtgcagttg 
ccc.gagaattitcgattacgcticaggctgacatgtcgatcaagaa.gc.ccgttgcc.gaatggcaa.cggcto 
ggggtgatgggaac galagcaa.gc gatt.ccggg.cgagct cqCacaggagcaa.gcatcggtoct9CtgCCC 
gcaggittatcgcgggcc agcatttatggtoctaagtaattitcc.gtag catcctg.cgctataacaactcc 
actgcc tatgcgctaac gatcgggctactago.cgacagttatoctogcggg accqgcgtgtc.tcaccc.g 
tggccaactgataatcc toccittgggcago attgcgcaggtaaccgatttgcagaaactgctgactgct 
aagggctact coct gggtgctgctgacggtgttatagggg.cgatgaccoggg.cggc catc.cgggcttac 
cagaag gatcago atttgccaccc.gacggittacgc.ca.goactotact actoga gag cotgc.gc.cgatag 
The protein encoded by this nucleic acid molecule has an 
amino acid sequence according to SEQ ID NO: 40 as gtgaaaatcaatctoccc.gc.gcticagaacaacgtc.ttcacgc.gtgcagat 
follows: 
citgcttgaccgcagtcc togctgtgcacaccgctdct gtttitcc.gc.gcatg 50 
cc.cagg cago.cggcacggcttctgaacaa.gc.caatgtggaagtgatgatt 
cgtoagctcaacgc.gctic gaggcc.gtogcc.ca.gc.gcagtgtc.gatctitcc 
acaag accoggcc.caacgctato acctggacitat coccggttggtoag.cg 
acatc.gc.gc.gcatcc.gc.cagggcttgcaagacitacctgtc.gc.cgt.ccc.gc 
gcacago.ccc.gc gaccc.cgtggagctato aggcc attacaacgtoag.cgg 
tgat cacacgc.catga 
The protein encoded by this nucleic acid molecule has an 
amino acid sequence according to SEQ ID NO: 38 as 
follows: 
55 
60 
65 
MRSRVITTSLWWIMLSCASAAPACFSADMTPSVSNESTSEADFQQWLATF 
RSNATTKGIDTATLDLAFONITLDPTVHQLDMAQPEFTTAIWDYLSERLT 
PKNIQQGQELLOKEPWLNEVERHYGWDAKIIAAIWCIESGYGKDIGSRDV 
IRSLATLAYKGRRMDYGATQLMAALHIVQNKDIARAQLIGSWAGAMGQTQ 
FIPTTYLDYAWDFNHDNRRDVWSSRADALASTASYLQRSAWNSRWSWGOE 
WQLPENFDYAQADMSIKKPWAEWQRLGWMGTKQAIPGELAQEQASWLLPA 
GYRGPAFMWLSNFRSILRYNNSTAYALTIGLLADSYAGGTGWSHPWPTDN 
PPLGSIAQWTDLQKLLTAKGYSLGAADGWIGAMTRAAIRAYQKDQHLPPD 
GYASTWILLESLRR 
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This protein has significant homology, as detected by 
BLAST analysis (1e-106), to a putative transglycolase from 
Pseudomonas aeruginosa and Ralstonia Solanacearum (re 
spectively, Genbank Accession Nos. NP 252681 and 
NP 522801, each of which is hereby incorporated by 5 
reference in its entirety). 
A twenty-first nucleic acid molecule encodes ORF22 and 
has a nucleotide sequence according to SEQ ID NO: 41 as 
follows: 
atgcttgctoctogacgg.cgtagaaatcgatat cqtgctato aggtatatgcggaacto atctgg.cggta 
ttgtcggg.ccgtgaaggtggagaggtoggcattatacgcgggcacgaag cagttgg catt attatc gat 
gtaggtaaggatgtag tacaccitacaaaaagg gatgcgggtggtggttgatcc caacgaatact.gtggc 
gtttgc galaccittgcc.gtc.ttgctaaaacgcaccitatgcaatgggggggtgaacgctdggttggatato 
gcaggtgtcaacaaacatggaacttittgcc gag.cgctt.cgttact.cgtgagcgttttgttgttatcaattg 
ccagacgatatgagctggg cagotggtgttgttggttgagcctdttgcctgcattctgaataatatagac 
caggcgttcattcgagcgg gaga.gc.gtgttgttgatcc tagggtotggcc citatgagtctgattgcgcag 
atcgttctg.cgctdaatgggagttgacacgctic gocactdatcgaaacacacatc.gcatacagttcggc 
cgct cacaaagt cittgatgttatacatgcc gatgat cittgagttgcagatgcago:accaagaaaagttt 
gatgttgttatcgatactgtcggtaatcagat.cgatacagottcacgctacatcggtogcggtoggaga 
attgtactttittggatttgatagtgacitat cactacatgctgcct gtaaagtact tcc to gttaacgct 
atcagtattatttctgctggagaatacaatcago acttitcctagagcaatticgtottgttgcaaaaactt 
cctgagctaggg.cggctggtaacgcatc.gctacgtact agaaaatcacticggaggtttitc gatgcactt 
citgaacgatgctitcc.gc.ccc.caatataaaaag.cgitattoacaccaaatctogcttatctittaa 
The protein encoded by this nucleic acid molecule has an 35 
34 
amino acid sequence according to SEQ ID NO: 42 as 
follows: 
MLAPDGWEIDIWLSGICGTDLAWLSGREGGEWGIIRGHEAWGIIIDWGKD 
WWHLQKGMRVWWDPNEYCGVCEPCRLAKTHLCNGGVNAGLDIAGVNKHGT 
FAERFWTRERFWYOLPDDMSWAAGVLVEPVACILNNIDQAFIRAGERVLI 
LGSGPMSLIAQIVLRSMGWDTLATDRNTHRIQFGRSQSLDWIHADDLELQ 
MQHQEKFDWWIDTVGNOIDTASRYIGRGGRIWLFGFDSDYHYMLPWKYFL 
40 
45 
-continued 
WNAISIISAGEYNQHFPRAIRLVOKLPELGRLWTHRYWLENHSEWFDALL 
NDASAPNIKSWFTPNLAYL 
This protein has significant homology, as detected by 
BLAST analysis (2e-18), to a putative sorbitol dehydroge 
nase (Genbank Accession No. NP 389115, which is hereby 
incorporated by reference in its entirety). 
A twenty-second nucleic acid molecule encodes ORF23 
and has a nucleotide sequence according to SEQID NO: 43 
as follows: 
atgaaagttactgtattoagtcagatatocaattgatggcaagttgacgatgggcaaag.gc.gcatccago 
aag.ccgttgtttcagaactittgatgatgatgacatgc gttittattoataagttcc.gc.ggcgaagttcgac 
gcaat catggtaggg.cgcaataca attgttactgacgatccaca attgaccaatcgctatoagtcgggit 
cgtaaccoaatacgitatcattcccaccaccitccittagatctgcc tactitcc.gc.cagtattittcaaatca 
ccagagaaaactattatcgcaactagogaac aggctcgtgat catgaaatggtoaaacatato.cgtgct 
tgtggaaag gaggtoctotttgcc.ggtgcaaag catgtcgacitttacacg acttittoccitatgctggag 
gcqc.gcggaataalaccacat catggttgaggg.cggtggccacctgaactggcagg tattoaatcto gat 
citggtagatgaaattatact catgcaggtgccitat catcataggtogtgcggcaactgcaacgcttgct 
gacggggtggggt atcgggatato aa catggccaattic gtttacgctgcatoctittagaag cacgc.ccc 
cattacaatctoratgcacttcaag.cgcgaatcgaacaatcggagcc.cgtact ga 
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The protein encoded by this nucleic acid molecule has an 
amino acid sequence according to SEQ ID NO: 44 as 
follows: 
MKVTVFSQISIDGKLTMGKGASSKPLFONFDDDDMRFIHKFRGEWDAIMV 
GRNTIVTDDPQLTNRYESGRNPIRIIPTTSLDLPTSASIFKSPEKTIIAT 
SEQARDHEMVKHIRACGKEWLFAGAKHVDFTRLFPMLEARGINHIMVEGG 
10 
GHLNWOWFNLDLVDEIILMQVPIIIGGAATATLADGWGYRDINMANSFTL 
HALEARPHYNLMHFKRESNNRSPY 
This protein possesses N-terminal Hop features (see U.S. 
patent application Ser. No. 10/341,180 to Collmer et al., filed 
Jan. 13, 2003, which is hereby incorporated by reference in 
its entirety), Suggesting that it is likely to be secreted, and 
has significant homology, as detected by BLAST analysis 
(8e-38), to a riboflavin specific deaminase (Genbank Acces 
sion No. NP 213307, which is hereby incorporated by 
reference in its entirety). 
A twenty-third nucleic acid molecule encodes ORF24 and 
has a nucleotide sequence according to SEQ ID NO: 45 as 
follows: 
15 
25 
atggag caggaaaagagttcc tdtttgcgctacggcgtgaccottaatga 
aaaagatctgtcacgttttittgg galactacacago act acatgtggagca 30 
cgattaaaaatgagtacgc.gctcactgaatcCatcgacCacttgatggca 
cago atcaiacagdaattaatgcgct caatcagttittgaattgtttcaatc 
catgcctggcgtggaggcgcttctoaatttactggagcataccggagtgc 35 
cctgtgcc.gtag cotctitcgtc.tccacgtaatttgg to gagcttatattg 
aagaaaacgaaattgcgtcgatttittcaaagaggittatttgttggtactga 
tgttaaagagagtaaac cqaatc.cggagatttittcttacggcggcca agg 40 
gacittggagtgtcaccitcgtgcatgtctggittattgaagacitcc.cat cac 
ggtgttaccgctg.cgaaggcc.gc.ccatatgttttgtataggtttgcgtoa 
titccagotcatttcago aggatctgag cqctgct gatctgatcgc.calata 45 
atcattatgacatcaa.gcaatggtttgcagaaaaatag 
The protein encoded by this nucleic acid molecule has an 
amino acid sequence according to SEQ ID NO: 46 as 
follows: 50 
MEQEKSSCLRYGWTLNEKDLSRFLGTTQHYMWSTIKNEYALTESIDHLMA 
QHQQQLMRSISFELFQSMPGWEALLNLLEHTGVPCAVASSSPRNLVELIL 55 
KKTKLRRFFKEWICGTDWKESKPNPEIFLTAAKGILGWSPRACLWIEDSHH 
GWTAAKAAHMFCIGLRHSSSFOODLSAADLIANNHYDIKQWFAEK 
This protein has significant homology, as detected by 60 
BLAST analysis (5e-32), to a putative phosphatase from 
Clostridium (Genbank Accession No. NP 347269, which is 
hereby incorporated by reference in its entirety). 
A twenty-fourth nucleic acid molecule encodes ORF25 
and has a nucleotide sequence according to SEQID NO: 47 
as follows: 
65 
36 
atgaatgc gttc.gcaa.ccggtoagcttgaatacagoctoaaaaagctggg 
atacgatgcc.gc.cgctttgcaggcc.ctd.cgcgaagaaggg tacttgctdt 
ggaaagggaaaaacgaccagaccagottgctggit gcc.citcggc.cgatctg 
gatgcacttittcgittatcaiacac gttgagctacatc gaccc.cgag catga 
cgcacgtotgctggcgcttgcattgcaccitta acctgtc.ccctgtccata 
cgatgagc.gc.ctgcatagoccitc gatgtcgagcaaaacacgttatgcctg 
cgctacacccatgaccttggcgg gag.cggggctdataccctgttgcttgc 
gotcgaaaacgcc caggcgctggcc.gaacagg to aggcaggtogatcgaaa 
cc titcaggcgtgaccalagg gogtc.cgtocgggcaaacgtc.tttgtc.ccgg 
caatccagtgctctgatgc gataa 
The protein encoded by this nucleic acid molecule has an 
amino acid sequence according to SEQ ID NO: 48 as 
follows: 
MNAFATGQLEYSLKKLGYDAAALQALREEGYLLWKGKNDQTSLLWPSADL 
DALFWINTLSYTDPEHDGRLLALALHLNLSPWHTMSACIALDWEQNTLCL 
RYTHDLGGSGADTLLLALENAQALAEQWRQVIETFRRDQGRPSGQTSLSR 
QSSALMR 
This protein shares features common to type III chaperones 
and is a putative chaperone for the product of ORF26 
(described below). 
A twenty-fifth nucleic acid molecule encodes ORF26 and 
has a nucleotide sequence according to SEQ ID NO: 49 as 
follows: 
atgaaaat atcc.ggctocacatcgcc to cacacacttcaac gaattcc.gc 
gcagaagticcitcttcaaaagggctgctdagtggitttggccaag catttca 
aggggatgctic gtttctggcaac acttctggtoatt.cgg.cgctcqgg cat 
tacgc.gtocatccago agcggctocaaaggcaagg caccggtacgggacga 
ttacagdaacggaccgcaaac acgc.cittaacaac acaccitctgaaacgag 
cactgg ccc.gaga.gcttgatcgctttggctacggttcatcggc gacc gag 
tottttgaccgct cattgcagogtaaggataaaaatccagagcttgggaa 
ggtotga 
The protein encoded by this nucleic acid molecule has an 
amino acid sequence according to SEQ ID NO: 50 as 
follows: 
MKISGSTSPAHTSTNSAQKSSSKGLLSGLAKHIFKGMLWSGNTSGHSALGH 
YASSSSGSKGKAPWRDDYSNGPOTRLNNTPLKRAL.ARELDRFGYGSSATE 
The protein of SEQ ID NO: 50 has been shown to be 
translocated by DC3000 in planta. 
A twenty-sixth nucleic acid molecule encodes ORF27 and 
has a nucleotide sequence according to SEQ ID NO: 51 as 
follows: 
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A twenty-ninth nucleic acid molecule encodes HopPtoS2 
(ORF30) and has a nucleotide sequence according to SEQ 
ID NO: 57 as follows: 
atgaatataaatcgacaactgcctgitatcaggctcqgagc gattgttgacitcc.cgacgtggg.cgitatct 
cgcc aggcttgttc.cgaaagg cattattotactggacaggatcgg catgatttittaccgttittgct gcc. 
aggctacatgtggatgcgcagtgttittggtctgtcaatagacgatttgatggataagttittctgacaag 
cactitcagggct gag catcctgaatacagg gatgtctato cqgaggaatgttctgc catttatatgcat 
accgctcaag actattotagt caccitcgta aggggggaaataggaacgcc.gct gtaccga gaggtoaat 
aattatctitcgacittcaa.cat gaga attctgggc gaga agctdaaattgataatcacgacgaaaagcta 
togcct cacataaaaatgctttcatctg.cgcttaatcgtttaatggatgtc.gc.cgcttittagaggaacg. 
gtttatagaggcattc.gcggtgatttagataccattgctoggctotaccatctattogatacgagcggc 
cggtacgtagagcc.cgctttcatgagtaca acto gaataaaggacagtgcc caggtgtttgagc.caggc 
acgc.caaacaa.catagotttccagataagcctaaaaag aggc.gc.cgacatttcgggat.ct tcc.caag.cg 
cc citcagaggaagaaatcatgct acco atgatgagtgagttcgtoattgaacatgcatcc.gctotttcc 
gaaggaaag catttatttgtattaagttcagatttga 
The HopPtoS2 protein encoded by this nucleic acid mol- 25 
ecule has an amino acid sequence according to SEQID NO: 
58 as follows: 
MNINRQLPWSGSERLLTPDWGVSRQACSERHYSTGODRHDFYRFAARLHVDAQCFGLSIDDLMDKFSDK 
HFRAEHPEYRDWYPEECSAIYMHTAODYSSHLVRGEIGTPLYREWNNYLRLQHENSGREAEIDNHDEKL 
SPHIKMLSSALNRLMDWAAFRGTWYRGIRGDLDTIARLYHLFDTGGRYWEPAFMSTTRIKDSAOVFEPG 
TPNNIAFQISLKRGADISGSSQAPSEEEIMLPMMSEFWIEHASALSEGKHLFWLSQI 
HopPtoS2 has been shown to be a protein that is secreted by ADP-ribosyltransferases, it was determined to possess an 
DC3000. HopPtoS2 has significant homology, as detected ART domain (pfam1129). In addition, HopPtoS2 has 20.5% 
by BLAST search (1e-5), to Clostridium exoenzyme C3 identity to the HopPtoS1 as determined using EMBOSS 
ADP-ribosyltransferase, (Nolling et al., J. Bacteriol. 183: 40 software. 
4823–4838 (2001); GenBank Accession No. NP 346979, A thirtieth nucleic acid molecule encodes HopPtoS3 
each of which is hereby incorporated by reference in its (ORF31) and has a nucleotide sequence according to SEQ 
entirety). Further confirming that HopPtoS2 has similarity to ID NO: 59 as follows: 
atgaatatoagtcc totatogggtgcc.cacggtag cago tacccittcagotcaatccacago atcgacg 
gcatcgaaaggtoccitctggatcc tittct caaacagotcggcggctgtttitt caccctgcctgggtagc 
agctotactggggccatactittct cocqctcat gag cagg tattgagccacaccitatto.ca.gcaatatt 
aaaggaaagttgcgcacgacgc.ccc.caaaag gaccg.tc.gc.ccaggttgtctgacacaccitatgaagcag 
gcqctttcttcaatgatcgtacaggagcgaaaacggcttaaaagttcaa.cccaagt cattggcc toggat 
atagaacgtccagacagtatgatcaaaaaag.cgcttgatgaaaaagacggccaccc.gtttggc gag.cgc 
ttittcagacgacgaatttcttgcg attcatctotatacgagctgtctittatagg.ccg atcaatcatcat 
ctg.cgg tatgcc.ccgaacaatgatgttgcaccggttgtc gaggcactgaaaagtggtttggcaaagctt 
gctcaag accotgattatcaagtgtctagocagottcatagagg catcaa.gcaaaagatgagtgatggc 
gaggtoatgagtcgtttcaaac cqggtaag accitatcgtgatgaag.cgttcatgagcacatcaactoat 
atgcaggtttcagaag agtttaccto cqacgttacgttgcacct gcigg to citcatcagotgtcaatata 
ggc.ccctttitcgaaaaatccatac gaggacgaag.cgcttatctogc.ccctgacgc.ctittcaaagtaacc 
ggtotg.cgcaa.gcaggacgataagtggcacgtogatttgaac gagatagoagata attcagacgagtga 
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HopPtoS3 has an amino acid sequence according to SEQID 
NO: 60 as follows: 
46 
MNISPWSGAHGSSYRSAQSTASTASKGPSGSFLKQLGGCFSPCLGSSSTGAILSPAHEQWLSHTYSSNI 
KGKLRTTPPKGPSPRLSDTPMKQALSSMIVQERKRLKSQPKSLASDIERPDSMIKKALDEKDGHPFGER 
FSDDEFLAIHLYTSCLYRPINHHLRYAPNNDWAPVVEALKSGLAKLAQDPDYQVSSQLHRGIKQKMSDG 
EVMSRFKPGKTYRDEAFMSTSTHMQVSEEFTSDWTLHLRSSSAVNIGPFSKNPYEDEALISPLTPFKVT 
GLRKQDDKWHVDLNEIADNSDE 
HopPtoS3 has significant homology, as detected by BLAST 
analysis (5e-3), to chicken ADP-ribosyltransferase 
(Tsuchiya et al., J. Biol. Chem. 269:27451–27457 (1994): 
Genbank Accession No. P55807, each of which is hereby 
incorporated by reference in its entirety). Further confirming 
that HopPtoS3 is an ADP-ribosyltransferase, it was deter 
15 
mined to possess an ART domain (pfam1129). In addition, 
HopPtoS3 has 71.7% identity to HopPtoS1 as determined 
using EMBOSS software. 
A thirty-first nucleic acid molecule encodes ORF32 and 
has a nucleotide sequence according to SEQ ID NO: 61 as 
follows: 
atgaatattaa.ccct tcc ctggg.cgctdatggcagogcc tactcgtc.gc.citcaaagtgatactitcgaag 
gcc actdgaaaag cacct go go cittcttttittcaaac agttggg.cggctgtttitt.cgc.cgtgccttggit 
toccatgcgtoaa.gcago caacaactgtcc.gc.cagtcatgcgcagacgcticagtcagaattactic cago 
aac attcaggggacgagcc.gcacacgc.ca.gcc.gagag cacccitc.gc.cacgc.ctgtcagatacgcc catg 
aag caggcgctitt cottcaatgatcgaacg.cgagcgtttgcggcttcaaggtotttcgg gaggaatgttc 
toggg cattgacitcc.gc.cgatgcc atgattgg to gag cqcto acgaagaaggattcaaaccolaaaggct 
gcqcgttittagtgatgatgagtttctic.gc.cgttcaccitctacacaacttgccitctacagaccitat caat 
catcatctitcggitatcaacactag 
35 
40 
45 
50 
55 
The protein encoded by this nucleic acid molecule has an 
amino acid sequence according to SEQ ID NO: 62 as 
follows: 
MNINPSLGAHGSAYSSPQSDTSKATGKAPAPSFFKQLGGCFSPCLGSHAS 
SSQQLSASHAQTLSQNYSSNIQGTSRTRQPRAPSPRLSDTPMKQALSSMI 
ERERLRLQGLSGGMFSGIDSADAMIGRALTKKDSNPKAARFSDDEFLAVH 
LYTTCLYRPINHHLRYOH 
This protein has significant homology, as detected by 
BLAST analysis (5e-3), to chicken ADP-ribosyltransferase 
(Tsuchiya et al., J. Biol. Chem. 269:27451–27457 (1994): 
Genbank Accession No. P55807, each of which is hereby 
incorporated by reference in its entirety). Further confirming 
that protein of SEQID NO: 62 is an ADP-ribosyltransferase, 
it was determined to possess an ART domain (pfam1129). In 
addition, this protein has 51.3% identity to HopPtoS1 as 
determined using EMBOSS software. 
A thirty-second nucleic acid molecule encodes ORF33 
and has a nucleotide sequence according to SEQID NO: 63 
as follows: 
atgagctic gatcacgcacacca acacgcc.gcaattgg.cggtoag.cgatto acggggtotgc.cggtacgc 
agtgtgcagttctato gtgg.cgct gatgg to agcctgttgacgc gagggtgacgcago act attitcgac 
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The protein encoded by this nucleic acid molecule has an 
amino acid sequence according to SEQ ID NO: 64 as 
follows: 
MSSITHTNTPOLAVSDSRGLPWRSWQFYRGADGQPWDARVTOHYFDKAGRLIASR 
PWNLMQIWSLSGALLLSKSWDSGWRVSLNGEAGQLVDSCDGRDNPRQIEYDGLLR 
583 B2 
50 
The protein encoded by this nucleic acid molecule has an 
amino acid sequence according to SEQ ID NO: 66 as 
follows: 
DPRFSSRLKYGWCA 
PLAINESGRMTERF 
TYGGPATEAHNOCNOLIRHDDTAGSRLLRDYGLSGRALSEKRYFLOSPDSPDWPLAEPDRDALLEPWGL 
QTRWAFNAQGEDLAOTDANGNVQRFSHGVAGQLHAVELTLANTAORQTLWSAIHY DAFNQAEQETAGNG 
WWSRYWYDQQDGRLTELSALSADGSVLQKLNYSYDPAGNWLLINDASQPDRYCGNORIEPINRYCYDTL 
YQLIEATGREWRNGASHGPALPGLQPLPTLDPCOWSNYTORYSYDAAGNLLQMRH 
DSNRSLPDNDRYWDFATSFDANGNLLQLVRGQTMSWDWRNOLRQITTVQREDAPN 
RKISTAQASGRTLTNEWRYLPGLEWRTTADGETLHWWTAQAGRNSWRVLHWEAGK 
DHLGSSTLELDQQGGLISQESYYPFGGTAWWAARSAWEAKYKTVRYSGKERDASG 
EGAHNFTRNMHWDP 
PGAIANDQWRYSLG 
RWINPDPAGDVDGLNLYRMVRNNPLWYWDAKGQQPEPWPKTIHQIWIGENKNALRAQVSNINRTVEMAW 
GYKWKLHLETRTPEAYSEIEKDLRSEWWLLPDSOVFQNFKEKPLYAAYEDFRRNNONYAFAWDVLRMHT 
WHELGGIYSDVDDWYAGAETGGMTQLGDNPLFAEPDEWLTLDPWHVPWEPQNSWESFMVNNSSFAAHSG 
AGWLLDMMGEGAKRYDEAWEGGSYPDPTGMNGIGLSLLWNPNPAWRWRTLSNWWGPGLFTDTLHASDTA 
YGELFSNLKGWWFOKQPFTFADQMARKMPLHRHIKSGAAQTWR 
This protein has significant homology, as detected by 
BLAST analysis (1e-128), to SepC insecticidal toxin (Hurst 
et al., J. Bacteriol. 182:5127–5138 (2000); Genbank Acces 
sion No. NP 065279, each of which is hereby incorporated 
by reference in its entirety). This protein also has significant 
homology (2e-128), as detected by BLAST search, to puta- a 
tive insecticidal toxin from Yersinia pestis (Parkhill et al., 
Nature 413:523-527 (2001); GenBank Accession 
NC 003143.1, each of which is hereby incorporated by 
reference in its entirety). 
45 
A thirty-third nucleic acid molecule encodes ORF34 and 
has a nucleotide sequence according to SEQ ID NO: 65 as 
follows: 
MPITAQQLLQILPSAGQKAGVFAPWLNTAMSKHQILTPLRIAAFIAQVGH 
ESGQLRYVREIWGPTPQQLGYEGRKDLGNTWAGDGSKYRGRGLIQITGRA 
NYAECGEALGLDLIHHPELLEQPEHATMSAAWYWSSRGLNSLADKGDFLQ 
ITRRINGGTNGLADRQALYDRALKVLA 
This protein has significant homology, as detected by 
BLAST analysis (3e-36), to a lytic enzyme (Nakayama et 
al., Mol. Microbiol. 38:213–231 (2000); Genbank Accession 
No. BAA83137, each of which is hereby incorporated by 
reference in its entirety). 
A thirty-fourth nucleic acid molecule encodes ORF35 and 
has a nucleotide sequence according to SEQ ID NO: 67 as 
follows: 
atgc.cgatcaccgc.gcagoagttgctgcagatacticco gag.cgctggcc agaaag.ccggc gtttittgca 
cc.cgtoctogalacacago gatgagcaag caccagatcttgacgcc.gctg.cgcatc.gcggctitt catcgcc 
caggtogg to atgagtc.cggccaactg.cgctacgtocgc.gagatttggggg.ccgacitcc.gcago agctg 
ggittatgaaggcc.gcaaggacct cqgcaat accgtggcgggtgatggttcgaagtaccgcggg.cgcggC 
citgatccagatcaccggcc.gggccaactatocc gaatgcggc gaggcgctggg cctag acct gatc cat 
caccc.ggaactgctic gag cago.cggag cacgc.cacaatgtcgg cagogtgg tactggagcago.cgtggc 
citgaactc.gctggc.cgacaaagggg actttcttcaaattacco gaagaatcaacggaggcaccalatgga 
Ctgg.cggatcgg Caggcgctgtacga.ccggg.cgctgaaggtgctggcgtga 
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TTFTRIPWDQRTPDMKALADEWTMTVQINLAIGIARRGQRQEALALLDRLQPWASGSPERQLTLASAYI 
DAGEPARGREMARAAIAQAPLPSADLMLQYAGLLLAAGDDWOWNAILRNVQGQPMSWQTRKRFDDLLYR 
YRIRQADLLREGGDLAGAYDTLAPALAQRPDDIQAVSAFARMYTANGDSARAFELYKPLLQRQPNDPOW 
LLGAADAAVKAHDYGFAEKALSQFRKLERNDPQTLTEAARIYQSMGQTGAATELLRKAVAIEQSEKQRA 
MAWQAVSTSTTSSNPFATGGSRSLAAASAIPAPAQVSLSGGRALETNSAPEISAPRDTAYPGQIAAPQP 
LSAARTQSWRGNPFMAATDRDOASSAQQALNRILEQRSGFWSQGLAVRSNNSESGLSKLTWWETPLEVN 
LPAGDNRWAVRVTPWSLNAGSLKSDAGARFGGGTSGAAGSQSDKGWGLAWAFERPEEGLKADIGTTPMG 
FKYTTWAGGASWDRPLGNNPDLRYGLNWSRRPVTDSWTSFAGSTDERSGLSWGGVTANGGRGQLSYDDQ 
TIGGYGYGSWHKLVGNNVKSNTRGEWGGGVYWYLRNAEDSKLTAGLSLMGMSYDNDQSYFTYGHGGYFS 
AGEYKLDSSLFMGASLGLDNARDYROFSGALYLRYMFEDITGPLALPWSPYRSPYSN 
This protein possesses N-terminal Hop features (see U.S. fluorescens (Spiers et al., Genetics 161:33–46 (2002); Gen 
patent application Ser. No. 10/341,180 to Collmer et al., filed Bank Accession P58937, each of which is hereby incorpo 
Jan. 13, 2003, which is hereby incorporated by reference in rated by reference in its entirety). 
its entirety), Suggesting that it is likely to be secreted. This A thirty-seventh nucleic acid molecule encodes ORF38 
protein also has significant homology (e=0), as detected by and has a nucleotide sequence according to SEQID NO: 73 
BLAST search, to cellulose synthase from Pseudomonas as follows: 
25 
atgaaactgatacgacagat.ccgctogcagggtogtoagtc.gcc cittgttcgagg accittgcc cagotc 
gagggg.cgcaa.gcgtcaatggctggc.cgagcgc.gc.cgtgcagttcgcactgggcttgcacggcc.gc.cgg 
ccagaggtogata accocittcaaaggcaaactg.cgtgaagacct gtgctgcatcatgttcgatgacctg 
togctgcacaccctdgtogagc gttacgcggcc agtgaag.ccct gcigacgacacgacago gagtacttic 
agcaaactgatc.gc.cacgacac gaaataccgtggaacgg.cgcatcgtotttcacgggctgctggalacac 
titcgacaggctgttgccitatcgaaaagag catctaccaactcaact accgcagogttcaatacgc.gcac 
citggagcaggaagaa.gc.cct gtacggcaaactgataatggaacaa.cccattagtgcactgctggaagtg 
cacacgc.ctgagtggcttcttgagaatctgtc.ttcgtttgagttitt.cgattgattga 
The protein encoded by this nucleic acid molecule has an 
amino acid sequence according to SEQ ID NO: 74 as 
45 follows: 
MKLIRQIRSQGRQSPLFEDLAQLEGRKRQWLAERAWQFALGLHGRRPEVD 
NPFKGKLREDLCCIMFDDLSLHTLVERYAASEALRRHDSEYFSKLIATTR 
50 NTVERRIVFHGLLEHFDRLLPIEKSIYQLNYRSWQYAHLEQEEALYGKLI 
MEQPISALLEVHTPEWLLENLSSFEFSID 
This protein possesses N-terminal Hop features (see U.S. 
55 patent application Ser. No. 10/341,180 to Collmer et al., filed 
Jan. 13, 2003, which is hereby incorporated by reference in 
its entirety), Suggesting that it is likely to be secreted. 
A thirty-eighth nucleic acid molecule encodes ORF39 and 
has a nucleotide sequence according to SEQ ID NO: 75 as 
follows: 
atgcg actoactactaaaggcc gatacgctgttgacago catgcttgacct gg.cgitta catgcgcagaac 
gggcc agtgtc.tctggcc.gacatctocq agcgg cagggcatttc.cctgtc.ttatcto galacagttgttc 
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ALLFPEACVOLAYAEAAQAPSAAGEWSWLQQHARHHQISLNTWFQQAQGYAAENNLPSLRVPERTIHAW 
RNSSTPQLVSTILFDPTPPKPAQYIAAASNVFOSEFFLALKRMIREHGTGPSYWOQIMDWSLSDASALY 
GELAR 
This protein possesses N-terminal Hop features (see U.S. 
patent application Ser. No. 10/341,180 to Collmer et al., filed 10 
Jan. 13, 2003, which is hereby incorporated by reference in 
its entirety), Suggesting that it is likely to be secreted. 
A forty-third nucleic acid molecule encodes ORF44 and 
has a nucleotide sequence according to SEQ ID NO: 85 as 
follows: 
atgaag cagotcgcggcaggcagdaatgtgcatottcttgaaaatgagt ctitt coagatagataaggtg 
cgctttittgggggccacagottggacagattitc.gcaac aggtogaaag.cgtgtaccaag.cgtoccaggag 
gcaaggcgaggcatcaatgacttitcgcttgatcc.gtgcaggc gagggittaccgc.gcattgag catcagt 
gatgttgat cagtcgaaatcatcgaacttacgagtggctcaaggaagagctogc catggagttcgatggit 
cagaccattgtcatcactcatcattgc.ccgttggtoaattact.gtggcc.ca.gagcagggcto accgcta 
atgcct gottattoaaatgattggccagaactic gttcg to aggct gatgtgtgggtotttgggcacacg 
cacagt catgtc gatgtcatggtggaaggatgcc.gact cattagtaaccotagaggittatcCaggtgag 
agttgcggctittgccaatgacitttgttggtogatattalactag 
30 
The protein encoded by this nucleic acid molecule has an 
amino acid sequence according to SEQ ID NO: 86 as -Continued 
CPLWNYCGPEQGSPLMPAYSNDWPELVROADWWWFGHTHSHVDWMVEGCR 
follows: 
35 LISNPRGYPGESCGFANDFV VDIN. 
This protein possesses N-terminal Hop features (see U.S. 
MKQLAAGSNVHVLENESFQIDKWRFLGATAWTDFATGESWYOASQEARRG patent application Ser. No. 10/341,180 to Collmer et al., filed 
Jan. 13, 2003, which is hereby incorporated by reference in 
its entirety), Suggesting that it is likely to be secreted. 
A forty-fourth nucleic acid molecule encodes ORF45 and 
has a nucleotide sequence according to SEQ ID NO: 87 as 
follows: 
MINDFRLIRAGEGYRALSISDWISRNHRTYEQLKEELAMEFDGQTIVITHH 40 
atgacgctgacgcagogt Cagg catggcatcgc gagg cacagcggtttgg.cgagCaggtggtgaacatg 
cgcaaag.ccagdaaggcgcactitcggc.caggcggaaaatgacago.cgcaccitatc.cggc.gc.gctittatc 
gaccagdaactggctoaactgctgaaccq gottatc catcgctgcaacggcgcaa.ca.gatcaat atttca 
citgacctacaggacgggcaccgaagtgctic gaaattic coggcgc.gc.ct gtattgc.ca.gaalacc.gagacc 
gagaacgtttcactcaggcaactggtgcatacccaggcc ctd.cgcaccaaggccaaggatgcc.gtgctt 
citacgc.gctgtcgacgcc galagg.cgt.ccc ccttgcgc acttggacaag caggcc.gta accq agctgatt 
gcc acgctggaagatcaccgatacct cagtgattaccttgacct gcacctgaaaaccitcgg.cgitatgca 
cagoagctoaa.gcggtoagaaaaag.ccatgttgcaa.gcticagatgaagatgg.cgctgctggagat.cgag 
caa.caggcttittgcaccago.cggtogcgagtggat.ca aggctgtgctggattic.gc.ca.gc.ccc.ccaagga 
cgtcgalaccatgg caggggaaag cattgaagtc.cgttttittcagogtcaiaccalattcaagatgaccaat 
gtoatgctgattgcto cago.cggtaaattic gagaagggg.ccgctggtgctittgcacgctggatgctitcc 
gacggtgtggtttitcc.gctggtttaa.cagoatgitatcacct gaccaccagotttctggaag aggcaccc 
titc.ca.gcagtatctgatticagoaaataccggtttcCagg cqtcttgagacgctgcatgc catgcagtac 
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SDIPWEEPKLDIEQVNQQSLRLIRLALLAGFWGALYLVWAELITVFAYLDNIILYEYTSGTGANMSMVP 
ISLSDFLGAGVIIWITFWLAGNLPGLLEWLVLSRMNLAQGSAYATTTLLSYTIAGIGFWTTLSTLGWSW 
DKLQWLVAALSWGLGFGMQEIFANFISGIMILFFRPVRIGDTITIGALSGTVSKIRIRATTITDFDRKD 
IIVPNKTFITGOLINWSLTDTWTRVTLKLGVDYGSDLDLVRSLLLQAARENPRVLKEPEPIWYFLNFGE 
STLDHELRMHVRDLGDRNPVLDEINRFINREFKKQHINISFROMEIYLKNTOGLEYKLVPAEPGEKHGA 
PAGQTTLQPWNTKVAPATKDAPRPPERLRD 
15 
The protein possesses N-terminal Hop features (see U.S. Yersinia pestis (Parkhill et al., Nature 413:523-527 (2001); 
patent application Ser. No. 10/341,180 to Collmer et al., filed GenBank Accession No. NP 406604, each of which is 
Jan. 13, 2003, which is hereby incorporated by reference in hereby incorporated by reference in its entirety). 
its entirety), Suggesting that it is likely to be secreted. This A fiftieth nucleic acid molecule encodes ORF51 and has 
protein also has significant homology (e=0), as detected by 20 a nucleotide sequence according to SEQ ID NO: 99 as 
BLAST search, to putative potassium efflux system from follows: 
atgtcaacgttgaatcatacgtctgctgtaaattgcc.gc.gtoagttittgatggtgaccgttgctatota 
gacaccc.cc ditccagatcat gcc.gggtgagc gatgggct gtaaatato gtacctaac gatttagt caca 
atcCactacgaggcc.gc.cagdaatcacgact accotttgctgctggccagoataaaaaatctgtttacc 
gatgagc gttgttgtc.gtgctaaag.ccc.ggccttacacagoaa.gctttgaacatgitatttitt cagaggitt 
aacagocittaa acctaacgc.gact catgttcgcttgttgcatcgag cqcagogtatttittctagaaaac 
atgatcc.gtag cqtacagata accitc.gcaaggitat cagogtcacttitcgcaa.ccgcc gaattcaaaaat 
tatalactaccagotaaaggtggataaatatacttittgcaaggcttgacaagggg.taccctcitctattog 
gagctggttgaaaacaccitggataac gaaattatc.cgtagcc cataatattotgitatto catctotgtg 
agcctggaccacticaag cacaccittatacacttittitt caggaac cotcgcggaag acaatatagt coag 
cc.gatacggg.cgcttittcaccgacaacac catgacitcaactcaccitcottggcc.gatcagaaaac cqtg 
gatgccttgtatacgacggtoaatggcaa.ccc.ggittatcagoatcaaaaaacgc.gcagattatcggtot 
tatctgaac atc.gcacagaagttact gct tccaagaacctacaccaaagtag tacggacagtgag cago 
citgtctgtgcattttacgggggaggc gtacaaacaattcaactacaagatgcttgttcaacaatgctitat 
gcatcc.gagat cacco gagggaaggottatt acto cagogtgag caatggggtgtggaccact tcc.ggit 
acgcatgacagogacgacaactgcaaagt cacttgttgattacaagggcgcaaccitacgtcc totacgag 
agtaatgcggcagatagacgcactgaaac citgggcacaagaccc.gtacgttacitcattgcg acco gaga 
gacct gtaa 
The protein encoded by this nucleic acid molecule has an 
amino acid sequence according to SEQ ID NO: 100 as 
55 follows: 
MSTLNHTSAVNCRVSFDGDRCYWDTPIQIMPGERWAVNIVPNDLVTIHYE 
AASNHDYPLLLASIKNLFTDERCWVLKPGLTQQALNMYFSEWNSLKPNAT 
60 
HVRLLHRAQRIFLENMIRSVQITSQGISWTFATAEFKNYNYQLKVDKYTF 
ARLDKGYPLYSELWENTWITKLSWAHNILYSISWSLDHSSTPYTLFSGTL 
AEDNIVQPIRALFTDNTMTQLTSLADQKTVDALYTTVNGNPVISIKKRAD 
65 
YRSYLNIAQKLLLPRTYTKVWRTVSSLSWHFTGEAYKQFNYKMLVNNAYA 
US 7,220,583 B2 
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This protein possesses N-terminal Hop features (see U.S. 
-continued patent application Ser. No. 10/341,180 to Collmer et al., filed 
Jan. 13, 2003, which is hereby incorporated by reference in 
SEITRGKAYYSSWSNGWWTTSGTHDSDDNCKWTCDYKGATYWLYESNAAD its entirety), Suggesting that it is likely to be secreted. 
RRTETWAQDPYWTHCDPRDL 
A fifty-first nucleic acid molecule encodes ORF52 and has 
a nucleotide sequence according to SEQ ID NO: 101 as 
follows: 
atgc.gc.ctgatc.gc.gcagattctg.ccc.ggcc toccggaaaacaccacttacagogcc.gcc.gctg.cgtoc 
aac accotggcgcgggcc at gcc.caacgc.cattcgcaatgcgctgggcaccotggggctggtggctd.cg 
cgcacccagocaa.gcatcttitc.cgttgcc.gtc.gc.gcaacgtoag.cggtgg.cgaaaaagaggac gacctg 
gag attctgctcaaactc.gc.ggcc.gc.cgctgtttc.gc.gc.ctgcaaag.ccaccagttggg.cggcctggag 
cagaccc.gtaccalatgcc gatggcactcaggtgactacatggcaactggaagtgc.cgatgcgcaacgc.c 
catgacatcgtgcc.gttgcaggtoaaggtgcagogcgaagacaa.gc.ct gatcaggacgccacc galagac 
cgc gacgatat cq agatcaaggaaac cogtgaaaaactctggaaagttc gatctggctitt.cg acctggag 
cc.gcttggc.cc catgcaggtgcatgcgcaactgctg.cgcggcacgctgtc.ca.gc.cagttatggg.ccgag 
cgc.ccggatago.gcaa.cact gatc galacatgaactgggg catttgcgc gag.cgc.gagcgc.cgattgcc.g 
citggcc.gtoggggaactggdgtgcago catggc gttcc.gcc.gcaagggcc.gc.gcaccgc.ccitcgaacaa 
cgctggatcgacgagaacgc.ctga 
30 
The protein encoded by this nucleic acid molecule has an 
amino acid sequence according to SEQ ID NO: 102 as 
follows: 
MRLIAQILPGLPENTTYSAAAASNTLARAMPNAIRNALGTLGLWAARTQPSIFPLPSRNWSGGEKEDDL 
EILLKLAAAAVSRLQSHQLGGLEQTRTNADGTOWTTWQLEWPMRNAHDIVPLQWKVOREDKPDQDATED 
RDDIETKETREKLWKVDLAFDLEPLGPMOWHAQLLRGTLSSQLWAERPDSATLIEHELGHLRERLIACG 
LAVGEIACSHGVPPQGPRTALEQRWIDENA 
45 
This protein possesses N-terminal Hop features (see U.S. 
patent application Ser. No. 10/341,180 to Collmer et al., filed 
Jan. 13, 2003, which is hereby incorporated by reference in 
its entirety), Suggesting that it is likely to be secreted. 
50 A fifty-second nucleic acid molecule encodes ORF53 and 
has a nucleotide sequence according to SEQID NO: 103 as 
follows: 
atgagtagcgtc.gcago act gatcaccatat cqactggacagacgcagttcgittaaagtc.gc.gcggacg 
to attittctgtgctacgaatcc cc citc.gc.cggcagatgtcgtgttgtcgtgtc.cgg gatcagttgaccac 
aagacagag cagaaac coataaaaatagggggaagagacgtgagcc-taaatgatcacttgaaaaaag.ca 
ttgattctgatccagogacgagcttgatgaaatcacc gacctittatgtgacgttgcc to cagaggtoga 
ttcagttgcttgaccatttcactc galagg gaattggaaggaaattgatagogtotggtotgctcggitta 
gacgcagoagattcaaagaataatacaaaatgtcacg to catat cqccaaaaaccalagcatcatc gatc 
aaaag caaacaggtttcttggaac agtgatggtagcc.gg catgataaaaaaacattc gatgtgaacgct 
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cittgtcag accottttctgaatcagot atc gagg tagt catgtc.catcgaaccocaacgtcagaaagaa 
cagocaccc.ggc.ca.gcacacgc.cagoggat cagg gcc.cggatcgcaatgatcc.ggc catcgagcc.gcag 
gtttcggacgtagagcc.ggag actdaaaaaggtogacggccagacgcaaggcca gaccoct gcc.cccago 
caaag.ccagt cacaaagtcagaatcagagc.ca.gcagtccaacggcagogcttacgtgcctgacitat gag 
cc.gcaggaaaaaaaggaag accagogcaatcatcagcc cactcaagg cact gatgctdatat cq acacc 
aatgcgggctga 
The protein encoded by this nucleic acid molecule has an 
amino acid sequence according to SEQ-ID NO: 108 as 15 
follows: 
MRCVRRSRRFFKLQAASCKKKQDRFSLADAPLSTFHRTIRKTLPRKLVRPFSESAIEVVMSIEPQRQKE 
QPPGQHTPADQGPDRNDPAIEPOVSDWEPETEKGDGOTOGOTPAPSQSQSQSQNQSQQSNGSAYWPDYE 
PQEKKEDORNHOPTOGTDADIDTNAG 
This protein possesses N-terminal Hop features (see U.S. 
patent application Ser. No. 10/341,180 to Collmer et al., filed 
Jan. 13, 2003, which is hereby incorporated by reference in 
its entirety), Suggesting that it is likely to be secreted. 
A fifty-fifth nucleic acid molecule encodes ORF56 and 
has a nucleotide sequence according to SEQID NO: 109 as 30 
follows: 
atgc.ccgt.cactggtgcaggotttatcaag.cgtttgacgcaattgtc.ccitctg.cgc.cggcatgg.cgctg 
gtoccggtggcc.gtacagg cago.cgaaag.cgatccttgggaaggcatcaa.ccgttc catttitcagottc 
aacgatacccttgacgcttatacgctoaa.gcc.gctggcaaagggittatcagtacatc.gcticcgcagttt 
gtogalagacgg tattoata acttcttcago: aatato gg.cgatgtcggcaatctggc gaacaacgtottg 
caggccaaacctgaag.cggcc.ggtgtagataccgcacgc.cittatcgtcaac actacgttcggtotgctg 
ggcttcattgacgt.cgg caccc.gcatgggcctgcaacgcagtgatgaag actt.cggccagacactgggc 
tactggggtgtgccaag.cggc.ccgttcgtggtgatticcgctgctgggcc caag cacggtgcgtgacgcc 
attgccaagtaccc.ggacaccitacaccitcc.ccgtaccgctatattgatcacgtacccaccc.gcaa.cacg 
gc gttggg.cgtoaatctggtogacacgc.gtgc.ca.gc.ctgctgtcc.gc.cgagcgc.ctggtoagtggtgat 
cgctacaccittcatcc.gcaacgcttacittgcaga accgc.gaattcaaggtoaaggacggg caggtogaa 
gacgatttittaa 
The protein encoded by this nucleic acid molecule has an 
amino acid sequence according to SEQ ID NO: 110 as 
follows: 
MPWTGAGFIKRLTQLSLCAGMALWPVAVOAAESDPWEGINRSIFSFNDTLDAYTLKPLAKGYOYIAPQF 
VEDGIHNFFSNIGDWGNLANNWLOAKPEAAGWDTARLIVNTTFGLLGFIDWGTRMGLQRSDEDFGQTLG 
YWGWPSGPFWWIPLLGPSTWRDAIAKYPDTYTSPYRYIDHWPTRNTALGWNLWDTRASILLSAERLWSGD 
RYTFIRNAYLQNRFFKWKDGOVEDDF 
65 
This protein possesses N-terminal Hop features (see U.S. Jan. 13, 2003, which is hereby incorporated by reference in 
patent application Ser. No. 10/341,180 to Collmer et al., filed its entirety), Suggesting that it is likely to be secreted. 
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ttgcacaggcaaaaagaga cagotcaacgc gttgctgaaagcatcaa.cago atgc.gagag cago: aaaat 
ggaatgcaacgc.gc.cga-agggcttctoragagccaaagaag.cgttgcaa.gctcgggaagcc.gc.gc.gcaag 
cagottctggacgtgctic gaggc catcCaggctdgcc.gtgaagacitccaccgacaagaagat cagogcc 
actgaaaagaacgc.cacgggcatcaactaccagtga 
The Hrp-A related protein has an amino acid sequence 10 
according to SEQ ID NO: 122 as follows: 
MNITPLTSAAGKGSSAQGTDKISIPNSTRMINAASIKWLNKVRSAISDHIRTSIEKGKLFELASLGSNM 
FGWPALSARPSTLQPWLAFEADPNHDLNLVRVYMODSAGKLTPWDPTPNAVTTTSNPSEPDAQSDTASS 
SLPRRPPAGSWLSLLGIALDHAQRHSPRADRSAKGRPGREERNGARFNAKQTKPTEAEAYGDHQTPNPD 
LHRQKETAQRVAESINSMREQQNGMQRAEGLLRAKEALQAREAARKQLLDWLEAIQAGREDSTDKKISA 
TEKNATGINYQ 
The HrpA-related protein, has significant homology, as 13, 2003, which is hereby incorporated by reference in its 
detected by BLAST analysis (5e-07), to the C-terminal 43 entirety), Suggesting that it is likely to be secreted. HrpA is 
amino acids of HrpA (GenBank Accession AF232004; the Hrp pilus subunit protein (Roine et al., Proc. Natl. Acad. 
Alfano et al., Proc. Natl. Acad. Sci. USA 97.4856. 4861 Sci. USA 94:3459 3464 (1997), which is hereby incorpo 
(2000), each of which is hereby incorporated by reference in rated by reference in its entirety) 
its entirety). Expression of the hrp-A-related gene is activated 
by HrpL, as indicated by miniTn5gus mutagenesis. This A sixty-second nucleic acid encodes ORFO1152 and has 
protein possesses N-terminal Hop features (see U.S. patent 30 a nucleotide Sequence according to SEQ ID NO: 123 as 
application Ser. No. 10/341,180 to Collmer et al., filed Jan. follows: 
atgaccittaagaatcaatacitc gttctgctaccc.cggttgtacctotggaalacaggotctacatcgcag 
cc.gacaccaccgc.cgg to acggcaa.gagcigacitgagcc tocc ccc.gtogccaatcct gcigg.cgcc-taaa 
totagogc.caggtgttcagdaag cacacgggctdaagacgc.gcatc.gctggcaa.gcttitc.cgaacgtcag 
accaattitcagtc.tc.gggattcc.cgg cactggtogtact citcaa.ccggcc cittgcgcagogggatto.cg 
gagga aggtgagcaggitatcgaac gaggaga.gtcatgatcc.gttgctdaaggaag.cgcatcaactgcag 
cgitatggtggagtcgg.cgct gacccatctgaaggcgg caccgacgtct citctgggagcgtoccgc.ccct 
toaacggta aggcgtattaccaccalagatttitt.ccgtggctaaag.cct gcc.ccgctg.cgcgaagtc.gca 
agcaatggcagdaacgc.caagaccalagatcaagatcaactcacago: aaag.ccctdaaac catcgcagog 
gcqgtgaaagagctgagcaccc.ggctic gatcaccagagcaaggtgctogccacagocac coacgcactg 
gtogctg.cgc.gtgagcatcttgaatcgctic galacaggccacccc.gc.ccitcgtcgacc galaccactggac 
catgc.cagggctc.gc.gttcaacaa.gc.cgacticcaccaccc.gc.ctggccagtcago aactitcgtgagctg 
attcagg gtacagacgtgttgcaactggg.cgc.gctgagtgaagggcaggatcaggttgaacagaaag.cc 
gagittittct 
55 
The protein encoded by the nucleic acid molecule has an 
amino acid sequence according to SEQ ID NO: 124 as 
follows: 
MTLRINTRSATPWVPLETGSTSQPTPPPVTARATEPPPVANPAAPKSAPGVQQAHGLKTRIAGKLSERQ 
TNFSLGIPGTGRTLNRPLRSGIPEEGEQVSNEESHDPLLKEAHELORMVESALTHLKAAPTSLWERPAP 
STVRRITTKIFPWLKPAPLREWASNGSNAKTKIKINSQQSPETIAAAVKELSTRLDHQSKVLATATHAL 
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WAAREHLESLEQATPPSSTEPLDHARARVQQADSTTRLASQQLRELIQGTDVLQLGALSEGQDQWEQKA 
EFS 
Expression of ORFO1152 is activated by HrpL, as indicated 
by miniTn5gus mutagenesis (Fouts et al., Proc. Natl. Acad. 
Sci. USA 99(4):2275–2280 (2001), which is hereby incor 
porated by reference in its entirety). This protein possesses 10 
N-terminal Hop features (see U.S. patent application Ser. 
No. 10/341,180 to Collmer et al., filed Jan. 13, 2003, which 
is hereby incorporated by reference in its entirety), Suggest 
ing that it is likely to be secreted. 
A sixty-third nucleic acid molecule encodes HopPtoF 15 
(formerly AVrPphF ORF2) and has a nucleotide sequence 
according to SEQ ID NO: 125 as follows: 
ataggtaatatttgcgg caccitcgggctoacgtoatgtgtatagoccatcc catacacaacgaataact 
totagotcc citctacatccact catgttggtggagatacactgacatc cattcatcagotttc.gcatagt 
cagaga gag cagtttctgaacatgcatgatccaatgagagtaatggg acttgaccatoataccgagctt 
ttcagaacgacggatagtc.gctatataaaaaacgataaactc.gcgggcaatccacaatccatgg.cgagt 
atccittatgcatgaagaactg.cgc.cccaatcgttittgc.ca.gc.catacaggtgcc.calaccacacgaagca 
aggg.cgtacgttcc gaaaagaataaaag.ccaccgatctaggagttcCatcactgaacgtaatgactggc 
togctagogc gagacggaattagagct tatgatcacatgagtgataatcaggtotctgtcaaaatgcga 
citgg gagattittcticgaaaggggtggcaaggtotatgcc.gacgctitcgtctgtagctdac gatggggaa 
108 
acat cacaag citctgattgtcacattgcc.caaaggacagaaagtgcc.ggtogaaagggtotga 
HopPtoF has an amino acid sequence according to SEQ ID 
NO: 126 as follows: 
MGNICGTSGSRHWYSPSHTQRITSAPSTSTHWGGDTLTSIHQLSHSQREQ 
FLNMHDPMRVMGLDHDTELFRTTDSRYIKNDKLAGNPQSMASILMHEELR 
PNRFASHTCAQPHEARAYWPKRIKATDLGVPSLNWMTGSLARDGIRAYDH 
MSDNQVSVKMRLGDFLERGGKWYADASSVADDGETSOALIVTLPKGOKWP 
WERW 
Contrary to the previously identified sequence of hopPtoF 
(see U.S. patent application Ser. No. 10/114.828 to Collmer 
et al., filed Apr. 2, 2002, which is hereby incorporated by 
reference in its entirety), hopPtoF possesses a rare ATA start 
codon, which is believed to be involved in regulating protein 
synthesis in DC3000. HopPtoF has been shown to be 
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expressed by DC3000 and it has been shown to be translo 
cated in planta, where it is localized to the plant plasma 
membrane and has a role in virulence. HopPtoF has also 
been shown to cause a hypersensitive response in Arabi 
dopsis Col-0. The homologous Pseudomonas Syringae pv. 
phaseolicola AVrPpbF effector protein has been shown to 
play a role in both development of the hypersensitive 
response and virulence in several plants (Tsiamis et al., 
“Cultivar-specific avirulence and virulence functions 
assigned to avrPphF in Pseudomonas syringae pv. phaseoli 
cola, the cause of bean halo-blight disease.” EMBO J. 
19(13):3204-3214 (2000), which is hereby incorporated by 
reference in its entirety). Finally, HopPtoF has since been 
shown to be cytotoxic to eukaryotic cells, specifically cul 
tured mammalian CHO and HEK293 cell lines. 
A sixty-fourth nucleic acid molecule encodes IaaLe, and 
has a nucleic acid sequence according to SEQ ID NO. 208 
as follows: 
atgactgccitacgatgtagaaaaggaatggagcagaattitccaatact gcc.gctaaaacto accagaac 
aac gattittgaaggtttcaccitaccaggactitcagaaccoacgtaccgatcatggacaaggaaggottc 
gcqgcacaaac cqaacgctgccttgagc.gcaac gag.cgcaactgcctgatcggctttaccagtgg cacc 
agcggcaac citcaaacgctgtt attactactacgactgttgaagttcgatgaag acagttc.ccgctocaac 
gtott.ccgcagdaatggttt cattcaa.ccc.ggtgatcgctg.cgc.ca acct gttcaccatca acctgttt 
totg.ccctdaacaa.catcaccaccatgatggcc.ggta actoc ggtgcgcatgtggtgtc.cgtagg.cgat 
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atcaccct gctgaccalagagt cactitc gaggcgctdaactic gatcaagctdaacgtactgctic gg.cgta 
cc citcgac catcct gcagttcatcgatgccatgcagcago acggtgtgcacatcgatatogaaaaggto 
gtottcaatggc gaggg cctogaaaacctttcagaagaaaatcatcagggaa.gc.ctttggc gaac aggto 
to catcgtcggcgtatatggcagttcc gaggg.cggcattctgg gttt caccaa.cagoc cittgcc acacc 
gaatacgagtttctittc.cgacaaatactitcatc.gagaaagaaggc gacago atcct catcaccitcgttg 
acco go gaga actt cacaccgctgcto cqgitatcgc.ctgg gag acaccgcaacgctitt.cgctgaaaggc 
gacaagctictatttgactgacatccagogg gaggacatgagcttcaactitcatgggcaacct cattggit 
citgggcatcattcaacaag.cgatcaaacagacactgggcc.gcacgctggaaatcCaggttcaccitgtca 
gtgact gatgcgc.gcaaagaactggtgaccgtttitc gttcaggcc toggaagttcaacgaagatgaacgc 
gccagaatcgaalacago catcgc.cgatatto.cggacatcaac gaggccitat cagaaag accagggcago 
gtgctggttgttgc.gcaaggatgc.ca.gagacitacgc.cgtc.tc.ggagcgaggcaaaatgctotacatcatt 
gaccgcaggaat 
IaaLe, has an amino acid sequence according to SEQ ID 
NO: 209 as follows: 
MTAYDWEKEWSRISNTAAKTHQNNDFEGFTYQDFRTHWPIMDKEGFAAQTERCLERNERNCLIGFTSGT 
SGNLKRCYYYYDCEVDEDSSRSNVFRSNGFIQPGDRCANLFTINLFSALNNITTMMAGNCGAHVVSVGD 
ITLLTKSHFEALNSIKLNVLLGVPSTILQFIDAMQOHGVHIDIEKVWFNGEGLKTFQKKIIREAFGEQV 
SIWGWYGSSEGGILGFTNSPCHTEYEFLSDKYFIEKEGDSILITSLTRENFTPLLRYRLGDTATLSLKG 
DKLYLTDIQREDMSFNFMGNLIGLGIIQQAIKQTLGRTLEIQVHLSVTDARKELWTVFWQASEWNEDER 
110 
ARIETAIADIPDINEAYQKDQGSWLVWRKDARDYAVSERGKMLYIIDRRN 
IaaL has significant homology, as detected by BLAST 
analysis (O), to IAA-lysine synthetase (GenBank accession 
M35373; Roberto et al., Proc. Natl. Acad. Sci. USA 87: 
5797–5801 (1990), each of which is hereby incorporated by 
reference in its entirety). 
Fragments of the above-identified proteins or polypep 
tides as well as fragments of full length proteins can also be 
used according to the present invention. 
Suitable fragments can be produced by several means. 
Subclones of the gene encoding a known protein can be 
produced using conventional molecular genetic manipula 
tion for Subcloning gene fragments, such as described by 
Sambrook et al., Molecular Cloning. A Laboratory Manual. 
Cold Springs Laboratory, Cold Springs Harbor, N.Y. (1989), 
and Ausubel et al. (ed.), Current Protocols in Molecular 
Biology, John Wiley & Sons (New York, N.Y.) (1999 and 
preceding editions), each of which is hereby incorporated by 
reference in its entirety. The subclones then are expressed in 
vitro or in vivo in bacterial cells to yield a smaller protein or 
polypeptide that can be tested for activity, e.g., as a product 
required for pathogen virulence. 
In another approach, based on knowledge of the primary 
structure of the protein, fragments of the protein-coding 
gene may be synthesized using the PCR technique together 
with specific sets of primers chosen to represent particular 
portions of the protein. Erlich, H. A., et al., “Recent 
Advances in the Polymerase Chain Reaction.” Science 252: 
1643–51 (1991), which is hereby incorporated by reference. 
These can then be cloned into an appropriate vector for 
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expression of a truncated protein or polypeptide from bac 
terial cells as described above. 
As an alternative, fragments of a protein can be produced 
by digestion of a full-length protein with proteolytic 
enzymes like chymotrypsin or Staphylococcus proteinase A, 
or trypsin. Different proteolytic enzymes are likely to cleave 
different proteins at different sites based on the amino acid 
sequence of the particular protein. Some of the fragments 
that result from proteolysis may be active virulence proteins 
or polypeptides. 
Chemical synthesis can also be used to make Suitable 
fragments. Such a synthesis is carried out using known 
amino acid sequences for the polyppetide being produced. 
Alternatively, Subjecting a full length protein to high tem 
peratures and pressures will produce fragments. These frag 
ments can then be separated by conventional procedures 
(e.g., chromatography, SDS-PAGE). 
Variants may also (or alternatively) be modified by, for 
example, the deletion or addition of amino acids that have 
minimal influence on the properties, secondary structure and 
hydropathic nature of the polypeptide. For example, a 
polypeptide may be conjugated to a signal (or leader) 
sequence at the N-terminal end of the protein which co 
translationally or post-translationally directs transfer of the 
protein. The polypeptide may also be conjugated to a linker 
or other sequence for ease of synthesis, purification, or 
identification of the polypeptide. 
The proteins or polypeptides used in accordance with the 
present invention are preferably produced in purified form 
(preferably at least about 80%, more preferably 90%, pure) 
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by conventional techniques. Typically, the protein or 
polypeptide of the present invention is secreted into the 
growth medium of recombinant host cells (discussed infra). 
Alternatively, the protein or polypeptide of the present 
invention is produced but not secreted into growth medium. 
In Such cases, to isolate the protein, the host cell (e.g., E. 
coli) carrying a recombinant plasmid is propagated, lysed by 
Sonication, heat, or chemical treatment, and the homogenate 
is centrifuged to remove bacterial debris. The supernatant is 
then Subjected to sequential ammonium Sulfate precipita 
tion. The fraction containing the protein or polypeptide of 
interest is subjected to gel filtration in an appropriately sized 
dextran or polyacrylamide column to separate the proteins. 
If necessary, the protein fraction may be further purified by 
HPLC. 
Other DNA molecules encoding other effector proteins or 
polypeptides can also be identified by determining whether 
such DNA molecules hybridize under stringent conditions to 
a nucleic acid molecule as identified above. An example of 
Suitable stringency conditions is when hybridization is car 
ried out for about 8 to about 20 hours at a temperature of 
about 37° C. using a hybridization medium that includes 
0.9x sodium citrate (“SSC) buffer, followed by washing for 
about 5 minutes to about 1 hour with 0.2XSSC buffer at 37° 
C. Higher stringency can readily be attained by increasing 
the temperature for either hybridization or washing condi 
tions or increasing the sodium concentration of the hybrid 
ization or wash medium. Nonspecific binding may also be 
controlled using any one of a number of known techniques 
Such as, for example, blocking the membrane with protein 
containing solutions, addition of heterologous RNA, DNA, 
and SDS to the hybridization buffer, and treatment with 
RNase. Wash conditions are typically performed at or below 
stringency. Exemplary high Stringency conditions include 
carrying out hybridization at a temperature of about 42°C. 
up to and including about 65° C. (inclusive of all tempera 
ture in such range) for about 8 up to about 20 hours in a 
hybridization medium containing 1M NaCl, 50 mM Tris 
HCl, pH 7.4, 10 mM EDTA, 0.1% sodium dodecyl sulfate 
(SDS), 0.2% ficoll, 0.2% polyvinylpyrrolidone, 0.2% bovine 
serum albumin, and 50 lug/ml E. coli DNA, followed by 
washing for about 5 minutes to about 1 hour, at about 42°C. 
up to and including about 65° C. (inclusive of all tempera 
tures in such range) in a 0.2xSSC buffer. Such hybridizing 
nucleic acid molecules preferably hybridize over substan 
tially over their entire length. Moreover, such hybridizing 
nucleic acid molecules does not include previously reported 
nucleic acid molecules that encode effector proteins. 
The delivery of effector proteins or polypeptides can be 
achieved in several ways: (1) as a stable transgene; (2) 
transiently expressed via Agrobacterium or viral vectors; (3) 
delivered by the type III secretion systems of disarmed 
pathogens or recombinant nonpathogenic bacteria which 
express a functional, heterologous type III Secretion system; 
or (4) delivered via topical application followed by TAT 
protein transduction domain-mediated spontaneous uptake 
into cells. Each of these is discussed infra. 
The DNA molecule encoding the protein or polypeptide 
can be incorporated in cells using conventional recombinant 
DNA technology. Generally, this involves inserting the DNA 
molecule into an expression system to which the DNA 
molecule is heterologous (i.e. not normally present). The 
heterologous DNA molecule is inserted into the expression 
system or vector in proper sense orientation and correct 
reading frame. The vector contains the necessary elements 
for the transcription and translation of the inserted protein 
coding sequences. 
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U.S. Pat. No. 4,237,224 to Cohen and Boyer, which is 
hereby incorporated by reference in its entirety, describes the 
production of expression systems in the form of recombinant 
plasmids using restriction enzyme cleavage and ligation 
with DNA ligase. These recombinant plasmids are then 
introduced by means of transformation and replicated in 
unicellular cultures including prokaryotic organisms and 
eukaryotic cells grown in tissue culture. 
Recombinant genes may also be introduced into viruses, 
Such as vaccina virus. Recombinant viruses can be generated 
by transfection of plasmids into cells infected with virus. 
Suitable vectors include, but are not limited to, the 
following viral vectors such as lambda vector system gt11, 
gt WES...thB, Charon 4, and plasmid vectors such as pBR322, 
pBR325, p.ACYC177, p.ACYC1084, puC8, puC9, puC18, 
pUC19, pI G339, pR290, pKC37, pKC101, SV 40, pBlue 
script II SK +/- or KS +/- (see "Stratagene Cloning Sys 
tems’ Catalog (1993) from Stratagene, La Jolla, Calif., 
which is hereby incorporated by reference), pOE, pIH821, 
pGEX, pET series (see F. W. Studier et. al., “Use of T7 RNA 
Polymerase to Direct Expression of Cloned Genes. Gene 
Expression Technology Vol. 185 (1990), which is hereby 
incorporated by reference in its entirety), and any derivatives 
thereof. Recombinant molecules can be introduced into cells 
via transformation, particularly transduction, conjugation, 
mobilization, or electroporation. The DNA sequences are 
cloned into the vector using standard cloning procedures in 
the art, as described by Sambrook et al., Molecular Cloning: 
A Laboratory Manual, Cold Springs Laboratory, Cold 
Springs Harbor, N.Y. (1989), which is hereby incorporated 
by reference in its entirety. 
A variety of host-vector systems may be utilized to 
express the protein-encoding sequence(s). Primarily, the 
vector system must be compatible with the host cell used. 
Host-vector systems include but are not limited to the 
following: bacteria transformed with bacteriophage DNA, 
plasmid DNA, or cosmid DNA; microorganisms such as 
yeast containing yeast vectors; mammalian cell systems 
infected with virus (e.g., vaccinia virus, adenovirus, etc.); 
insect cell systems infected with virus (e.g., baculovirus); 
and plant cells infected by bacteria. The expression elements 
of these vectors vary in their strength and specificities. 
Depending upon the host-vector System utilized, any one of 
a number of Suitable transcription and translation elements 
can be used. 
Different genetic signals and processing events control 
many levels of gene expression (e.g., DNA transcription and 
messenger RNA (mRNA) translation). 
Transcription of DNA is dependent upon the presence of 
a promoter which is a DNA sequence that directs the binding 
of RNA polymerase and thereby promotes mRNA synthesis. 
The DNA sequences of eukaryotic promoters differ from 
those of prokaryotic promoters. Furthermore, eukaryotic 
promoters and accompanying genetic signals may not be 
recognized in or may not function in a prokaryotic system, 
and, further, prokaryotic promoters are not recognized and 
do not function in eukaryotic cells. 
Similarly, translation of mRNA in prokaryotes depends 
upon the presence of the proper prokaryotic signals which 
differ from those of eukaryotes. Efficient translation of 
mRNA in prokaryotes requires a ribosome binding site 
called the Shine-Dalgarno (“SD) sequence on the mRNA. 
This sequence is a short nucleotide sequence of mRNA that 
is located before the start codon, usually AUG, which 
encodes the amino-terminal methionine of the protein. The 
SD sequences are complementary to the 3'-end of the 16S 
rRNA (ribosomal RNA) and probably promote binding of 
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mRNA to ribosomes by duplexing with the rRNA to allow 
correct positioning of the ribosome. For a review on maxi 
mizing gene expression, see Roberts and Lauer, Methods in 
Enzymology, 68:473 (1979), which is hereby incorporated 
by reference in its entirety. 5 
Promoters vary in their “strength” (i.e. their ability to 
promote transcription). For the purposes of expressing a 
cloned gene, it is desirable to use strong promoters in order 
to obtain a high level of transcription and, hence, expression 
of the gene. Depending upon the host cell system utilized, 10 
any one of a number of suitable promoters may be used. For 
instance, when cloning in E. coli, its bacteriophages, or 
plasmids, promoters such as the T7 phage promoter, lac 
promoter, trp promoter, recA promoter, ribosomal RNA 
promoter, the P and P. promoters of coliphage lambda and 15 
others, including but not limited, to lacUV5, ompl, bla, lpp, 
and the like, may be used to direct high levels of transcrip 
tion of adjacent DNA segments. Additionally, a hybrid 
trp-lacUV5 (tac) promoter or other E. coli promoters pro 
duced by recombinant DNA or other synthetic DNA tech- 20 
niques may be used to provide for transcription of the 
inserted gene. 
Bacterial host cell strains and expression vectors may be 
chosen which inhibit the action of the promoter unless 
specifically induced. In certain operations, the addition of 25 
specific inducers is necessary for efficient transcription of 
the inserted DNA. For example, the lac operon is induced by 
the addition of lactose or IPTG (isopropylthio-beta-D-ga 
lactoside). A variety of other operons, such as trp, pro, etc., 
are under different controls. 
Specific initiation signals are also required for efficient 
gene transcription and translation in prokaryotic cells. These 
transcription and translation initiation signals may vary in 
'strength' as measured by the quantity of gene specific 
messenger RNA and protein synthesized, respectively. The 35 
DNA expression vector, which contains a promoter, may 
also contain any combination of various "strong transcrip 
tion and/or translation initiation signals. For instance, effi 
cient translation in E. coli requires an SD sequence about 
7–9 bases 5' to the initiation codon (ATG') to provide a 40 
ribosome binding site. Thus, any SD-ATG combination that 
can be utilized by host cell ribosomes may be employed. 
Such combinations include but are not limited to the SD 
ATG combination from the cro gene or the N gene of 
coliphage lambda, or from the E. coli tryptophan E, D, C, B 
or A genes. Additionally, any SD-ATG combination pro 
duced by recombinant DNA or other techniques involving 
incorporation of synthetic nucleotides may be used. 
Once the isolated DNA molecule encoding the polypep 
tide or protein has been cloned into an expression system, it 
is ready to be incorporated into a host cell. Such incorpo 
ration can be carried out by the various forms of transfor 
mation noted above, depending upon the vector/host cell 
system. Suitable host cells include, but are not limited to, 
bacteria, virus, yeast, mammalian cells, insect, plant, and the 
like. 
Because it is desirable for recombinant host cells to 
secrete the encoded protein or polypeptide, it is preferable 
that the host cell also possess a functional type III secretion 
system. The type III Secretion system can be heterologous to 
host cell (Ham et al., “A Cloned Erwinia chrysanthemi Hrp 
(Type III Protein Secretion) System Functions in Escheri 
chia coli to Deliver Pseudomonas syringae AVr Signals to 
Plant Cells and Secrete Avr Proteins in Culture, Microbiol. 
95:10206-10211 (1998), which is hereby incorporated by 
reference in its entirety) or the host cell can naturally possess 
a type III secretion system. Host cells which naturally 
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contain a type III secretion system include many pathogenic 
Gram-negative bacterium, Such as numerous Erwinia spe 
cies, Pseudomonas species, Xanthomonas species, etc. 
Other type III secretion systems are known and still others 
are continually being identified. Pathogenic bacteria that can 
be utilized to deliver effector proteins or polypeptides are 
preferably disarmed according to known techniques, i.e., as 
described above. Alternatively, isolation of the effector 
protein or polypeptide from the host cell or growth medium 
can be carried out as described above. 
Another aspect of the present invention relates to a 
transgenic plant which express a protein or polypeptide of 
the present invention and methods of making the same. 
In order to express the DNA molecule in isolated plant 
cells or tissue or whole plants, a plant expressible promoter 
is needed. Any plant-expressible promoter can be utilized 
regardless of its origin, i.e., viral, bacterial, plant, etc. 
Without limitation, two suitable promoters include the nopa 
line synthase promoter (Fraley et al., Proc. Natl. Acad. Sci. 
USA 80:4803–4807 (1983), which is hereby incorporated by 
reference in its entirety) and the cauliflower mosaic virus 
35S promoter (O'Dell et al., “Identification of DNA 
Sequences Required for Activity of the Cauliflower Mosaic 
Virus 35S Promoter,” Nature, 313(6005):810-812 (1985), 
which is hereby incorporated by reference in its entirety). 
Both of these promoters yield constitutive expression of 
coding sequences under their regulatory control. 
While constitutive expression is generally suitable for 
expression of the DNA molecule, it should be apparent to 
those of skill in the art that temporally or tissue regulated 
expression may also be desirable, in which case any regu 
lated promoter can be selected to achieve the desired expres 
Sion. Typically, the temporally or tissue regulated promoters 
will be used in connection with the DNA molecule that are 
expressed at only certain stages of development or only in 
certain tissues. 
In some plants, it may also be desirable to use promoters 
which are responsive to pathogen infiltration or stress. For 
example, it may be desirable to limit expression of the 
protein or polypeptide in response to infection by a particu 
lar pathogen of the plant. One example of a pathogen 
inducible promoter is the gstl promoter from potato, which 
is described in U.S. Pat. Nos. 5,750,874 and 5,723,760 to 
Strittmayer et al., each of which is hereby incorporated by 
reference in its entirety. 
Expression of the DNA molecule in isolated plant cells or 
tissue or whole plants also requires appropriate transcription 
termination and polyadenylation of mRNA. Any 3' regula 
tory region Suitable for use in plant cells or tissue can be 
operably linked to the first and second DNA molecules. A 
number of 3' regulatory regions are known to be operable in 
plants. Exemplary 3' regulatory regions include, without 
limitation, the nopaline synthase 3' regulatory region (Fraley 
et al., Proc. Natl. Acad. Sci. USA, 80:4803–4807 (1983), 
which is hereby incorporated by reference in its entirety) and 
the cauliflower mosaic virus 3' regulatory region (Odell, et 
al., Nature, 313(6005):810–812 (1985), which is hereby 
incorporated by reference in its entirety). 
The promoter and a 3' regulatory region can readily be 
ligated to the DNA molecule using well known molecular 
cloning techniques described in Sambrook et al., Molecular 
Cloning: A Laboratory Manual, Second Edition, Cold 
Spring Harbor Press, NY (1989), which is hereby incorpo 
rated by reference in its entirety. 
One approach to transforming plant cells with a DNA 
molecule of the present invention is particle bombardment 
(also known as biolistic transformation) of the host cell. This 
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can be accomplished in one of several ways. The first 
involves propelling inert or biologically active particles at 
cells. This technique is disclosed in U.S. Pat. Nos. 4,945, 
050, 5,036,006, and 5,100,792, all to Sanford, et al., each of 
which is hereby incorporated by reference in its entirety. 
Generally, this procedure involves propelling inert or bio 
logically active particles at the cells under conditions effec 
tive to penetrate the outer surface of the cell and to be 
incorporated within the interior thereof. When inert particles 
are utilized, the vector can be introduced into the cell by 
coating the particles with the vector containing the heter 
ologous DNA. Alternatively, the target cell can be sur 
rounded by the vector so that the vector is carried into the 
cell by the wake of the particle. Biologically active particles 
(e.g., dried bacterial cells containing the vector and heter 
ologous DNA) can also be propelled into plant cells. Other 
variations of particle bombardment, now known or hereafter 
developed, can also be used. 
Another method of introducing the DNA molecule into 
plant cells is fusion of protoplasts with other entities, either 
minicells, cells, lysosomes, or other fusible lipid-surfaced 
bodies that contain the DNA molecule. Fraley et al., Proc. 
Natl. Acad. Sci. USA, 79:1859–63 (1982), which is hereby 
incorporated by reference in its entirety. 
The DNA molecule may also be introduced into the plant 
cells by electroporation. Fromm, et al., Proc. Natl. Acad. Sci. 
USA, 82:5824 (1985), which is hereby incorporated by 
reference in its entirety. In this technique, plant protoplasts 
are electroporated in the presence of plasmids containing the 
DNA molecule. Electrical impulses of high field strength 
reversibly permeabilize biomembranes allowing the intro 
duction of the plasmids. Electroporated plant protoplasts 
reform the cell wall, divide, and regenerate. 
Another method of introducing the DNA molecule into 
plant cells is to infect a plant cell with Agrobacterium 
tumefaciens or Agrobacterium rhizogenes previously trans 
formed with the DNA molecule. Under appropriate condi 
tions known in the art, the transformed plant cells are grown 
to form shoots or roots, and develop further into plants. 
Generally, this procedure involves inoculating the plant 
tissue with a Suspension of bacteria and incubating the tissue 
for 48 to 72 hours on regeneration medium without antibi 
otics at 25–28° C. 
Agrobacterium is a representative genus of the Gram 
negative family Rhizobiaceae. Its species are responsible for 
crown gall (A. tumefaciens) and hairy root disease (A. 
rhizogenes). The plant cells in crown gall tumors and hairy 
roots are induced to produce amino acid derivatives known 
as opines, which are catabolized only by the bacteria. The 
bacterial genes responsible for expression of opines are a 
convenient source of control elements for chimeric expres 
sion cassettes. In addition, assaying for the presence of 
opines can be used to identify transformed tissue. 
Heterologous genetic sequences such as a DNA molecule 
of the present invention can be introduced into appropriate 
plant cells by means of the Tiplasmid of A. tumefaciens or 
the Ri plasmid of A. rhizogenes. The Ti or Ri plasmid is 
transmitted to plant cells on infection by Agrobacterium and 
is stably integrated into the plant genome. Schell, Science, 
237:1176–83 (1987), which is hereby incorporated by ref 
erence in its entirety. 
Plant tissue suitable for transformation include leaf tissue, 
root tissue, meristems, Zygotic and somatic embryos, and 
anthers. 
After transformation, the transformed plant cells can be 
selected and regenerated. 
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Preferably, transformed cells are first identified using, 
e.g., a selection marker simultaneously introduced into the 
host cells along with the DNA molecule of the present 
invention. Suitable selection markers include, without limi 
tation, markers coding for antibiotic resistance, such as 
kanamycin resistance (Fraley et al., Proc. Natl. Acad. Sci. 
USA, 80:4803–4807 (1983), which is hereby incorporated 
by reference in its entirety). A number of antibiotic-resis 
tance markers are known in the art and other are continually 
being identified. Any known antibiotic-resistance marker 
can be used to transform and select transformed host cells in 
accordance with the present invention. Cells or tissues are 
grown on a selection media containing an antibiotic, 
whereby generally only those transformants expressing the 
antibiotic resistance marker continue to grow. 
Once a recombinant plant cell or tissue has been obtained, 
it is possible to regenerate a full-grown plant therefrom. 
Thus, another aspect of the present invention relates to a 
transgenic plant that includes a DNA molecule of the present 
invention, wherein the promoter induces transcription of the 
first DNA molecule in response to infection of the plant by 
an oomycete. Preferably, the DNA molecule is stably 
inserted into the genome of the transgenic plant of the 
present invention. 
Plant regeneration from cultured protoplasts is described 
in Evans, et al., Handbook of Plant Cell Cultures, Vol. 1: 
(MacMillan Publishing Co., New York, 1983); and Vasil I. 
R. (ed.), Cell Culture and Somatic Cell Genetics of Plants, 
Acad. 
Press, Orlando, Vol. I, 1984, and Vol. III (1986), each of 
which is hereby incorporated by reference in their entirety. 
It is known that practically all plants can be regenerated 
from cultured cells or tissues, including but not limited to, all 
major species of rice, wheat, barley, rye, cotton, Sunflower, 
peanut, corn, potato, Sweet potato, bean, pea, chicory, let 
tuce, endive, cabbage, cauliflower, broccoli, turnip, radish, 
spinach, onion, garlic, eggplant, pepper, celery, carrot, 
Squash, pumpkin, Zucchini, cucumber, apple, pear, melon, 
Strawberry, grape, raspberry, pineapple, soybean, tobacco, 
tomato, Sorghum, and Sugarcane. 
Means for regeneration vary from species to species of 
plants, but generally a suspension of transformed protoplasts 
or a petri plate containing transformed explants is first 
provided. Callus tissue is formed and shoots may be induced 
from callus and Subsequently rooted. Alternatively, embryo 
formation can be induced in the callus tissue. These embryos 
germinate as natural embryos to form plants. The culture 
media will generally contain various amino acids and hor 
mones, such as auxin and cytokinins. It is also advantageous 
to add glutamic acid and proline to the medium, especially 
for Such species as corn and alfalfa. Efficient regeneration 
will depend on the medium, on the genotype, and on the 
history of the culture. If these three variables are controlled, 
then regeneration is usually reproducible and repeatable. 
After the DNA molecule is stably incorporated in trans 
genic plants, it can be transferred to other plants by sexual 
crossing or by preparing cultivars. With respect to sexual 
crossing, any of a number of standard breeding techniques 
can be used depending upon the species to be crossed. 
Cultivars can be propagated in accord with common agri 
cultural procedures known to those in the field. 
Diseases caused by the vast majority of bacterial patho 
gens result in limited lesions. That is, even when everything 
is working in the pathogen's favor (e.g., no triggering of the 
hypersensitive response because of R-gene detection of one 
of the effectors), the parasitic process still triggers defenses 
after a couple of days, which then stops the infection from 
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spreading. Thus, the very same effectors that enable para 
sitism to proceed must also eventually trigger defenses. 
Therefore, premature expression of these effectors is 
believed to “turn on plant defenses earlier (i.e., prior to 
infection) and make the plant resistant to either the specific 
bacteria from which the effector protein was obtained or 
many pathogens. An advantage of this approach is that it 
involves natural products and plants seem highly sensitive to 
pathogen effector proteins. 
According to one embodiment, a transgenic plant is 
provided that contains a heterologous DNA molecule of the 
present invention. When the heterologous DNA molecule is 
expressed in the transgenic plant, plant defenses are acti 
vated, imparting disease resistance to the transgenic plant. 
The transgenic plant can also contain an R-gene whose 
product is activated by the protein or polypeptide product of 
the heterologous DNA molecule. The R gene can be natu 
rally occurring in the plant or heterologously inserted 
therein. By disease resistance, it is believed that the effector 
proteins of the present invention can impart to plants resis 
tance against bacterial, viral, and/or fungal diseases. 
In addition to imparting disease resistance, it is believed 
that stimulation of plant defenses in transgenic plants of the 
present invention will also result in a simultaneous enhance 
ment in growth and resistance to insects. 
Alternative to transgenic expression is topical application 
of the effector proteins to plants. The embodiments of the 
present invention where the effector polypeptide or protein 
is applied to the plant can be carried out in a number of ways, 
including: 1) application of an isolated protein (or compo 
sition containing the same) or 2) application of bacteria 
which do not cause disease and are transformed with a gene 
encoding the effector protein of the present invention. In the 
latter embodiment, the effector protein can be applied to 
plants by applying bacteria containing the DNA molecule 
encoding the effector protein. Such bacteria are preferably 
capable of secreting or exporting the protein so that the 
protein can contact plant cells. In these embodiments, the 
protein is produced by the bacteria in planta. 
Such topical application can be carried out using an 
effector-TAT protein, which will afford transduction 
domain-mediated spontaneous uptake of the effector protein 
into cells. Basically, this is carried out by fusing an 11-amino 
acid peptide (YGRKKRRQRRR, SEQ ID No. 127) by 
standard rDNA techniques to the N-terminus of the effector 
protein, and the resulting tagged protein is taken up into 
animal cells by a poorly understood process. This peptide is 
the protein transduction domain (PTD) of the human immu 
nodeficiency virus (HIV) TAT protein (Schwarze et al., 
“Protein transduction: unrestricted delivery into all cells? 
Trends Cell Biol. 10:290–295 (2000), which is hereby incor 
porated by reference in its entirety). Other PTDs are known 
and can be used for this purpose (Prochiantz, "Messenger 
proteins: homeoproteins, TAT and others. Curr. Opin. Cell 
Biol. 12:400–406 (2000), which is hereby incorporated by 
reference in its entirety). See PCT Application Publication 
No. WO 01/19393 to Collmer et al., which is hereby 
incorporated by reference in its entirety. 
When the effector protein is topically applied to plants, it 
can be applied as a composition, which includes a carrier in 
the form, e.g., of water, aqueous solutions, slurries, or dry 
powders. In this embodiment, the composition contains 
greater than about 5 nM of the protein of the present 
invention. 
Although not required, this composition may contain 
additional additives including fertilizer, insecticide, fungi 
cide, nematicide, and mixtures thereof. Suitable fertilizers 
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include (NH)NO. An example of a suitable insecticide is 
Malathion. Useful fungicides include Captan. 
Other suitable additives include buffering agents, wetting 
agents, coating agents, and, in Some instances, abrading 
agents. These materials can be used to facilitate the process 
of the present invention. 
According to one embodiment, a transgenic plant includ 
ing a heterologous DNA molecule of the present invention 
expresses one or more effector proteins, wherein the trans 
genic plant is capable of Supporting growth of compatible 
nonpathogenic bacteria. The compatible nonpathogenic bac 
teria can be naturally occurring or it can be recombinant. 
Preferably, the nonpathogenic bacteria is recombinant and 
expresses one or more useful products. Thus, the transgenic 
plant becomes a green factory for producing desirable 
products. Desirable products include, without limitation, 
products that can enhance the nutritional quality of the plant 
or products that are desirable in isolated form. If desired in 
isolated form, the product can be isolated from plant tissues. 
To prevent competition between the non-pathogenic bacteria 
which express the desired product and those that do not, it 
is possible to tailor the needs of recombinant, non-patho 
genic bacteria so that only they are capable if living in plant 
tissues expressing a particular effector protein or polypep 
tide of the present invention. 
The effector proteins or polypeptides of the present inven 
tion are believed to alter the plant physiology by shifting 
metabolic pathways to benefit the parasite and by activating 
or Suppressing cell death pathways. Thus, they may also 
provide useful tools for efficiently altering the nutrient 
content of plants and delaying or triggering Senescence. 
There are agricultural applications for all of these possible 
effects. 
Thus, a further aspect of the present invention relates 
more generally to a method of modifying a metabolic 
pathway in a cell by introducing into the cell an effector 
protein or polypeptide of the present invention which inter 
acts with a native cellular protein involved in a metabolic 
pathway of the cell. As a result of introducing the protein or 
polypeptide into the cell, the protein or polypeptide modifies 
the metabolic pathway through its interaction with the native 
cellular protein. By way of example, it is believed that 
HopPtol 2 is a tyrosine phosphatase that interacts with 
MAPK 
Yet another aspect of the present invention relates to a 
method of causing eukaryotic cell death which is carried out 
by introducing into a eukaryotic cell a protein which is 
cytotoxic and causes cell death. The eukaryotic cell which is 
treated can be either in vitro or in vivo. When treating 
eukaryotic cells in vivo, a number of different protein- or 
DNA-delivery systems can be employed to introduce the 
effector protein into the target eukaryotic cell. 
Another aspect of the present invention relates to a 
method of inhibiting programmed cell death which is carried 
out by introducing into a eukaryotic cell Susceptible to 
programmed cell death, a protein that is a hypersensitive 
response Suppressor, where the introduction thereof is per 
formed under conditions effective to inhibit programmed 
cell death of the eukaryotic cell. By inhibiting programmed 
cell death, it is intended that such inhibition includes both 
delaying the occurrence of programmed cell death as well as 
preventing programmed cell death. The eukaryotic cell 
which is treated can be either in vitro or in vivo. When 
treating eukaryotic cells in vivo, a number of different 
protein- or DNA-delivery systems can be employed to 
introduce the effector protein into the target eukaryotic cell. 
By way of example, hypersensitive response Suppressor 
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proteins include, without limitation, AVrPphE, 
AvrPpiB1, AvrPtoB, HopPtold 1, HopPtoE, HopPtoF (pre 
viously designated AvrPphF ORF2), and HopPtoK. 
Because programmed cell death (including apoptosis) is 
involved in the pathogenesis of a variety of diseases, the HR 
Suppressor proteins of the present invention can be used in 
the regulation thereof and, thus, as therapeutic agents in the 
intervention of a wide array of disease processes or maladies 
(see Rudin & Thompson, Ann. Rev. Med. 48:267-81 (1997), 
which is hereby incorporated by reference in its entirety). 
The protein- or DNA-delivery systems can be provided in 
the form of pharmaceutical compositions which include the 
delivery system in a pharmaceutically acceptable carrier, 
which may include suitable excipients or stabilizers. The 
dosage can be in Solid or liquid form, Such as powders, 
Solutions, Suspensions, or emulsions. Typically, the compo 
sition will contain from about 0.01 to 99 percent, preferably 
from about 20 to 75 percent of active compound(s), together 
with the carrier, excipient, stabilizer, etc. 
The compositions of the present invention are preferably 
administered in injectable or topically-applied dosages by 
Solution or Suspension of these materials in a physiologically 
acceptable diluent with a pharmaceutical carrier. Such car 
riers include sterile liquids, such as water and oils, with or 
without the addition of a surfactant and other pharmaceuti 
cally and physiologically acceptable carrier, including adju 
vants, excipients or stabilizers. Illustrative oils are those of 
petroleum, animal, vegetable, or synthetic origin, for 
example, peanut oil, soybean oil, or mineral oil. In general, 
water, Saline, aqueous dextrose and related Sugar Solution, 
and glycols, such as propylene glycol or polyethylene gly 
col, are preferred liquid carriers, particularly for injectable 
Solutions. 
Alternatively, the effector proteins can also be delivered 
via Solution or Suspension packaged in a pressurized aerosol 
container together with Suitable propellants, for example, 
hydrocarbon propellants like propane, butane, or isobutane 
with conventional adjuvants. The materials of the present 
invention also may be administered in a non-pressurized 
form such as in a nebulizer or atomizer. 
Depending upon the treatment being effected, the com 
pounds of the present invention can be administered orally, 
topically, transdermally, parenterally, Subcutaneously, intra 
venously, intramuscularly, intraperitoneally, by intranasal 
instillation, by intracavitary or intravesical instillation, 
intraocularly, intraarterially, intralesionally, or by applica 
tion to mucous membranes, such as, that of the nose, throat, 
and bronchial tubes. 
Compositions within the scope of this invention include 
all compositions wherein the compound of the present 
invention is contained in an amount effective to achieve its 
intended purpose. While individual needs vary, determina 
tion of optimal ranges of effective amounts of each compo 
nent is within the skill of the art. 
One approach for delivering an effector protein into cells 
involves the use of liposomes. Basically, this involves 
providing a liposome which includes that effector protein to 
be delivered, and then contacting the target cell with the 
liposome under conditions effective for delivery of the 
effector protein into the cell. 
Liposomes are vesicles comprised of one or more con 
centrically ordered lipid bilayers which encapsulate an aque 
ous phase. They are normally not leaky, but can become 
leaky if a hole or pore occurs in the membrane, if the 
membrane is dissolved or degrades, or if the membrane 
temperature is increased to the phase transition temperature. 
Current methods of drug delivery via liposomes require that 
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the liposome carrier ultimately become permeable and 
release the encapsulated drug at the target site. This can be 
accomplished, for example, in a passive manner wherein the 
liposome bilayer degrades over time through the action of 
various agents in the body. Every liposome composition will 
have a characteristic half-life in the circulation or at other 
sites in the body and, thus, by controlling the half-life of the 
liposome composition, the rate at which the bilayer degrades 
can be somewhat regulated. 
In contrast to passive drug release, active drug release 
involves using an agent to induce a permeability change in 
the liposome vesicle. Liposome membranes can be con 
structed so that they become destabilized when the environ 
ment becomes acidic near the liposome membrane (see, e.g., 
Proc. Natl. Acad. Sci. USA 84:7851 (1987); Biochemistry 
28:908 (1989), each of which is hereby incorporated by 
reference in their entirety). When liposomes are endocy 
tosed by a target cell, for example, they can be routed to 
acidic endosomes which will destabilize the liposome and 
result in drug release. 
Alternatively, the liposome membrane can be chemically 
modified such that an enzyme is placed as a coating on the 
membrane which slowly destabilizes the liposome. Since 
control of drug release depends on the concentration of 
enzyme initially placed in the membrane, there is no real 
effective way to modulate or alter drug release to achieve 
“on demand drug delivery. The same problem exists for 
pH-sensitive liposomes in that as soon as the liposome 
vesicle comes into contact with a target cell, it will be 
engulfed and a drop in pH will lead to drug release. 
This liposome delivery system can also be made to 
accumulate at a target organ, tissue, or cell via active 
targeting (e.g., by incorporating an antibody or hormone on 
the surface of the liposomal vehicle). This can be achieved 
according to known methods. 
Different types of liposomes can be prepared according to 
Bangham et al., J. Mol. Biol. 13:238–252 (1965); U.S. Pat. 
No. 5,653,996 to Hsu et al.; U.S. Pat. No. 5,643,599 to Lee 
et al.; U.S. Pat. No. 5,885,613 to Holland et al.; U.S. Pat. No. 
5,631,237 to Dzau et al.; and U.S. Pat. No. 5,059,421 to 
Loughrey et al., each of which is hereby incorporated by 
reference in their entirety. 
An alternative approach for delivery of effector proteins 
involves the conjugation of the desired effector protein to a 
polymer that is stabilized to avoid enzymatic degradation of 
the conjugated effector protein. Conjugated proteins or 
polypeptides of this type are described in U.S. Pat. No. 
5,681,811 to Ekwuribe, which is hereby incorporated by 
reference in its entirety. 
Yet another approach for delivery of proteins or polypep 
tides involves preparation of chimeric proteins according to 
U.S. Pat. No. 5,817,789 to Heartlein et al., which is hereby 
incorporated by reference in its entirety. The chimeric pro 
tein can include a ligand domain and, e.g., an effector protein 
of the present invention. The ligand domain is specific for 
receptors located on a target cell. Thus, when the chimeric 
protein is delivered intravenously or otherwise introduced 
into blood or lymph, the chimeric protein will adsorb to the 
targeted cell, and the targeted cell will internalize the chi 
meric protein, which allows the effector protein to de 
stabilize the cell checkpoint control mechanism, affording 
its cytotoxic effects. 
When it is desirable to achieve heterologous expression of 
an effector protein of the present invention in a target cell, 
DNA molecules encoding the desired effector protein can be 
delivered into the cell. Basically, this includes providing a 
nucleic acid molecule encoding the effector protein and then 
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introducing the nucleic acid molecule into the cell under 
conditions effective to express the effector protein in the cell. 
Preferably, this is achieved by inserting the nucleic acid 
molecule into an expression vector before it is introduced 
into the cell. 
When transforming mammalian cells for heterologous 
expression of an effector protein, an adenovirus vector can 
be employed. Adenovirus gene delivery vehicles can be 
readily prepared and utilized given the disclosure provided 
in Berkner, Biotechniques 6:616–627 (1988) and Rosenfeld 
et al., Science 252:431–434 (1991), WO 93/07283, WO 
93/06223, and WO 93/07282, each of which is hereby 
incorporated by reference in their entirety. Adeno-associated 
viral gene delivery vehicles can be constructed and used to 
deliver a gene to cells. The use of adeno-associated viral 
gene delivery vehicles in vitro is described in Chatterjee et 
al., Science 258:1485–1488 (1992); Walsh et al., Proc. Natl. 
Acad. Sci. 89:7257 7261 (1992); Walsh et al., J. Clin Invest. 
94: 1440–1448 (1994); Flotte et al., J. Biol. Chem. 268: 
3781–3790 (1993); Ponnazhagan et al., J. Exp. Med 179: 
733–738 (1994); Miller et al., Proc. Nat'l Acad. Sci. 
91:10183–10187 (1994); Einerhand et al., Gene Ther. 
2:336–343 (1995); Luo et al., Exp. Hematol. 23:1261–1267 
(1995); and Zhou et al., Gene Ther. 3:223–229 (1996), each 
of which is hereby incorporated by reference in their 
entirety. In vivo use of these vehicles is described in Flotte 
et al., Proc. Nat'l Acad. Sci. 90:10613-10617 (1993); and 
Kaplitt et al., Nature Genet. 8:148-153 (1994), each of 
which is hereby incorporated by reference in their entirety. 
Additional types of adenovirus vectors are described in U.S. 
Pat. No. 6,057,155 to Wickham et al.; U.S. Pat. No. 6,033, 
908 to Bout et al.; U.S. Pat. No. 6,001,557 to Wilson et al.: 
U.S. Pat. No. 5,994,132 to Chamberlain et al.; U.S. Pat. No. 
5,981,225 to Kochanek et al.; and U.S. Pat. No. 5,885,808 
to Spooner et al.; and U.S. Pat. No. 5,871,727 to Curiel, each 
of which is hereby incorporated by reference in their 
entirety). 
Retroviral vectors which have been modified to form 
infective transformation systems can also be used to deliver 
nucleic acid encoding a desired effector protein into a target 
cell. One such type of retroviral vector is disclosed in U.S. 
Pat. No. 5,849,586 to Kriegler et al., which is hereby 
incorporated by reference in its entirety. 
Regardless of the type of infective transformation system 
employed, it should be targeted for delivery of the nucleic 
acid to a specific cell type. For example, for delivery of the 
nucleic acid into tumor cells, a high titer of the infective 
transformation system can be injected directly within the 
tumor site so as to enhance the likelihood of tumor cell 
infection. The infected cells will then express the desired 
effector protein, thereby causing cytotoxic effects. 
Particularly preferred is use of the effector proteins of the 
present invention to treat a cancerous condition (i.e., the 
eukaryotic cell which is affected is a cancer cell). This can 
be carried out by introducing or administering to a patient, 
a cytotoxic Pseudomonas protein under conditions effective 
to inhibit cancer cell division, thereby treating the cancer 
condition. 
By introducing, it is intended that the effector protein is 
administered to the patient, preferably in the form of a 
composition which will target delivery to the cancer cells. 
Alternatively, when using DNA-based therapies, it is 
intended that the introducing be carried out by administering 
a targeted DNA delivery system to the patient such that the 
cancer cells are targeted and the effector protein is expressed 
therein. A number of targeted delivery systems are known in 
the art and can be employed herewith. 
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EXAMPLES 
The following Examples are intended to be illustrative 
and in no way are intended to limit the scope of the present 
invention. 
Materials & Methods for Example 1–2 
Strains and Media: Escherichia coli strain DH5O. was used 
for cloning experiments, and P. S. tomato DC3000 or deriva 
tives and P. S. phaseolicola 3121 were used for secretion or 
translocation assays, respectively. Routine culture condi 
tions for bacteria are similar to those described (van Dijk et 
al., J. Bacteriol. 181:4790 4797 (1999), which is hereby 
incorporated by reference in its entirety). Antibiotics were 
used at the following concentrations: 100 g/ml ampicillin, 
20 ug/ml chloramphenicol, 10 ug/ml gentamicin, 100 ug/ml 
rifampicin, 10 g/ml kanamycin, and 20 g/ml tetracycline. 
Secretion Assays: All of the secretion assays used P. S. 
tomato DC3000 strains carrying a pML 123 derivative con 
taining a PCR-cloned ORF (encoding a candidate Hrp 
secreted protein) fused to nucleotide sequences that encoded 
either the hemagglutinin or FLAG epitopes along with their 
native ribosome binding sites (Labes et al., Gene 89:37-46 
(1990), which is hereby incorporated by reference in its 
entirety). Details about the primers and the constructs are 
provided below. 
HopPtoE: The hopPtoE gene was cloned using forward 
primer 
(agtaggatccatagaaaaataccataggggtgca, SEQ ID No. 128) 
containing a BamHI site and reverse primer 
(agtatictagatcacttgtcatcgtegtCcttgtagtegtcaatcacatgcgcttg. 
SEQ ID No: 129) containing an Xbal site and FLAG 
epitope codons. The hopPtoC gene was cloned into 
plasmid vector plN162. 
HopPtoG: The hopPtoG gene was cloned using forward 
primer 
(atgcggatcccgtatgaccttgtaaaat, SEQID No: 130) contain 
ing a BamHI site and reverse primer 
(atgctictagatcaag.cgtaatctggaa 
catcgtatgggtagccgttgtaaaactgctt, SEQID No. 131) con 
taining an Xbal site and HA epitope codons. The 
hopPtoG gene was cloned into plasmid vector plN131. 
HopPtoH: The hopPtoH gene was cloned using forward 
primer 
(agtcggatccgataatcctggatgatccattg, SEQID No: 132) con 
taining a BamHI site and reverse primer 
(agtcctcgagtcacttgtcatcgtcgtccttgtagtettgatgtgccctgtactt, 
SEQ ID No: 133) containing an XhoI site and FLAG 
epitope codons. The hopPtoH gene was cloned into 
plasmid vector plN150. 
HopPtol: The hopPtol gene was cloned using forward 
primer 
(agtaaagcttacgggcagg tattgcaag, SEQ ID No. 134) con 
taining a BamHI site and reverse primer 
(agtatictagatcacttgtcatcgtegtCcttgtagtettttittgggcagccagcg, 
SEQ ID No: 135) containing an Xbal site and FLAG 
epitope codons. The hopPtoC gene was cloned into 
plasmid vector plN165. 
HopPtol: The hopPtoll gene was cloned using forward 
primer 
(agtaggatcctgcctccaactattggct, SEQID No: 136) contain 
ing a BamHI site and reverse primer 
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(agtatictagatcacttgtcatcgtcgtccttgtagtictetcgctttgaacgcctg. 
SEQ ID No: 137) containing an Xbal site and FLAG 
epitope codons. The hopPtoL gene was cloned into 
plasmid vector plN224. 
HopPtoS1: The hopPtoS1 gene was cloned using forward 
primer 
(ataggat.ccc.gagaacggcgcggacgtg, SEQ ID No: 138) con 
taining a BamHI site and reverse primer 
(atatotagatcatttatcatcatcatctittataatcctcgtcagagctictetgc. 
SEQ ID No: 139) containing an Xbal site and FLAG 
epitope codons. The hopPtoC gene was cloned into 
plasmid vector plN142. 
HopPtoS2: The hopPtoS2 gene was cloned using forward 
primer 
(gatggatccacgcacataacaacggtg, SEQID No. 140) contain 
ing a BamHI site and reverse primer 
(atatctagatcatttatcatcatcatctittataatcaatctgacttaatac, SEQ 
ID No: 141) containing an Xbal site and FLAG epitope 
codons. The hopPtoC gene was cloned into plasmid 
vector plN223. 
Constructs carrying different epitope-tagged ORFs were 
electroporated into DC3000 and a DC3000 hrcC mutant and 
grown in Hrp-inducing conditions (Yuan & He, J. Bacteriol. 
178:6399–6402 (1996), which is hereby incorporated by 
reference in its entirety). Additionally, all of the DC3000 
strains also carried pCPP2318, a construct that contains 
blaM lacking signal peptide sequences (Charkowski et al., J. 
Bacteriol. 179:3866–3874 (1997), which is hereby incorpo 
rated by reference in its entirety). DC3000 cultures were 
separated into cell-bound and Supernatant fractions as 
described (van Dijk et al., J. Bacteriol. 181:4790 4797 (1999), which is hereby incorporated by reference in its 
entirety). Proteins were separated with SDS/PAGE by stan 
dard procedures (Sambrook et al., Molecular Cloning. A 
Laboratory Manual, Cold Spring Harbor Lab Press, Plain 
view, N.Y. (1989), which is hereby incorporated by refer 
ence in its entirety), transferred to polyvinylidene difluoride 
membranes, and immunoblotted by using anti-FLAG (Sigma), anti-hemagglutinin (Roche Molecular Biochemi 
cals), or anti-B-lactamase (5 Prime->3 Prime) as primary 
antibodies. Primary antibodies were recognized by goat 
anti-rabbit IgG-alkaline phosphatase conjugate (Sigma), 
which were visualized by chemiluminescence by using a 
Western-Light chemiluminescence detection system 
(Tropix. Bedford, Mass.) and X-Omat X-ray film. 
Plant Materials and Translocation Assays: Arabidopsis 
thaliana accession Columbia (Col-0) and rps2-201 (Kunkel 
et al., Plant Cell 5:865-875 (1993), which is hereby incor 
porated by reference in its entirety) mutant plants were 
grown in a growth chamber with 12 h of light at 24°C. (22 
C. at night) and 70% relative humidity. Details about the 
primers and constructs described below. 
AvrRpt2: The avrRpt2 gene was cloned using forward 
primer 
(attggtacctictagaggatccaaccttcaatctgaa, SEQ ID No: 142) 
containing KpnI, Xbal, and BamHI sites and reverse 
primer 
(atgtcgacttagcggtagagcattgcg, SEQID No. 143) contain 
ing an Sal site. The avrRpt2 gene was cloned into plasmid vector pNavrRpt2. 
HopPtoG-AVrRpt2: The chimeric gene was cloned using 
forward primer 
(gcgaatticgttagttgattttgtctagcg, SEQID NO: 144) contain 
ing an EcoRI site, and reverse primer (gaggatccg.ccgt 
tgtaaaactgcttaga, SEQ ID NO: 145) containing a 
BamHI site. The chimeric gene was cloned into plas 
mid vector phopPtoGNavrRpt2. 
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The partial avrRpt2 gene with the N-terminal 40 codons 
deleted was amplified by using standard PCR procedures 
and cloned into pMOD (Epicentre Technologies, Madi 
son, Wis.). After confirmation by sequence analysis, it 
was cloned into the KpnI and SalI sites of the broad-host 
plasmid pLK, resulting in paavrRpt2. DNA fragments 
spanning 200 bp upstream of the Hrp boxes and the 
complete ORF for hopPtoG was cloned into paavrRpt2 to 
produce phopPtoG-AavrRpt2. The construct was intro 
duced in P. S. phaseolicola 3121 by electroporation. 
Bacterial strains in 10 mM MgCl, at a cell density of 10 
colony-forming units/ml were infiltrated into A. thaliana 
Col-0 and Col-0 rps2-201 plants with a needleless 
Syringe. 
Identification of Putative Effector Protein ORFs: Several 
approaches were employed for the identification of putative 
effector proteins, including the use of a Hidden Markov 
Model to analyze regions upstream of ORFs for hrp-related 
promoters (Fouts et al., Proc. Natl. Acad. Sci. USA 99(4): 
2275–2280 (2001), which is hereby incorporated by refer 
ence in its entirety), a miniTn5gus transposon-based assay 
which identifies HrpL-activated insertions, via insertions 
downstream of Hrp boxes (Fouts et al., Proc. Natl. Acad. Sci. 
USA99(4):2275–2280 (2001), which is hereby incorporated 
by reference in its entirety), and computer search for can 
didate Hrp-secreted proteins based on an algorithm that 
identifies compliance or non-compliance with export signal 
rules of known effector proteins (N-terminal 50 amino acids) 
(Petnicki-Ocwieja et al., Proc. Natl. Acad. Sci. USA 
99:7652–7657 (2002); U.S. patent application Ser. No. 
10/341,180 to Collmer et al., filed Jan. 13, 2003, each of 
which is hereby incorporated by reference in its entirety). 
Materials & Methods for Example 3–8 
Bacterial Strains, plasmids, and media: Escherichia coli 
strains DH5C. and DB3.1. (Invitrogen) were used for general 
cloning and Gateway technology manipulations, respec 
tively. P. S. pv. tomato DC3000 and P. fluorescens strains 
were grown in King's B (KB) broth at 30° C. (King et al., 
J. Lab. Med. 22:301–307 (1954), which is hereby incorpo 
rated by reference in its entirety). E. coli and Agrobacterium 
tumefaciens C58C1 were grown in LB broth at 37° C. or 30° 
C., respectively. Unless otherwise noted, constructs used 
were made by PCR and Table 1 below includes a list of 
nucleotide primer sequences that were used. The pHIR11 
derivative, pIN 18, which lacks she A and hopPsyA was 
generated as described previously (van Dijk et al., Mol. 
Microbiol. 44:1469–1481 (2002), which is hereby incorpo 
rated by reference in its entirety). Briefly, 2 kb regions 
upstream and downstream of she A and hopPsyA were PCR 
cloned into pEBluescript-II KS on either side of an inptII 
antibiotic marker. When transformed into the E. coli strain 
C2110 (Kahn and Hanawalt, J. Mol. Biol. 128:501-525 
(1979), which is hereby incorporated by reference in its 
entirety) containing pHIR11, this construct recombined into 
pHIR11 because ColE1 plasmids, such as pBluescript-II KS, 
cannot replicate in this polA mutant at 42° C. When this 
strain was grown at 30° C., the ColE1 replicon replicated, 
forcing it to recombine out of pHIR11. pHIR11 derivatives 
that lacked she A and hopPsy A were identified with PCR. 
Antibiotics were used at the following concentrations (ug/ 
ml): rifampicin, 100; ampicillin, 100; gentamicin, 10; kana 
mycin, 50; tetracycline. 20; nalidixic acid, 20; and specti 
nomycin 50. 

US 7,220,583 B2 
127 
TABLE 1-continued 
Additional information on plasmid constructions 
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Gene Primer Nucleotide Sequences (5'-->3') and Other SEQ ID Parent Plasmid 
Name Relevant Features NO: Plasmid Construct 
avrPpiB1P P860: ttggatccgtatgcacgcaaatcctittaagctic 200 pCilda pLN507 
(Bam HI) 
P861: ttctegagtcagtcgcctaggaaattatttagttcc 2O1 
(Xho I) 
hopPtoE P858: ttgaatticatgaatagagttccggtagctic (Eco RI) 202 pCilda pLN504 
P859: ttctegagtcagtcaatcacatgcgcttgg (Xho I) 2O3 
hopPtoF P856: ttgaatticatgggtaatatttgcggcacctic (Eco RI) 204 pGilda pLN505 
P857: ttctegagtcagacccttitcga.ccgg (Xho I) 205 
hopPtoG P862: ttgaatticatgcaaataaagaacagtcatcto (Eco RI) 206 pCilda pLN506 
P863: ttctegagtcagccgttgtaaaactgcttagag (Xho I) 2O7 
Hypersensitive Response Assays: The broad-host-range vec 
tor pML 123 was used to express effector genes in 
Pseudomonas strains (Labes et al., Gene 89:37-46 (1990), 
which is hereby incorporated by reference in its entirety). 
The pML 123 constructs containing hopPtoC, hopPtold1, 
hopPtol)2, and hopPtol are described in U.S. patent appli 
cation Ser. No. 10/114.828 to Collmer et al., filed Apr. 2, 
2002, which is hereby incorporated by reference in its 
entirety; and pML 123 constructs containing hopPtoE, hopP 
toG, hopPtoh, hopPtol, hopPtoL, hopPtoS1, and hopPtoS2 
are described above. A pML 123 construct containing hopP 
toB was similarly prepared. pML123 constructs containing 
hopPtoF, hopPtoK, hopPtoT, avrPtoB, avrPphEPto, 
avrPpiB1Pto, and avrPto are detailed in Table 1. Pfluore 
scens(pHIR11) carrying pML 123 constructs with effector 
genes or vector controls with an OD600 of 0.2 (ca. 10 
cells/ml) in 5 mM MES (pH 5.6) and infiltrated into Nic 
Otiana tabacum cv. Xanthi, N. benthamiana, or A. thaliana 
WS-0 leaves. For bacterial mixing experiments involving 
two different P. fluorescens strains, Pfluorescens(pLN 18) 
and a pML 123 effector construct were infiltrated 2 h before 
P. fluorescens(pHIR11). The plants were scored for the 
production of an HR after 24 h. DC3000 strains were tested 
for their ability to elicit an HR on Nicotiana tabacum cv. 
xanthi by infiltrating strains with an OD600 of 0.2 along 
with 10-fold serially diluted samples with a needleless 
Syringe. 
Type III secretion assays, SDS-PAGE, and immunoblot 
analysis: DC3000 and DC3000 hrcC mutant (Yuan and He, 
J. Bacteriol. 178:6399–6402 (1996), which is hereby incor 
porated by reference in its entirety) carrying the plasmids 
pLN162, pIN526, pCPP2318, which encode for HopPtoE 
FLAG, AVrPto, and B-lactamase, respectively, were grown 
in type III-inducing minimal medium (Huynh et al., Science 
245:1374–1377 (1989), which is hereby incorporated by 
reference in its entirety). Cells were adjusted to an initial 
OD600 of 0.3 and grown for 6 h and separated into cell 
bound and Supernatant fractions by centrifugation at 4° C. 
Protein samples from bacterial cultures were prepared simi 
larly as described (van Dijk et al., J. Bacteriol. 
181:4790 4797 (1999), which is hereby incorporated by 
reference in its entirety). Cell and supernatant fractions were 
analyzed by SDS-PAGE (Sambrook and Russell, Molecular 
Cloning: A Laboratory Manual, Cold Spring Harbor Labo 
ratory Press, Cold Spring Harbor, N.Y. (2001), which is 
hereby incorporated by reference in its entirety), transferred 
to polyvinylidene difluoride membranes, and immunobloted 
using anti-AVrPto, -8-lactamase, or -FLAG as primary anti 
bodies. Generation of anti-AVrPto antibodies has been 
described (van Dijk et al., J. Bacteriol. 181:4790 4797 (1999), which is hereby incorporated by reference in its 
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entirety). The anti-B-lactamase antibodies were purchased 
from Chemicon International and the anti-FLAG antibodies 
were purchased from Sigma Chemical Co. Primary antibod 
ies were recognized by goat anti-immunoglobulin G-alka 
line phosphatase conjugate (Sigma Chemical Co.), and 
visualized by chemiluminescence using a chemiluminces 
cence detection system and X-Omat X-ray film. 
Agrobacterium-mediated transient assays: The avr gene 
hopPsyA was recombined into a derivative of pPZP212 
(Hajdukiewicz et al., Plant Mol. Biol. 25:989–994 (1994), 
which is hereby incorporated by reference in its entirety), 
pIN462, which was modified to be a Gateway Destination 
vector, resulting in plN474. The bax gene was PCR-cloned 
into pTA7002, creating plN531, and expression of bax was 
induced with dexamethasome as previously described 
(Aoyama and Chua, Plant Journal 11:605–612 (1997), 
which is hereby incorporated by reference in its entirety). 
The effector genes carried on Gateway entry vectors avrP 
phEPto, avrPpiB1Pto, avrPtoB, hopPtoE, hopPtoF, and 
hopPtoG were recombined into pIN462 (which fused each 
gene to a hemagglutinin epitope) creating constructs 
pLN535, pI N503, pI N502, pI N524, pI N525, and 
pIN530, respectively. Agrobacterium-mediated transient 
expression experiments were done by infiltrating A. tume 
faciens C58C1 (van Larebeke et al., Nature 252: 169-170 (1974), which is hereby incorporated by reference in its 
entirety) harboring the disabled Tiplasmid pMP90 (Koncz 
and Schell, Mol. Gen. Genet. 204:383–396 (1986), which is 
hereby incorporated by reference in its entirety) at an 
OD600 of 0.4 into N. benthamiana and N. tabacum cv. 
xanthi plants using a needleless Syringe as described (van 
den Ackerveken et al., Cell 87: 1307–1316 (1996), which is 
hereby incorporated by reference in its entirety). For co 
expression experiments, Agrobacterium strains carrying 
pPZP212 binary plasmids with different effector genes were 
infiltrated 4h prior to infiltration of strains expressing either 
Bax or HopPsyA. Evidence of production of effectors from 
transient assays was acquired by harvesting 1 cm diameter 
leaf disks from infiltrated Zones, grinding leaf tissue with a 
mortar and pestle in the presence of liquid nitrogen, and 
resuspending plant material in 50 ul of 1x SDS-PAGE 
tracking buffer. SDS-PAGE and immunoblot analysis were 
performed as described above using high affinity anti 
hemagglutinin antibodies (Roche). 
Construction of DC3000 effector mutants: In-frame internal 
fragments of the effector genes were PCR cloned into XcmI 
digested pKnockout-. (Windgassen et al., FEMS Microbiol. 
Lett. 193:201–205 (2000), which is hereby incorporated by 
reference in its entirety) using the primer sets listed in Table 
1 above. The resulting constructs were conjugated sepa 
rately into DC3000 by triparental mating using spectinomy 
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cin as selection for the plasmid marker. The following 
effector mutants were confirmed with primers that flanked 
each coding region: hopPtol) 1, UNL104; hopPtoC, 
UNL106; hopPtoE, UNL139; hopPtoK, UNL107; hopPtol, 
UNL108; hopPtoF, UNL109; avrPhEPto, UNL113: 
avrPpiB1Pto, UNL114; hopPtoH, UNL118; hopPtoT, 
UNL122; hopPtoG, UNL124; hopPtoS1, UNL126; and 
avrPtoB, UNL127. 
Yeast viability assays: To determine whether type III effec 
tor-encoding plasmids rescued yeast from Bax-induced 
lethality, the effector genes avrPphEPto, avrPpiB1Pto, hopP 
toG, hopPtoF, and hopPtoE were PCR-cloned into the yeast 
expression vector pGilda (Clontech, Palo Alto, Calif.) result 
ing in constructs plN508, pI N507, pILN506, pILN505, and 
pIN504, respectively. Table 1 above contains information 
for the nucleotide primers used to make these constructs. S. 
cerevisiae EGY48 strain containing pG4-5-Bax (kindly 
provided by J. C. Reed, Burnham Institute, La Jolla, Calif.) 
and various pGilda plasmids containing effector genes were 
grown in SC-U-L/glucose media overnight. The chicken 
Bcl-XL cloned in pGilda was kindly provided by C. Thomp 
son (University of Chicago, Chicago, Ill.), which acted as a 
positive control for PCD suppression in these experiments. 
The yeast cultures were then serial 10-fold diluted into SC 
medium, and 5 ul of each dilution was dropped onto 
SC-U-L/Galactose or SC-UL/Glucose plates. Cells were 
Initial 
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with mobile genetic elements suggested horizontal acquisi 
tion. Several of the predicted proteins shared amino acid 
identity with proteins likely to be effectors. For example, 
HopPtoS1 (ORF5) yields several ADP-ribosyltransferases in 
BLASTP searches (highest BLAST E value 1e-5), including 
a type III-secreted ADP-ribosyltransferase from Pseudomo 
nas aeruginosa (Yahr et al., Mol. Microbiol. 22:991–1003 (1996)), and HopPtoh (ORF2) is homologous to an ORF 
adjacent to the avrPpiC2 avr gene of P. S. pisi (Arnold et al., 
Microbiology 147: 1171–1182 (2001), which is hereby incor 
porated by reference in its entirety) (see Table 2 below). 
To test whether these proteins travel the Hrp pathway, the 
ORFs were cloned into a broad-host-range vector fused to 
either the hemagglutinin or FLAG epitope. DC3000 wild 
type and Hrp mutant cultures carrying these constructs were 
separated into Supernatant and cell fractions and analyzed 
with SDS/PAGE and immunoblots. Five of the eight pro 
teins tested were secreted via the DC3000 Hrp system (FIG. 
1A) and consequently were designated as HopPtoE, HopP 
toG, HopPtoH, HopPtol, and HopPtoS1, respectively. 
Although three ORFs (ORF6, ORF 7, and ORF8) were not 
detectably secreted in culture, they may still be effectors 
because AvrB similarly is not secreted in culture although 
translocated in planta (van Dijk et al., J. Bacteriol. 181: 
4790 4797 (1999); Gopalan et al., Plant Cell 8:1095-1105 
(1996), each of which is hereby incorporated by reference in 
its entirety). 
TABLE 2 
ORFs with 5' Hrp Promoter Sequences and Encoding Proteins 
Demonstrated to be Secreted by the P. Syrigae Hrp System 
designation 
ORF1 
ORF2f 
ORF3 
ORF4 
ORF5 
New Size % Homolog GenBank 
designation (bp) G + C (BLASTP E value) Accession 
HopPtol 1,899 48.9 None NA 
HopPtoH 657 47.2 ORF3 from P. s. pisi CAC 16702 
avrPpiC2 locus (le-114) 
HopPtoE 636 50.7 None NA 
HopPtoG 1,482 43.7 Hypothetical protein from NP 521884 
R. Solanacearum (le-137) 
HopPtoS1 852 46.5 Chicken ADP- P55807 
ribosyltransferase (1e-5) 
fEach of the listed Genbank Accessions is hereby incorporated by reference in its 
entirety. 
ORF2: homolog described in Arnold et al., Microbiology 147:1171-1182 (2001), which 
is hereby incorporated by reference in its entirety. 
*ORF5:homolog described in Tsuchiya et al., J.Biol.Chem. 269:27451-27457 (1994), 
which is hereby incorporated by reference in its entirety. Determined to possess an ART 
domain (pfam1129), further confirming its similarity to ADP-ribosyltransferases. 
incubated at 30° C. for 5 days, and photographed. For 
oxidative stress experiments, EGY48 strains containing 
pGilda effector constructs were grown in SC-U media 
overnight and treated as described in Abramovitch et al. 
(Abramovitch et al., EMBO 22:60–69 (2003), which is 
hereby incorporated by reference in its entirety). 
Example 1 
Demonstration of Pseudomonas syringae pv. tomato 
DC3000 Protein Secretion 
From the hidden Markov model analysis, 28 candidate 
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effector ORFs were identified that were not homologs of 65 
known Avr proteins/Hops or of any proteins unlikely to be 
secreted, and whose low G+C '% content and association 
To determine whether the export signal-based search had 
identified any novel Hrp-secreted proteins, secretion assays 
were also performed on ORF29 and ORF30, both of which 
seemed to be particularly promising candidates. The prod 
ucts encoded by ORF29 and ORF30 share similarity with a 
putative type III effector from S. enterica, SrfC, and ADP 
ribosyltransferases, respectively. Both ORFs were PCR 
cloned into a broad-host-range vector fused to the FLAG 
epitope, and each construct was introduced into DC3000 
wild-type and Hrp mutant strains. The epitope-tagged 
ORF29 and ORF30 proteins were secreted by DC3000 in a 
Hrp-dependent manner without leakage of a cytoplasmic 
marker protein (FIG. 1B), and consequently they were 
designated as HopPtol, and HopPtoS2, respectively (see 
Table 3 below). 
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TABLE 3 
132 
Selected ORFs Encoding Candidate Effector Proteins That Were 
Identified by the Genomewide Search Based on Export-Signal Patterns 
Homolog 
New Size % Hrp Mobile (BLASTP E GenBank 
Designation Designation (bp) G + C promoterf DNA value) Accession 
ORF29. HopPtoL 270 61.0 l l SPI-2 regulated AAF74575 
O SrfC (1e-21) 
ORF308. HopPtoS2 795 46.5 y in Clostridium NP 346979 
exoenzyme C3 
ADP ribosyl 
Tansferase (1e-5) 
ORF312, NA 897 49.8 y y Chicken ADP P55807 
ribosyl 
transferase (5e-3) 
ORF32.É. NA 507 54.2 y y Chicken ADP P55807 
ribosyl 
transferase (5e-3) 
ORF33 NA 282 55.2 l y SepC insecticidal NP O65279 
3 toxin (1e-128) 
ORF34: NA 534 63.5 y in Lytic enzyme BAA83137 
(3e-36) 
findicates that the ORF is within 10 kb of a HrpL-responsive Hrp promoter identified in Fouts 
Indicates that a transposon, plasmid, or a phage-related sequence is within 10 kb. 
Each of the listed Genbank Accessions is hereby incorporated by reference in its entirety. 
"ORF was determined to possess an ART domain (pfam1129), further confirming its similarity to ADP 
ribosyltransferases. 
Homolog identified in Worley et al., Mol. Microbiol. 36:749-761 (2000), which is hereby incorporated 
by reference in its entirety. 
Homolog identified in Nolling et al., J. Bacteriol. 183:4823-4838 (2001), which is hereby incorporated 
by reference in its entirety. 
Homolog identified in Tsuchiya et al., J. Biol. Chem. 269:27451-27457 (1994), which is hereby incor 
porated by reference in its entirety. 
Homolog identified in Hurst et al., J. Bacteriol. 182:51.27-5138 (2000), which is hereby incorporated 
by reference in its entirety. 
*Homolog identified in Nakayama et al., Mol. Microbiol. 38:213-231 (2000), which is hereby incorpo 
rated by reference in its entirety. 
Interestingly, the export signal-based search found a puta 
tive effector, SrfC, that is predicted to travel the type III 
pathway encoded by SPI2 of S. enterica (Worley et al., Mol. 
Microbiol. 36:749-761 (2000), which is hereby incorporated 
by reference in its entirety). A further indicator of the 
efficacy of the search was the finding of three additional 
ADP-ribosyltransferases, ORF 30, 31, and 32, all with 
significant amino acid sequence identity to HopPtoS 1 
(Table 3). 
Example 2 
AvrRpt2 Translocation Assay Indicates that at Least One of 
the Additional Hops Is Translocated into Plant Cells. 
HopPtoG was selected to test for translocation into plant 
cells because it shared no similarities with any sequences in 
the databases and was shown to be secreted (FIG. 1B). P. s. 
phaseolicola carrying a plasmid expressing hopPtoG-A avr 
Rpt2 elicited an RPS2-dependent hypersensitive response in 
A. thaliana Col-0 (FIG. 1C), indicating that targeting infor 
mation in HopPtoG directed translocation of the AvrRpt2 
fusion protein into plant cells. Thus, HopPtoG appears to be 
a Hrp-injected effector protein. 
Discussion of Examples 1-2 
One demonstration of the selectivity of the export signal 
rules is that only the chicken ADP-ribosyltransferase 
NRT2, shows major violations of the rules even though 
this protein is more similar to HopPtoS1 and S2 than either 
of the type III-secreted ADP-ribosyltransferases from P 
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aeruginosa, ExoS and ExoT (see Petnicki-Ocwieja et al., 
Proc. Natl. Acad. Sci. USA 99:7652–7657 (2002); U.S. 
patent application Ser. No. 10/341,180 to Collmer et al., filed 
Jan. 13, 2003, each of which is hereby incorporated by 
reference in its entirety). 
HopPtoS1 and HopPtoS2 share sequence similarity with 
ADP-ribosyltransferases, proteins that have long been impli 
cated in bacterial pathogenesis in animals through the modi 
fication of host signal transduction pathways (Finlay & 
Falkow, Microbiol. Mol. Biol. Rev. 61:136–169 (1997), 
which is hereby incorporated by reference in its entirety), 
but until now have not been implicated in the bacterial 
pathogenesis of plants. The DC3000 genomic studies 
described in Fouts et al. (Proc. Natl. Acad. Sci. USA 
99:2275–2280 (2002), which is hereby incorporated by 
reference in its entirety) clearly show that several of the 
effectors in DC3000 are redundant. By using the pattern 
based export prediction, three ADP-ribosyltransferase genes 
(in addition to hopPtoS1) that have N-termini putative 
export signals were identified in the genome of DC3000. 
One of these, ORF32, appears to be truncated. The other 
two, HopPtoS2 and ORF31, are full-length genes based on 
sequence alignments. HopPtoS2 is secreted by the Hrp 
system (FIG. 1B) and ORF31 shares high amino acid 
sequence identity with the Hrp-secreted HopPtoS1. Inter 
estingly, HopPtoS1 contains putative myristoylation and 
palmitoylation sites at its N terminus, whereas the other two 
do not, indicating that HopPtoS1 may be localized to the 
plasma membrane. Thus, there appear to be at least three 
Hrp-secreted ADP-ribosyltransferases and these may local 
ize to different regions of the plant cell. The existence of 
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these proteins in Pseudomonas Syringae is particularly note 
worthy given that ADP-ribosyltransferase genes have not 
been identified in the bacterial plant pathogen genomes that 
have been published thus far (Simpson et al., Nature 406: 
151-159 (2000); Wood et al., Science 294:2317-2323 
(2001); Goodner et al., Science 294:2323–2328 (2001): 
Salanoubat et al., Nature 415:497–502 (2002), each of 
which is hereby incorporated by reference in its entirety). 
Significantly, the genomewide search for export signals 
yielded a homolog of the S. enterica candidate effector SrfC, 
further adding to the growing list of effectors shared between 
plant and animal pathogens. It is also noteworthy that one of 
the ORFs found by the genomewide search (ORF48) is a 
homolog of a bacterial catalase (BLASTP 1e-126), and 
another (ORF49) is a glucokinase homolog (BLASTP 
3e-42). These putative effectors likely have a role in oxida 
tive stress and regulation of Sugar metabolism, respectively. 
Example 3 
HopPtoE Suppresses the Hypersensitive Response in 
Tobacco and a DC3000 hopPtoE Mutant Possesses an 
Enhanced Hypersensitive Response Phenotype 
In the course of experiments with confirmed DC3000 type 
III effectors, the effector HopPtol 2 was observed capable of 
suppressing the HR elicited by P. S. phaseolicola on Nic 
Otiana benthamiana plants. These results prompted the 
screening other effector proteins for HR suppressor activity 
(Collmer et al., Trends Microbiol. 10:462-470 (2002)). To 
do this, the pHIR11 system was used, allowing nonpatho 
gens such as E. coli and Pfluorescens to elicit the HR and 
secrete effectors in culture via the TTSS. This tool allowed 
for testing whether individual effectors were capable of 
suppressing the HopPsyA-dependent HR as depicted in FIG. 
2A. P. fluorescens(pHIR11) strains carrying a number of 
different effector constructs were infiltrated into tobacco (N. 
tabacum cv. xanthi). Interestingly, HopPtol)2, the effector 
that suppressed an HR elicited by P. phaseolicola, did not 
suppress the HopPsyA-dependent HR (FIG. 4A). The first 
identified effector to suppress or block the HR elicited by P 
fluorescens(pHIR11) was HopPtoE (FIG. 2B). To detect a 
potential phenotype consistent with HopPtoE acting as an 
HR suppressor, a DC3000 mutant defective in HopPtoE was 
constructed. Both DC3000 and the hopPtoE mutant, 
UNL 139, elicited an HR in tobacco when infiltrated into leaf 
panels at high inoculum (FIG. 2C). 
Based on this result, it is likely that effectors have 
functionally redundant roles, which may partially mask a 
phenotype. Therefore, a more sensitive HR assay was per 
formed, where 10-fold serially diluted bacterial strains were 
infiltrated into tobacco leaf panels to detect any subtle 
difference in the 5 ability of different strains of bacteria to 
elicit an HR. When UNL 139 was tested in this assay, it was 
more effective than DC3000 at HR elicitation at lower cell 
density (FIG. 2C). Interestingly, when hopPtoE was pro 
vided in trans to UNL 139, the mutant strain was less 
effective at HRelicitation than DC3000 (FIG. 2C). Thus, the 
enhanced HR phenotype of the hopPtoE mutant was 
complemented by hopPtoE. These observations are consis 
tent with HopPtoE acting as an HR Suppressor and Suggest 
that HopPtoE contributes incrementally to the ability of the 
pathogen to Suppress the HR. 
Example 4 
HopPtoE. Does Not Block the DC3000 Type III Secretion 
System 
One possible explanation for the observed phenotypes 
was that HopPtoE was blocking the type III secretion of 
5 
10 
15 
25 
35 
40 
45 
50 
55 
60 
65 
134 
other type III substrates, including Avr proteins. There is 
actually a precedent for type III substrates, such as HrpZ and 
HrpW, to block the type III secretion of proteins from P 
syringae (Alfano et al., Mol. Microbiol. 19:715–728 (1996): 
Charkowski et al., J. Bacteriol. 180:5211–5217 (1998), each 
of which is hereby incorporated by reference in its entirety) 
and it was crucial to consider this alternative. To test this, 
DC3000 and a DC3000 hrcC mutant defective in the TTSS, 
both carrying plasmids that contained avrPto and hopPtoE, 
were grown in a medium that induced type III Secretion. 
These cultures were separated into Supernatant and cell 
fractions, and analyzed them by SDS-PAGE and immuno 
blots with either anti-FLAG or -AVrPto antibodies. Both 
AvrPto and HopPtoE were secreted in culture via the TTSS 
(FIG. 3B), indicating that, at least in culture, over-expres 
sion of hopPtoE did not block type III secretion. It was next 
determined whether expression of hopPtoE in DC3000 
altered its HR-eliciting ability. Because DC3000 contains a 
native copy of hopPtoE in its genome, these experiments 
actually tested whether over-expression of HopPtoE altered 
the HR phenotype. DC3000 strains, with and without plas 
mid-encoded hopPtoE, were infiltrated into tobacco at high 
inoculum levels (10 cells/ml). After 24 hours, DC3000 
elicited an HR on tobacco, whereas DC3000 with a plasmid 
containing hopPtoE did not (FIG. 3B), indicating that over 
expression of HopPtoE suppressed the HR. However, after 
approximately 3 h, DC3000 with hopPtoE in trans also 
elicited an HR. Thus, hopPtoE in trans in DC3000 only 
delayed the ability of this pathogen to elicit an HR. When 
these experiments were repeated in N. benthamiana, the HR 
delay was greater than 24 h, indicating that the Suppression 
ability of HopPtoE depended to a certain extent on the test 
plant. To eliminate the possibility that HopPtoE affected the 
ability of Pfluorescens(pHIR11) to deliver the Avr protein 
HopPsyA into plant cells, a different bacterial strain was 
used to deliver HopPsy A (as compared to the strain used to 
deliver HopPtoE) into plant cells. To accomplish this, a 
pHIR11 derivative, pIN 18, was constructed so as to lack 
hopPsyA and ShcA, a gene that encodes a chaperone for 
HopPsyA (van Dijk et al., Mol. Microbiol. 44:1469–148 
(2002), which is hereby incorporated by reference in its 
entirety). P. fluorescens(pLN 18) does not elicit an HR on 
tobacco because it lacks HopPsy A (FIG. 3C), while main 
taining the ability to secrete proteins via its functional TTSS. 
In planta mixed-inoculum experiments were performed 
by first infiltrating into tobacco Pfluorescens(pLN 18) with 
hopPtoE contained in a broad-host-range plasmid and, after 
2 h, P. fluorescens(pHIR11). P. fluorescens(pHIR11) was 
infiltrated at an OD600 sufficient to cause HR elicitation. 
FIG. 3C shows that P. fluorescens(pLN 18) retained the 
ability to suppress the pHIR11-dependent HR. This indicates 
that the HR suppression activity does not occur in the 
bacterial cell. 
Example 5 
pHIR11 Assays Identify Seven Effectors Capable of Sup 
pressing the HopPsyA-Dependent Hypersensitive Response 
Nineteen confirmed effector genes were cloned into a 
broad-host-range plasmid and tested to determine whether 
the encoded effectors were able to suppress the HR elicited 
by P. fluorescens(pHIR11) (see FIG. 4A for a list of the 
effectors tested). Each candidate Suppressor gene was 
expressed in Pfluorescens(pHIR11) and these strains were 
infiltrated into tobacco and Arabidopsis thaliana ecotype 
Ws-0, two plants that produce an HR in response to pHIR11 
containing bacteria. 
Surprisingly, seven of the nineteen effectors tested were 
able to suppress the pHIR11-dependent HR on both A. 
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thaliana and tobacco (FIGS. 4B-C). In planta mixed-inocu 
lum experiments similar to those describe in FIG. 3C 
demonstrated that all of the identified suppressors were able 
to inhibit the pHIR11-dependent HR. These results indicate 
that the site of suppressor activity was outside of the 
bacteria. Two of the identified suppressors, HopPtoF and 
AvrPtoB, were homologs of AvrPphF and VirPphA, respec 
tively, two AVr proteins able to “block” the HR produced by 
P. S. phaseolicola (Jackson et al., Proc. Natl. Acad. Sci. USA 
96:10875–10880 (1999); Tsiamis et al., EMBO J. 
19:3204-3214 (2000), each of which is hereby incorporated 
by reference in its entirety). The VirPphA homolog, AvrP 
toB, was recently reported to suppress the HR elicited by 
AvrPto (Abramovitch et al., EMBO J. 22:60–69 (2003), 
which is hereby incorporated by reference in its entirety). 
Thus, these findings demonstrate that AvrPtoB and HopPtoF 
are HR suppressors. The other HR suppressors identified 
were AvrPphE, AvrPpiB1, HopPtol)1, and HopPtoK. 
The HR suppression observed for HopPtoD1 and HopPtoK 
was not complete (i.e., the HR was present, although much 
reduced). 
Example 6 
Agrobacterium Transient Assays that Co-Deliver HopPsyA 
and Individual Hypersensitive Response Suppressors Con 
firm that Each Effector Alone Suppresses the HopPsyA 
Dependent Hypersensitive Response Inside Plant Cells 
To determine if the HR suppression is due solely to the 
suppressor proteins, both HopPsyA and individual HR Sup 
pressor effectors were transiently co-delivered using Agro 
bacterium-mediated transient assays (agroinfiltrations) (van 
den Ackerveken et al., Cell 87: 1307–1316 (1996), which is 
hereby incorporated by reference in its entirety). In each 
case, the effector suppressed the HopPsyA-dependent HR 
(FIG. 5A). Protein expression was confirmed with immu 
noblots that showed the agroinfiltrations produced both 
HopPsy A and the specific suppressor tested (FIG. 5B). 
These data complement the bacteria-delivered suppressor 
data shown above, because agroinfiltrations demonstrate 
that the Suppressor activity is dependent only on the Sup 
pressor and that the Suppressor acts within plant cells, 
whereas the experiments where P. fluorescens(pHIR11) 
deliver each Suppressor resemble what happens in nature 
and protein levels are closer to the levels that the pathogen 
"inject' into plant cells. 
Example 7 
DC3000 Suppressor Mutants Display an Enhanced Ability 
to Elicit a Hypersensitive Response on Nonhost Plants, 
Consistent with Loss of Hypersensitive Response Suppres 
sion Activity in the Pathogen 
Based on the above findings, it was recognized that a 
pathogen may encode multiple HR Suppressors, each con 
tributing, perhaps incrementally, to the Suppression of the 
HR and/or plant defenses. To analyze these proteins in more 
detail, mutants defective in each gene corresponding to the 
effectors listed in FIG. 4A were made. The ability of 
DC3000 and the suppressor mutants to induce defense 
responses on non-host plants were tested, similar to the 
experiments described in FIG. 2C. Tobacco leaves were 
infiltrated with different dilutions of DC3000 or each 
mutant, and then their ability to elicit an HR was analyzed. 
Interestingly, all the mutants were more effective at eliciting 
an HR at lower concentrations, generally producing an HR 
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at 10-fold higher dilution than wild type DC3000 (FIG. 6). 
As an example, UNL105 caused a confluent HR at a titer of 
10° cells/ml, whereas DC3000 only produced a spotty HR or 
no HR at this titer. It is important to note that DC3000 
produced a typical HR at dilutions of 10° cells/ml or higher. 
This enhanced HR phenotype produced by each suppressor 
mutant resulted from the absence of the effector, because 
when each was supplied in trans the HR-eliciting ability 
returned to a DC3000-like HR (FIG. 6). 
Although HopPtoG was not identified as an HR suppres 
sor in the assays with Pfluorescens(pHIR 11), the hopPtoG 
mutant UNL 124 caused an enhanced HR phenotype. More 
over, additional assays shown below Suggest that HopPtoG 
does function as a Suppressor. Thus, these findings demon 
strate that the phenotype of potential Suppressor mutants on 
non-host plants is consistent with and complements HR 
suppression data. Therefore, the HR titration assays should 
be useful in the identification of other HR suppressors in 
bacterial plant pathogens. 
Example 8 
Pseudomonas Syringae Hypersensitive Response Suppres 
sors Inhibit Programmed Cell Death Induced by the Pro 
apoptotic Protein Bax in both Plants and Yeast 
The pro-apoptotic mouse protein Bax has been shown to 
induce PCD in plants that resembles the HR (Kawai-Yamada 
et al., Proc. Natl. Acad. Sci. USA 98: 12295–12300 (2001): 
Lacomme and Santa Cruz, Proc. Natl. Acad. Sci. USA 
96:7956–7961 (1999), each of which is hereby incorporated 
by reference in its entirety). Bax is a member of the Bcl-2 
family of pro-apoptotic proteins and is thought to initiate 
programmed cell death (PCD) by localizing to the mito 
chondria and causing the release of pro-apoptotic factors, 
including cytochrome c (Jurgensmeier et al., Proc. Natl. 
Acad. Sci. USA 95:4997-5002 (1998), which is hereby 
incorporated by reference in its entirety). Recently, Abra 
movitch et al. (EMBO J. 22:60–69 (2003), which is hereby 
incorporated by reference in its entirety) reported that AvrP 
toB suppresses Bax-induced PCD in plants. The suppressors 
identified in Examples 3–7 were tested in their ability to 
suppress Bax-induced PCD in plants. With the exception of 
AVrPpiB1, all of them suppressed Bax-induced cell death 
in plants (FIG. 7A). Interestingly, AvrPphE, HopPtoG, 
HopPtoF, and HopPtoE also suppressed Bax-induced PCD 
in yeast (FIG. 7B). The fact that AvrPtoB was unable to 
suppress Bax-induced PCD in yeast highlights a difference 
between the activity of these suppressors. Moreover, AvrP 
phE, HopPtoG, HopPtoF, and HopPtoE were unable to 
suppress the PCD initiated in yeast by H.O., while AvrPtoB 
did suppress PCD in this assay (Abramovitch et al., EMBO 
J. 22:60–69 (2003), which is hereby incorporated by refer 
ence in its entirety). This further demonstrates that the PCD 
Suppressors display different PCD Suppressing characteris 
tics. 
Discussion of Examples 3–8 
Effectors delivered by the Hrp TTSS appear central to P. 
syringae pathogenesis, but the anti-host functions of these 
proteins remain obscure. The above Examples identify a 
founding inventory of Hrp effectors from P. S. tomato 
DC3000 using several novel bioassays and provide evidence 
that many of these proteins appear to suppress one or more 
broadly conserved eukaryote PCD pathways. To understand 
these results, it is useful to consider the collection of 
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effectors that were assayed, the utility and limitations of the 
bioassays, and the role of plant cell death in disease and 
defense. The nineteen effectors considered here were 
recently identified in DC3000 on the basis of their homology 
with known effectors and/or their ability to be secreted 
and/or translocated by the Hrp TTSS. In general, P. syringae 
TTSS effectors identified on the basis of avirulence pheno 
types are designated AVrs, whereas those identified through 
secretion assays are designated Hops. However, the working 
assumption is that all of the “AVrs' are injected into plant 
cells by the Hrp system and many of the “Hops' will confer 
avirulence phenotypes to bacteria if tested in hosts that 
happen to carry a corresponding R gene; that is, effectors, 
AVrs, and Hops are synonymous terms. 
It must be noted that the effector described herein do not 
represent the entire inventory of DC3000 effectors. Effectors 
encoded within the Hrp pathogenicity island are described 
els where (Alfano et al., Proc. Natl. Acad. Sci. USA 
97:4856–4861 (2000), which is hereby incorporated by 
reference in its entirety. Additional candidate effectors in 
DC3000 have also been identified (Collmer et al., Trends 
Microbiol. 10:462-470 (2002), which is hereby incorporated 
by reference in its entirety). 
However, the set of effectors analyzed here suggests that 
many DC3000 effectors have HR suppression activity. The 
bioassays used herein were designed to efficiently detect HR 
Suppressor activity, determine whether Suppressor action 
occurs in plant cells rather than in bacteria, and determine if 
the test effectors could also suppress PCD in other plants and 
the model eukaryote, yeast. The primary Screen, based on 
suppression of the HR elicited by Pfluorescens(pHIR11) in 
tobacco, proved to be simple and effective (FIG. 2). 
Although there is the formal possibility that suppressors 
identified with this bioassay could be merely interfering with 
the delivery of HopPsyA, multiple lines of evidence indicate 
that they act after delivery into plant cells. For example, 
HopPtoE overexpression had no effect on the secretion of 
AvrPto (FIG. 3A), a representative type III substrate, and 
HopPtoE suppressed HopPsyA-dependent HR elicitation 
when delivered by a functional TTSS in a different strain 
(FIG. 3C) or when transiently expressed in plant cells 
following inoculation with A. tumefaciens (FIG. 5A). It is 
also noteworthy that the suppressors identified herein func 
tioned when delivered via the TTSS, a natural route that is 
thought to yield relatively low levels of effectors within 
plant cells. Agrobacterium-mediated transient expression, in 
contrast, can produce far higher levels of effectors within 
plant cells potentially leading to artifactual responses. It 
should also be noted that HopPtold1 and HopPtoK appear to 
exhibit limited suppressor activity. 
In an attempt to identify plant targets or sites of action of 
the Suppressors in plants, HopPtoE, AVrPphE, 
AvrPiB1, AvrPtoB, HopPtoF, and HopPtoG were sub jected to cursory bioinformatic analyses. BLASTP and PSI 
BLAST searches (Altschul et al., Nucleic Acids Res. 25: 
3389–3402 (1997), which is hereby incorporated by refer 
ence in its entirety) did not identify any proteins (other than 
clear AVr homologs) that shared significant similarity with 
any of the suppressors. However, 3D-PSSM analyses, a 
method that uses protein fold recognition to identify proteins 
with similar folding patterns (Kelley et al., J. Mol. Biol. 
299:499–520 (2000), which is hereby incorporated by ref 
erence in its entirety), indicated that AVrPtoB had similarity 
to heme-dependent peroxidases (above 90% certainty: 
PSSM E value 0.0895). Moreover, when AvrPtoB was 
aligned with a lignin peroxidase, a representative heme 
dependent peroxidase (Welinder, Eur: J. Biochem. 151: 
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497–504 (1985), which is hereby incorporated by reference 
in its entirety), the amino acids within the peroxidase active 
site were present similarly spaced in AvrPtoB. This result is 
intriguing because of the clear involvement of reactive 
oxygen species (ROS) in plant defense (Mittler, Trends 
Plant Sci. 7:405–410 (2002), which is hereby incorporated 
by reference in its entirety) and the potential of peroxidases 
to modulate ROS. Moreover, there have been reports of 
peroxidases rescuing Bax-induced cell death in yeasts (Ka 
mpranis et al., J. Biol. Chem. 275:29207–29216 (2000); 
Moon et al., Biochem. Biophys. Res. Commun. 290:457-462 
(2002), each of which is hereby incorporated by reference in 
its entirety) and transgenic antisense tobacco plants with 
reduced amounts of ascorbate peroxidase were "hyperre 
sponsive' to Psyringae (Mittler et al., Proc. Natl. Acad. Sci. 
USA 96:14165-14170 (1999), which is hereby incorporated 
by reference in its entirety), producing a phenotype remi 
niscent of the enhanced HR phenotypes produced by the 
suppressor mutants reported here. However, Abramovitch et 
al. (EMBO J. 22:60–69 (2003), which is hereby incorporated 
by reference in its entirety) reported that AvrPtoB possessed 
predicted structural features similar to domains within Bcl-2 
family members, an equally intriguing finding due to the 
involvement of these proteins in PCD regulation. Yeast has 
emerged as model for studying PCD and has proven par 
ticularly useful for the analysis of cell death inducers and 
suppressors obtained from multicellular eukaryotes with 
more complex PCD pathways (Madeo et al., Curr. Genet. 
41:208–216 (2002), which is hereby incorporated by refer 
ence in its entirety). An example of the utility of the yeast 
system to plant PCD research is found in the induction of 
yeast PCD by the plant defense protein osmotin (Narasim 
han et al., Mol. Cell 8:921-930 (2001), which is hereby 
incorporated by reference in its entirety). A particularly 
fruitful use of the yeast system involves heterologous 
expression of the mammalian Bax protein, which induces 
PCD in yeast. Yeast expressing Bax can be screened, as done 
here, for heterologously expressed genes that block Bax 
induced PCD. This system has been used to identify the 
Arabidopsis ethylene-responsive element binding protein 
(AtEBP) as a suppressor of PCD (Pan et al., FEBS Lett. 
508:375-378 (2001), which is hereby incorporated by ref. 
erence in its entirety) and its relevance to plant biology is 
further indicated by observations that Bax expression in 
tobacco can induce an apparent HR and that Bcl-2 (an 
anti-aptototic gene of the Bax/Bcl-2 family) expression in 
tobacco strongly alters plant-pathogen interactions (Dick 
man et al., Proc. Natl. Acad. Sci. USA 98.6957–6962 (2001): 
Lacomme and Santa Cruz, Proc. Natl. Acad. Sci. USA 
96:7956–7961 (1999), each of which is hereby incorporated 
by reference in its entirety). 
Four of the five effectors tested (AVrPphE, HopPtoG, 
HopPtoF, and HopPtoE) suppress Bax-induced yeast PCD, 
indicating that the targets are likely to be broadly conserved 
and not unique to plants. Interestingly, AvrPpiB1 and 
AvrPtoB failed to do so, even though both suppressed the 
HR elicited by Pfluorescens(pHIR11) in both tobacco and 
Arabidopsis, and DC3000 avrPtoB and avrPpiB1Pto 
mutants produced enhanced HRS. It is also puzzling that 
HopPtoG failed to suppress the HR elicited by Pfluorescens 
(pHIR11) although a DC3000 hopPtoG mutant had 
enhanced HR activity and HopPtoG suppressed Bax-in 
duced yeast PCD. Moreover, it is also noteworthy that 
HopPtol)2, an effector that was recently identified to sup 
presses an HR elicited by avirulent P. syrinage strains did 
not suppress the HR elicited by P. fluorescens(pHIR11). 
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These exceptions suggest that multiple bioassays will be 
required to identify all of the DC3000 effectors with some 
ability to suppress PCD. 
While the suppressors described here were identified due 
to their ability to suppress PCD, it is possible they suppress 
other more general plant defenses as well. Indeed, HopP 
toD2 has been found to be an active protein tyrosine 
phosphatase that appears to modulate a mitogen-activated 
protein kinase (MAPK) pathway in tobacco. An analogous 
MAPK pathway in Arabidopsis is part of the plant innate 
immune system activated in response to bacterial flagellin 
(Asal et al., Nature 415:977–983 (2002); Felix et al., Plant 
J. 18:265-276 (1999), each of which is hereby incorporated 
by reference in its entirety). The innate immune systems of 
mammals, insects, and plants have the capacity to recognize 
common markings on microorganisms, such as flagellin or 
LPS (Boller, Annu. Rev. Plant Physiol. Plant Mol. Biol. 
46:189–214 (1995); Medzhitov and Janeway, Trends Micro 
biol. 8:452–456 (2000), each of which is hereby incorpo 
rated by reference in its entirety). These common compo 
nents have been referred to as pathogen-associated 
molecular patterns (PAMPs) and they are not known to elicit 
the HR in plants. Thus, the assays used herein would not 
detect the activity of Suppressors that specifically targeted 
PAMP-induced defense pathways unless the target was at 
convergence points of PCD pathways and PAMP-induced 
innate immunity pathways. Future research will determine 
whether these PCD suppressors specifically target AVr 
induced PCD pathways or also suppress other plant defenses 
generally grouped into a broad category of defenses typi 
cally referred to as non-host resistance (Heath, Curr. Opin. 
Plant Biol. 3:315–319 (2000), which is hereby incorporated 
by reference in its entirety). 
A general model of Suppressor function must also recon 
cile several behaviors of bacterium-plant interactions that 
involve multiple effectors. Expression in P. syringae of a 
heterologous effector typically results in HR elicitation in 
test plants that carry a corresponding R gene despite the 
presence of resident Suppressor effectors. For example, 
DC3000 heterologously expressing avrRpt2 or avrRps4 elic 
its the HR in Arabidopsis plants carrying the corresponding 
R genes (Hinsch and Staskawicz, Mol. Plant—Microbe 
Interact. 9:55–61 (1996); Kunkel et al., Plant Cell 
5:865-875 (1993), which is hereby incorporated by refer 
ence in its entirety). On the other hand, Suppressors can 
block HR elicitation by resident effectors, as revealed by the 
original discovery of suppressors like VirPphA and effectors 
with masked avirulence activity in P. S. phaseolicola (Jack 
SEQUENCE LISTING 
<160> NUMBER OF SEQ ID NOS: 209 
<21 Oc 
<211 
<212> 
SEQ ID NO 1 
LENGTH 1899 
TYPE DNA 
<400 SEQUENCE: 1 
atgcttatc g g g cacagctt goatcacatg cq acco act g citgtggattic tag cctacca 
actitcc.gcaa citagc.ca.gac tatcagdaat accaaaagtc. g.gctggatcc goat cqtgtc 
cgtgaactta cattcatcgg agtggg tagt agtgttgcct acct actoraa toagcttaat 
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son et al., Proc. Natl. Acad. Sci. USA 96:10875–10880 
(1999), which is hereby incorporated by reference in its 
entirety) and by the observations presented here that several 
effectors can block HR elicitation by HopPsyA in the 
heterologous P. fluorescens(pHIR11) system. Perhaps the 
simplest explanation is that there is a hierarchy in the 
delivery of effectors by wild-type strains. Such a hierarchy 
in delivery has been proposed to explain the deployment of 
effectors with conflicting activities, such as the Salmonella 
SopB and SptP proteins, in animal pathogens (Cornelis and 
van Gujsegem, Annu. Rev. Microbiol. 54:734–774 (2000); 
Galán and Zhou, Proc. Natl. Acad. Sci. USA 97:8754–8761 
(2000), each of which is hereby incorporated by reference in 
its entirety). The global identification of a set of suppressors 
in P. S. tomato DC3000 should facilitate systematic inves 
tigation of the underlying functions of TTSS effectors in P. 
Syringae pathogenesis. 
A final aspect of PCD and pathogenesis is that the ability 
to elicit host cell death appears to be a general characteristic 
of TTSS-dependent pathogens like P. syringae despite the 
fact that these bacteria typically rely upon living host cells 
as sites of multiplication (Alfano and Collmer, J. Bacteriol. 
179:5655–5662 (1997); Knodler and Finlay, Microbes 
Infect. 3:1321–1326 (2001), each of which is hereby incor 
porated by reference in its entirety). This is particularly 
puzzling with P. syringae because late-stage infections with 
most strains produce necrotic lesions, but the symptomless 
growth of P. S. syringaegacS mutants suggests that such cell 
killing maybe gratuitous (Willis et al., Mol. Plant—Microbe 
Interact. 3:149-156 (1990), which is hereby incorporated by 
reference in its entirety). Similarly puzzling are recent 
observations suggesting that plants compromised in PCD 
pathways are unexpectedly more resistant to P syringae 
(Lincoln et al., Proc. Natl. Acad. Sci. USA 99:15217–15221 
(2002); Stone et al., Plant Cell 12:1811–1822 (2000); 
Richael et al., Physiol. Mol. Plant Pathol. 59:213–221 
(2001), each of which is hereby incorporated by reference in 
its entirety). Thus, rapid and delayed host cell death are 
associated with defense and disease, respectively, and patho 
gen manipulation of cell death pathways may be a central 
process in pathogenesis. 
Although the invention has been described in detail for 
the purposes of illustration, it is understood that such detail 
is solely for that purpose, and variations can be made therein 
by those skilled in the art without departing from the spirit 
and scope of the invention which is defined by the following 
claims. 
ORGANISM: Pseudomonas syringae pv. tomato DC3000 
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Gly 
Asp 
Wall 
435 
Pro 
Ala 
Wall 
Ser 
Glu 
100 
Tyr 
Ile 
Glin 
His 
18O 
Arg 
Wall 
Thr 
Asp 
Thr 
260 
Ala 
Ile 
Ser 
Asp 
Ala 
340 
Asp 
Telu 
Ala 
His 
Glin 
420 
Glin 
Pro 
Arg 
Thr 
Trp 
85 
Ile 
Ala 
Thr 
Ser 
Ile 
1.65 
Thr 
Teu 
Teu 
Phe 
Ala 
245 
Arg 
Pro 
Ser 
Tyr 
325 
Ala 
Tyr 
Glin 
Ala 
Ala 
405 
Thr 
Ile 
Asp 
Asp 
Thr 
70 
Ala 
Ile 
Ala 
Wall 
Arg 
15 O 
Teu 
Ser 
Asp 
Asp 
Ala 
230 
Ala 
Ser 
Glu 
Pro 
Teu 
310 
Ala 
Asp 
Ser 
Wall 
390 
Teu 
Glu 
Glin 
Tyr 
470 
143 
Pro 
Glu 
Ser 
Glu 
135 
Teu 
Glin 
Ile 
Asn 
Teu 
215 
Gly 
Glu 
Thr 
Teu 
Thr 
295 
Gly 
Wall 
Ile 
Glin 
Arg 
375 
Ala 
Asp 
Lys 
Thr 
Glin 
455 
Phe 
Phe 
Asn 
Glin 
Ala 
120 
Telu 
Asp 
Ser 
Trp 
Ile 
200 
Asp 
Lys 
Asn 
Ala 
280 
Lys 
Glin 
Tyr 
Telu 
Wall 
360 
Gly 
Glin 
Telu 
Tyr 
4 40 
Wall 
Glin 
Telu 
Wall 
Trp 
105 
Glu 
Gly 
Asp 
Asn 
185 
Lys 
Glu 
Thr 
Ala 
Pro 
265 
Lys 
Telu 
Asp 
Ala 
Gly 
345 
Tyr 
Ser 
Telu 
Ile 
Ser 
425 
Telu 
Telu 
Arg 
Gly 
Arg 
90 
Asp 
Phe 
Ala 
Gly 
Glin 
170 
Ser 
Telu 
Phe 
Wall 
Gly 
250 
Wall 
Ser 
Glu 
Ser 
Met 
330 
Ser 
Ser 
Asn 
Ala 
Telu 
410 
Glin 
Lys 
Glin 
Glin 
Lys 
75 
Gly 
Glin 
Ser 
Glu 
Cys 
155 
Ile 
Wall 
His 
Met 
Wall 
235 
Glu 
Teu 
Ala 
Asn 
Arg 
315 
Gly 
Teu 
Asp 
Ser 
Thr 
395 
Glu 
Met 
Thr 
Asn 
Thr 
475 
US 7,220,583 B2 
-continued 
Wall 
Lys 
Glin 
Ala 
His 
1 4 0 
Phe 
Wall 
Thr 
Glu 
Arg 
220 
Ile 
Teu 
Teu 
Ile 
Gly 
Glu 
Glin 
Teu 
Glin 
Asp 
Asn 
Glu 
Teu 
Trp 
Glin 
460 
Asn 
Ser 
Gly 
Wall 
Ser 
125 
Teu 
Arg 
Teu 
Ser 
Glin 
Ala 
His 
Gly 
Asp 
His 
285 
Phe 
Pro 
Asp 
Asp 
Pro 
365 
Asn 
Wall 
Met 
Teu 
Glin 
4 45 
Wall 
Glu 
Ile 
Tyr 
Pro 
110 
Asn 
Ile 
Gly 
His 
19 O 
Ser 
Gly 
Ala 
Gly 
27 O 
Ile 
His 
35 O 
Phe 
Gly 
Glin 
Thr 
Glu 
43 O 
Telu 
Glu 
Glin 
Wall 
Ile 
95 
Arg 
Ala 
Asn 
Thr 
175 
Thr 
Ala 
Asp 
Pro 
Asn 
255 
Asn 
Wall 
Lel 
His 
335 
Lel 
Lel 
His 
Arg 
415 
Gly 
Asp 
Asn 
Gly 
8O 
Asn 
Arg 
Glin 
Telu 
160 
Gly 
Glin 
Telu 
Ala 
Asn 
240 
Ala 
Glin 
Asp 
Arg 
Wall 
320 
Glu 
Thr 
Ile 
Ser 
400 
Telu 
Ala 
Ser 
Gly 
480 
144 
Asn 
Wall 
Ala 
Asn 
Ala 
545 
Glu 
Wall 
Arg 
Ala 
Ser 
625 
<400 
Telu 
Ala 
Ala 
Asn 
530 
Arg 
Wall 
Ala 
Pro 
Tyr 
610 
Glin 
145 
Asp Gly Val Ala Ala Glu 
485 
Ser Wall Ile Wal Ser Pro 
5 OO 
Ala Leu Ser Gly Lieu Met 
515 
Phe Thr Thr Asp Asn Arg 
535 
Tyr Pro Asn. Ile Gly Asn 
550 
Val Thr Leu Arg His Leu 
565 
Gly Glu Met Met Asp Lys 
Pro Val Leu Gly Val Pro 
595 600 
Lieu. His Ala Lieu. Asn. Ser 
615 
Arg Trp Lieu Pro Lys Lys 
630 
SEQ ID NO 3 
LENGTH 657 
TYPE DNA 
ORGANISM: Pseudomonas syringae pv. tomato DC3000 
SEQUENCE: 3 
atgatcactc cqtctogata 
gcagotcaca catttaaaga 
totggc gata agctattgcg 
acgctaaaag agattgaaat 
caactggaaa agtacgaacc 
to acgaaagg ggacctttac 
gacaaagcaa goatacgctt 
gacgacaaaa toacgaccct 
agct cottag cqgatggcgg 
cittagg gcc.g. ttggattaga 
to catc.cgag citgaac acgg 
<400 
Met 
1 
Asn 
Teu 
Ile 
SEQ ID NO 4 
LENGTH 218 
TYPE PRT 
ORGANISM: Pseudomonas syringae pv. tomato DC3000 
SEQUENCE: 4 
to caggcatc 
acaag cagag 
aaaaatatoc 
aaataaccag 
agaaaactitt 
caaaggtgaa 
aaatcagaat 
agctdatgag 
agatcgctat 
taagtaccgc 
cctg.cctotg 
Wall Lys 
490 
Gln Leu 
505 
Pro Ala 
Thr Met 
Ala Glu 
Asn. Ser 
570 
Gly Ala 
585 
Ala Ser 
Gly Ala 
Asn 
Gly 
Teu 
Ala 
555 
Glin 
Glin 
Wall 
His 
tatato.gc.cc 
gaag cacttg 
acticttgcca 
tgttataccg 
aac gaga acc 
ggalagcaa.cg 
ggcto accqt 
citcgttcatg 
aatccacgta 
tattoactita 
cgcatcaagt 
Ile Thr Pro Ser Arg Tyr Pro Gly Ile Tyr 
Glu 
Asp 
Ser 
5 O 
5 10 
Pro Thr Ala Ala His Thr Phe Lys Glu 
25 
His Ile Ser Ala Ala Pro Ser Gly Asp 
35 40 
Thir Lieu Ala Ser Glin Lys Asp Arg Lys 
55 
US 7,220,583 B2 
-continued 
Glin 
Thr 
Wall 
Arg 
540 
Ser 
Arg 
Pro 
Arg 
Asp 
62O 
Thr 
Ile 
Ala 
525 
Ala 
Ala 
Phe 
Teu 
Thr 
605 
Gly 
Telu 
Lys 
Asn 
Gly 
Phe 
Ile 
Wall 
59 O 
Ala 
Thr 
cccitcagtaa 
accatat cag 
gtoaaaaaga 
aagctgttct 
ggcacattgc 
cgattattgg 
tacaccittgg 
citcgacatgt 
Cgggatctgg 
Caaaaaaac C. 
a Cagg gCaca 
Ile 
Glin 
Wall 
60 
Ala 
Ala 
Teu 
45 
Thr 
Pro 
Glu 
3O 
Telu 
Telu 
Thr 
495 
Ala 
Gly 
Ile 
Ile 
Glu 
575 
Ser 
Pro 
Telu 
15 
Glu 
Arg 
Glu 
Ser 
Glu 
Ala 
Asp 
560 
Telu 
Glu 
Telu 
c galacc.gaca 
cgcc.gcaccc 
tagaaaagtic 
gag cagragg 
atcacagcta 
citggtoacca 
aatggataac 
gttaggtggc 
Caaagaggaa 
gtoagagaac 
totaatag 
Ser 
Ala 
Glu 
60 
120 
18O 
240 
360 
420 
480 
540 
600 
657 
146 
Ile Glu Ile 
65 
Glin Leu Glu 
Ala Ser Glin 
Asn Ala Ile 
115 
Glin Asn Gly 
130 
Thir Thr Leu 
145 
Ser Ser Lieu 
Gly Lys Glu 
Lieu. Thir Lys 
195 
Pro Leu Arg 
210 
Asn. Asn. G 
Lys Tyr G 
85 
Teu Ser A. 
100 
Ile Gly. T 
Ser Pro L 
Ala His G 
1 
Ala Asp G 
1.65 
Glu Lieu. A 
18O 
Lys Pro S 
Met Lys T 
<210 SEQ ID NO 5 
&2 11s LENGTH 636 
&212> TYPE 
<213> ORGANISM: Pseudomonas 
DNA 
<400 SEQUENCE: 5 
atgaatagag 
caagtaag.cg 
aacaaaccgg 
acggatagcg 
caaaggaaaa 
acgcaactica 
Caggcgctgg 
tacago aacc 
alaaggagcga. 
cgattgaaat 
atc.gagagat 
titt.cogg tag 
agagaaccac 
aaaaatcaga 
C galagc gaac 
totatogcac 
cagattgcgt. 
aaatcggctt 
gtaagttaag 
ttgtag acto 
toaa.gcaccg 
acggccaa.gc 
<210> SEQ ID NO 6 
<211& LENGTH 211 
&212> TYPE PRT 
147 
ln Cys Tyr 
70 
lu Pro Glu 
rp Ser Pro 
120 
eu. His Lieu 
135 
lu Lieu Wall 
50 
ly Gly Asp 
rg Ala Val 
er Glu Asn 
200 
yr Arg Ala 
215 
citcgt.ca.gc.g 
gttgttctacg 
tgcggatgcg 
ttatatttcg 
Calacagoggg 
acagaagtgc 
gcaccittcga 
ccatalactat 
ttggacggga 
ggalagagaac 
gcatgtgatt 
Thr Glu Ala 
75 
Asin Phe Asn 
90 
Thr Phe Thr 
105 
Asp Lys Ala 
Gly Met Asp 
His Ala Arg 
155 
Arg Tyr Asn 
170 
Gly Lieu. Asp 
185 
Ser Ile Arg 
His Glin 
actitggcagg 
acaggittatc 
citgatgacta 
gaaacgctda 
aacttgcgtg 
cgc galagagg 
cataagttag 
gtggtocatcc 
Caggg.cgtgg 
tacgcagtga 
gactga 
US 7,220, 
-contin 
Wall Leu Ser 
Glu Asn Arg 
Lys Gly Glu 
110 
Ser Ile Arg 
125 
Asn Asp Asp 
1 4 0 
His Wall Leu 
Pro Arg Thr 
19 O 
Ala Glu His 
2O5 
syringae pv. tomato DC3000 
cagtcaacga 
agacggcaat 
tgaggagggc 
tgaatctggc 
gc gcgattga 
ggttctocaa 
gaatctoaga 
acco cagcaa 
tggagctgga 
acgc.caatat 
<213> ORGANISM: Pseudomonas syringae pv. tomato DC3000 
<400 SEQUENCE: 6 
Met Asn Arg Val Ser Gly Ser Ser Ser Ala Thr 
1 5 10 
Asp Leu Val Glu Glin Val Ser Glu Arg Thr Thr 
25 
Tyr Glin Thr Ala Met Gly Arg Lieu. Asn Lys Pro 
35 40 
Asp Ala Lieu Met Thr Met Arg Arg Ala Glin Glin 
5 O 55 
Trp Glin Ala 
Leu Ser Thr 
3O 
Glu Lys Ser 
45 
Tyr Thr Asp 
60 
583 B2 
ued 
Arg Arg 
8O 
His Ile 
95 
Gly Ser 
Lieu. Asn 
Lys Ile 
Gly Gly 
160 
Gly Ser 
175 
Tyr Ser 
Gly Lieu 
tottgttggag 
ggg.ccgcttg 
gcaa.cagtac 
agatttgcag 
gatgacgc.ct 
ttgttgacata 
titt caccatc. 
tgcatttcc.g 
cittcaag acc 
gCacgagtgg 
Wall Asn 
15 
Thr Gly 
Asp Ala 
Ser Ala 
60 
120 
18O 
240 
360 
420 
480 
540 
600 
636 
148 
Lys Arg Thr 
65 
Glin Arg Lys 
Glu Met Thr 
Glu Gly Phe 
115 
Leu Arg His 
130 
Lys Lieu Ser 
145 
Lys Gly Ala 
Asp Phe Lys 
Wall Asn Ala 
195 
Val Ile Asp 
210 
Tyr Ile S 
149 
er Glu Thr 
70 
Ile Tyr Arg Thr Asn 
85 
Pro Thr G 
100 
ln Leu Thr 
Ser Asn. Cys Asp Ile 
Lys Lieu G 
120 
ly Ile Ser 
135 
His Asn Tyr Val Val 
1 50 
Ile Val Asp Ser Trp 
1.65 
Thr Arg L. 
18O 
Asn Met H 
<210 SEQ ID NO 7 
<211& LENGTH: 1482 
&212> TYPE DNA 
eu Lys Phe 
is Glu Trip 
200 
Teu Met Asn 
75 
Ser Gly Asn 
90 
Asp Cys Wall 
105 
Glin Ala Leu 
Asp Phe Thr 
Ile His Pro 
155 
Thr Gly Glin 
170 
Lys His Arg 
185 
Ile Glu Arg 
US 7,220,583 B2 
-contin 
Leu Ala Asp 
Leu Arg Gly 
Glin Lys Cys 
110 
Glu Ile Gly 
125 
Ile Tyr Ser 
1 4 0 
Ser Asn Ala 
Gly Val Val 
Glu Glu Asn 
19 O 
Tyr Gly Glin 
2O5 
<213> ORGANISM: Pseudomonas syringae pv. tomato DC3000 
<400 SEQUENCE: 7 
atgcaaataa 
gcct cqccita 
agcgctacgc 
totaaattgc 
tacgataaaa 
ggttttacca 
aacaac cata 
ggagagaatc 
gacctagttg 
ggtgagctta 
tatgacctta 
aaaaatgagg 
gaaaaaggcC 
cagtgitatgg 
caattic goag 
tggggggatg 
gatgaagctg 
atgtttalaga 
caagaaaaaa 
gcag acttga 
galagacgc.ct 
agaacagtica 
agatggaagt 
aaactgcaaa 
cctitcc.gc.gc 
citgccaataa 
gCgatgc.ca.g 
gcago actict 
agttcttaac 
acacggagca 
ccaatgaaga 
caaatagoga 
agacgggatc 
tgaaac actt 
aaactcittga 
CaggcCaggC 
Cggaacgggt 
ataaaataga 
ggaataccag 
tottcaa.gct 
aaaacctgcc 
Cagggittagg 
totctattoa 
aactaatgca 
gacacacgaa 
catgaggtac 
ttittitt tott 
gottaacgat 
tgaaaataaa 
gatgattgat 
agcgcacaca 
ggcaataaaa 
agcctatata 
tactggittat 
tataaaag.cg 
talactitactit 
acttittggitt 
catattgaaa 
actaagtagg 
cattgcaggg 
accoccc.gac 
tittgacticat 
agacitcgttt 
gottcaagaa 
atagoaaaaa 
ggc gattcaa 
gctgcatacc 
totaccactt 
gcacaagata 
aactc.gctitt 
tat cqtgcag 
tdaattctga 
aaactica acc 
agcaagaa.ca 
acatctogtt 
act catggcg 
cgaaaaagta 
ttcagacagg 
agc cattata 
cc.gttctdag 
ccagtgctdt 
aaaatagaag 
gttaa.gctta 
acagotcitca 
tggtgcagaa 
ataatgalacc 
aaggccaatc 
ttgcagg cag 
citctgcatca 
aag.cgcgaala 
taag.ccc.gct 
caactaagat 
agaat attat 
cggaaaaaac 
aatattoctitt 
citaticacaaa. 
aaaaagctot 
toacgctcaa 
totatgcggg 
atcgggg CaC 
agcaagattit 
accacgcata 
atttgaaa.ca 
gcaattic.cgg 
acgcgacgto 
ued 
Leu Glin 
8O 
Ala Ile 
95 
Arg Glu 
Lieu. His 
Asn Arg 
Phe Pro 
160 
Glu Lieu 
175 
Tyr Ala 
Ala His 
tacttittaat 
tgctg.cgctg 
cagdaataac 
cgcctacctc 
tggcaaaggit 
gc gctaccala 
taggotttgc 
ttacctcitcc. 
gtgcctgaaa 
accaaaagac 
gaccggc gtt 
gcc atttgtg 
cacgc.ccaag 
cagtgattoc 
tgaagacgct 
tgtactccaa 
agcaaagaac 
tatttatata 
taaatcaatg 
tgtgggattit 
citgttgttaat 
60 
120 
18O 
240 
360 
420 
480 
540 
600 
660 
720 
840 
9 OO 
96.O 
1020 
1080 
1140 
1200 
1260 
150 
cacgcaagaa 
ggttgcctica 
gCac gagggit 
cagatctgca 
<400 
Met 
1 
Asn 
His 
Phe 
65 
Asp 
Asp 
Asn 
Phe 
145 
Asp 
Met 
Asn 
Thr 
225 
Glu 
Teu 
Ser 
Teu 
Glu 
305 
Asp 
taatgagtgg 
acgc.cgtata 
gctttgttggg 
aaaacgc.citc 
SEQ ID NO 8 
LENGTH 493 
TYPE 
ORGANISM: Pseudomonas syringae pv. tomato 
PRT 
SEQUENCE: 8 
151 
tgagc citc.cc 
cgacaatticg 
tgctggittitt 
taagcagttt 
Glin Ile Lys Asn. Ser His Lieu 
Thr 
Asn 
Glu 
5 O 
Arg 
Asp 
Gly 
Lys 
130 
Telu 
Telu 
Pro 
Ile 
210 
Gly 
Thr 
Ile 
Wall 
29 O 
Arg 
Glu 
Phe 
Asn 
35 
Gly 
Ala 
Lys 
Ala 
115 
Asn 
Thr 
Wall 
Telu 
Glu 
195 
Ser 
Ser 
Gly 
Pro 
Thr 
275 
Phe 
Wall 
Ala 
5 
Asn Ala Ser Pro Lys 
Glu Pro Ala Ala Leu 
40 
Asp Ser Lys Gly Glin 
55 
Met Arg Tyr Ala Ala 
70 
Thr Ala Asn. Asn. Phe 
85 
Gly Gly Phe Thr Ser 
100 
Arg Lys Arg Tyr Glin 
120 
Ser Leu Lleu Ser Pro 
135 
Met Ile Asp Tyr Arg 
15 O 
Asp Thr Glu Glin Ala 
1.65 
Lys Gly Glu Lieu. Thr 
18O 
Lys Thr Pro Lys Asp 
200 
Lys Asn Lys Tyr Ser 
215 
Thr Gly Tyr Thr Ser 
230 
Lieu Lys His Phe Ile 
245 
Lys Glin Cys Met Glu 
260 
Lieu. Asn. Ser Asp Ser 
280 
Arg Glin Val Tyr Ala 
295 
Ile Leu Lys Ser His 
310 
Asp Lys Ile Glu Lieu 
325 
ttgtcaaaag 
agcggaataa 
acggtoc agg 
tacaacggct 
Tyr 
Met 
25 
Ser 
Ser 
Phe 
Asp 
105 
Asn 
Telu 
Ala 
His 
Asn 
185 
Telu 
Arg 
Thr 
265 
Glin 
Gly 
Tyr 
Ser 
Ser 
10 
Glu 
Ala 
Ser 
Telu 
Telu 
90 
Ala 
Asn 
Arg 
Ala 
Thr 
170 
Glu 
Asp 
Thr 
Ser 
Ala 
250 
Telu 
Phe 
Glu 
Asn 
Arg 
330 
Ala 
Wall 
Thr 
Asn 
Ala 
75 
Ser 
Arg 
His 
Teu 
Thr 
155 
Ser 
Glu 
Teu 
Gly 
Ile 
235 
Thr 
Asp 
Ala 
Asp 
Arg 
315 
Pro 
US 7,220,583 B2 
-continued 
atgatgttgt gattctgata 
ggcattctot cogcqaaatt 
acggtgacga cittctacaaa 
a.a. 
Ser 
Thr 
Glin 
Asn 
60 
Gly 
Thr 
Teu 
Ser 
Cys 
1 4 0 
Ile 
Ala 
Thr 
Wall 
220 
Thr 
His 
Asn 
Ala 
Ala 
3OO 
Gly 
Phe 
DC3 OOO 
Arg 
Asn 
Thr 
45 
Ser 
Ser 
Thr 
Asn 
Ser 
125 
Gly 
Ile 
Teu 
Ile 
Asn 
2O5 
Gly 
Teu 
Gly 
285 
Trp 
Thr 
Ser 
Met 
Ala 
3O 
Ala 
Ala 
Ser 
Asp 
110 
Thr 
Glu 
Lys 
19 O 
Ser 
Asn 
Pro 
Glu 
Telu 
27 O 
Glin 
Gly 
Wall 
Glu 
Wall 
15 
Ile 
Telu 
Telu 
95 
Ala 
Telu 
Asn 
Telu 
Asn 
175 
Glu 
Glu 
Phe 
Lys 
255 
Arg 
Ala 
Asp 
Telu 
Glin 
335 
Glin 
Ala 
Thr 
Pro 
Telu 
His 
Glin 
Glu 
Glin 
Ser 
160 
Ile 
Telu 
Ala 
Glu 
Wall 
240 
Ala 
Telu 
Ala 
Glin 
320 
Asp 
1320 
1380 
1440 
1482 
152 
Leu Ala Lys 
Leu Tyr His 
355 
Pro Asp Lys 
370 
Asn Lieu Pro 
385 
Glu Asp Ala 
Ser Cys Val 
435 
Asn. Ser Ser 
450 
Phe Val Gly 
465 
Glin Ile Cys 
153 
Asn Met Phe Lys Arg 
340 
Ala Tyr Ile Tyr Ile 
360 
Ile Glu Asp Leu Lys 
375 
Leu Thir His Val Lys 
390 
Ser Gly Lieu Gly Asp 
405 
Asn His Ala Arg Ile 
420 
Wal Wall Ile Leu. Ile 
4 40 
Gly Ile Arg His Ser 
455 
Ala Gly Phe Thr Val 
470 
Lys Asn Ala Ser Lys 
485 
<210 SEQ ID NO 9 
&2 11s LENGTH 852 
212. TYPE DNA 
Asn. Thir Ser 
345 
Glin Glu Lys 
His Lys Ser 
Teu Ser Asn 
395 
Ser Phe Thr 
410 
Met Ser Gly 
425 
Gly Cys Lieu 
Leu Arg Glu 
Glin Asp Gly 
475 
Glin Phe Tyr 
490 
US 7,220,583 B2 
-contin 
Ile Ala Gly 
35 O 
Ile Phe Lys 
365 
Met Ala Asp 
38O 
Ser Gly Val 
Ala Lieu. Asn 
Glu Pro Pro 
43 O 
Asn Ala Wall 
4 45 
Ile Ala Arg 
460 
Asp Asp Phe 
Asn Gly 
<213> ORGANISM: Pseudomonas syringae pv. tomato DC3000 
<400 SEQUENCE: 9 
atgggtaata 
caac atgcat 
agtcatgaac 
aaccoccgaa 
toagtgatca 
attcagocto 
ggtgattgct 
agaccgatca 
gcaatgaata 
citgcatagag 
ggtaatacitt 
gaatttacitt 
ttittcaaaaa. 
accggtotgc 
totgacgagt 
tttgtggtac 
citggttcgto 
aaatattaag 
aag gaccatc 
cacaag agaa 
caaacago at 
titt cagacga 
accatcatct 
gCggtttggC 
gcatcaagca 
atcgtgatga 
cc gatgtcac 
accoatacga 
acalagcagga 
ga 
<210> SEQ ID NO 10 
&2 11s LENGTH 2.83 
&212> TYPE PRT 
ttctggctcc 
cacaccagtg 
ccagaactat 
toctaggctt 
aaag.cgacitt 
gatcaaaaat 
tgaatttctt 
gc gg tatgcc 
caaacttgct 
aaagatggat 
cgc gttcatg 
gttacatctg 
ggacgaag.cg 
Cgataggtgg 
aatcatgttgt 
cccagtgctt 
gctagoaata 
totgatacgc 
aaaagtcaac 
gcacttgatg 
gc gatccatc 
cc.gaaaaatg 
caataccctg 
gatggtgaag 
agcacatcga 
cagtcctcat 
citcatccc.gc 
cacgtccact 
atagt cogcc 
citgggiac gat 
taaaggggaa 
tgatgaagca 
caaagtcaat 
aaaaaga cag 
totatac gag 
attatcaggt 
titatgagtcg 
citagaatgga 
cago.cgtcaa 
ccctdacgc.c 
tgaac gagat 
<213> ORGANISM: Pseudomonas syringae pv. tomato DC3000 
ued 
Pro Wall 
Leu Pro 
Lieu Lys 
Gly Phe 
400 
Ala Thr 
415 
Teu Ser 
480 
tattagccct 
gctittctdtc 
atato go acg 
ggcgctgtct 
agcc.caagat 
ccaccottitt 
ttgttctttac 
tgttgtc gag 
gtotggtoag 
cittcaagcc.g 
tgttacagaa 
tataggtocc 
tittcaaagta 
cgcagaga.gc 
60 
120 
18O 
240 
360 
420 
480 
540 
600 
660 
720 
840 
852 
154 
<400 SEQUENCE: 10 
Met 
1 
Pro 
Ala 
Asn 
Gly 
65 
Ser 
Ile 
Asp 
Phe 
His 
145 
Ala 
Wall 
Glu 
Phe 
Asp 
225 
Phe 
Pro 
His 
<400 
Gly Asn. Ile Cys G 
Ile 
Ser 
Tyr 
5 O 
Pro 
Wall 
Ala 
Glu 
Telu 
130 
His 
Met 
Ser 
Wall 
Met 
210 
Wall 
Ser 
Phe 
Telu 
Ser 
Gly 
35 
Ala 
Ser 
Ile 
Glin 
Lys 
115 
Ala 
Telu 
Asn 
Gly 
Met 
195 
Ser 
Thr 
Asn 
275 
5 
Pro Glin H 
2O 
Thr Met L 
Ser Asn. I 
Pro Arg L. 
Thr Glin G 
85 
Asp Ile G 
100 
Asp Ser H 
Ile His L. 
155 
ly Thr Ser 
is Ala Ser 
eu Ser Lieu 
40 
le Lys Gly 
55 
eu Ser Asp 
70 
lu Lys Lys 
lin Pro Pro 
is Pro Phe 
120 
eu Tyr Thr 
135 
Arg Tyr Ala Pro Lys 
1 
Ser Gly L. 
1.65 
Glin Lieu. H 
18O 
50 
eu Ala Lys 
is Arg Gly 
Ser Arg Phe Lys Pro 
200 
Thr Ser Thr Arg Met 
Lieu. His L. 
2 
215 
eu Glin Ser 
30 
Asn Pro Tyr Glu Asp 
245 
Wall Thr G 
260 
ly Lieu. His 
Glu Ile Ala Glu Ser 
SEQ ID NO 11 
LENGTH 393 
TYPE 
ORGANISM: Pseudomonas 
DNA 
SEQUENCE: 11 
atgagctitat cqc.cgacgct 
aagcct gtca 
ggcgacagcC 
attittattgc 
cittaccatca 
citggacaaag 
C gagacacag 
cagaggctat 
ttacct tact 
accotgatga 
ccc.gttittga 
cgacacattt 
280 
gcaaaagcta 
C CagtggCag 
agctaaaatc 
tacccatacg 
aagtgcc.ctg 
gag cotgctg 
togttittaac 
Gly Ser Asn 
10 
Gly Ser Ser 
25 
Ser His Glu 
Lys Tyr Arg 
Thir Leu Met 
75 
Arg Lieu Lys 
90 
Asn. Ser Met 
105 
Gly Asp Cys 
Ser Cys Lieu 
Asn Asp Wall 
155 
Leu Ala Glin 
170 
Ile Lys Gln 
185 
Gly Asn Thr 
Asp Val Thr 
Ser Ser Ala 
235 
Glu Ala Leu 
250 
Lys Glin Asp 
265 
Ser Asp Glu 
actaatatat 
galagg catgg 
atagaactoc 
titt.cogggcc 
gttittctott 
gccaactittg 
tga 
US 7,220,583 B2 
-contin 
His Val Tyr 
Thr Pro Wall 
3O 
Glin Ile Leu 
45 
Thir Asn Pro 
60 
Lys Glin Ala 
Ser Glin Pro 
Ile Lys Asn 
110 
Phe Ser Asp 
125 
Tyr Arg Pro 
1 4 0 
Ala Pro Wall 
Tyr Pro Asp 
Lys Met Asp 
19 O 
2O5 
Glu Glu Phe 
220 
Wall Asn. Ile 
Ile Pro Pro 
Asp Arg Trp 
27 O 
syringae pv. tomato DC3000 
tgggCCC gaC 
atataacgct 
gtacagaccc 
atgaacacga 
citgaaacggc 
ued 
Ser Pro 
15 
Pro Ser 
Ser Glin 
Arg Lys 
Teu Ser 
8O 
Lys Ser 
95 
Ala Leu 
Asp Glu 
Ile Asn 
Wall Glu 
160 
Tyr Glin 
175 
Asp Gly 
Asp Ala 
Thir Ser 
Gly Pro 
240 
Leu. Thr 
255 
His Wall 
aaaaaatgcc 
gcatgtcago 
taaagacgac 
CCgtggcgc.g 
titt to accitt 
gcaggagctt 
60 
120 
18O 
240 
360 
393 
156 
<400 
Met 
1 
Thr 
Met 
Lys 
65 
Teu 
Asp 
Phe 
Phe 
<400 
SEQ ID NO 12 
LENGTH 130 
TYPE 
ORGANISM 
PRT 
SEQUENCE: 12 
157 
Ser Leu Ser Pro Thr Leu Glin 
Lys 
Asp 
Ile 
5 O 
Telu 
Thr 
Phe 
Ala 
Asn 
130 
Asn 
Ile 
35 
Ile 
Telu 
Ile 
His 
Glu 
115 
atgaaacaac 
ccaaaatc.cc. 
gCggtgtacg 
agcgagccitt 
ggcg accitta 
galagacggitt 
<400 
Ala Lys P 
2O 
Thir Lieu. H 
Glu Lieu. A 
ro Wall Thr 
is Wal Ser 
40 
rg Thr Asp 
55 
Thr His Thr Phe Pro 
Asn. Pro A. 
85 
Teu Lleu. A 
100 
Thr Ala G 
SEQ ID NO 13 
LENGTH 387 
TYPE 
ORGANISM: Pseudomonas syringae pv. tomato DC3000 
DNA 
SEQUENCE: 13 
gag.cga-cagt 
gctgggctitt 
gc gagctttg 
agaaaggtga 
cgc.cccagaa 
aggc.ca.gcag 
tacticagogc 
SEQ ID NO 14 
LENGTH 128 
TYPE 
ORGANISM: Pseudomonas syringae pv. tomato DC3000 
PRT 
SEQUENCE: 14 
Met Lys Glin Arg Ala T 
1 5 
Tyr Val Arg Llys Pro L. 
Glu Ala Gly Glu Thr P 
Glu Thr Gly Lieu Glu 
Lys 
65 
5 O 
35 
Gly Glu Val Thr H 
sp Glu Ser 
sp Lys Ala 
ln Glu Lieu 
120 
catctgcaaa 
gcc aggtggC 
cgaagaalacc 
ggtoacgcac 
cgagatttct 
cgc gaccalag 
taactag 
hir Wall Ile 
ys Ser Arg 
ro Phe Glin 
40 
Asn Lieu. Asp 
55 
is Tyr Val 
70 
Lys Lieu 
10 
Glu Ala 
25 
Gly Asp 
Pro Lys 
Gly Lieu 
Ala Leu 
90 
Arg Phe 
105 
Arg Asp 
Thr 
Ile 
Ser 
Asp 
Arg 
75 
Wall 
Glu 
Thr 
CgtgacggCC 
aagattgaag 
ggtctggaaa 
tacgtgttca 
gcc togcaaat 
gctatogtoa 
Cys Lys 
10 
Trp Ala 
25 
Ala Ala 
Telu Telu 
Phe Thr 
Arg 
Teu 
Wall 
Tyr 
Thr 
75 
US 7,220,583 B2 
-continued 
Asn 
Glin 
Teu 
Asp 
60 
Teu 
Phe 
Ser 
Ala 
Ile 
Trp 
Thr 
45 
Ile 
Arg 
Ser 
Teu 
Thr 
125 
Pseudomonas syringae pv. tomato DC3000 
Telu 
Glin 
3O 
Telu 
Telu 
Tyr 
Telu 
110 
His 
aggtgctitta 
CCggggaaac 
atctogatct 
ccacticaggt 
ggcttgc gcc 
agtcgitatgg 
Asp 
Pro 
Arg 
Teu 
60 
Glin 
Gly Glin 
Gly Pro 
15 
Glu Gly 
Leu Ala 
Leu Arg 
Gly Ala 
8O 
Glu. His 
95 
Ala Asn 
Phe Arg 
cgitacgcaaa 
gccttitccag 
gttgtacctg 
toct9.ccitac 
caaaaatctt 
cc.gc.caggct 
Wall Leu 
15 
Gly Gly Lys Ile 
Glu 
45 
Ala 
Wall 
Telu 
Wall 
Pro 
Cys Glu 
Tyr Glu 
Ala Tyr 
8O 
60 
120 
18O 
240 
360 
387 
158 

161 
Val Ile Gly Asn Ala Glin Met Asn 
115 
Asn Ala Cys 
130 
Ser Thr Pro 
145 
Trp Lieu Lieu 
Val Val Gly 
Lys Lieu Lys 
195 
Leu Tyr Tyr 
210 
Ala Gly Pro 
225 
Met Arg Lieu 
Pro Leu Ser 
Met Phe Wall 
275 
Ala Glu Arg 
29 O 
Glu Ser Pro 
305 
Wall Leu Ala 
Pro 
120 
Asn Wall Ala Wal Wall 
135 
Val Glu Gly Leu Met 
15 O 
Gly Ser Asp Cys Lys 
1.65 
Glu Ser Ala Gly Gly 
18O 
Ala Arg Pro Asp Lieu 
200 
Gly Val Tyr Asp Lieu 
215 
Glu Thir Lieu Wall Leu 
230 
Leu Ala Pro Asp Arg 
245 
Pro Leu Tyr Gly Asp 
260 
Gly Glu Lieu. Asp Pro 
280 
Trp Lys Asn Ser Ala 
295 
His Gly Phe Ile His 
310 
Arg Ser His Glu Trp 
325 
<210 SEQ ID NO 17 
&2 11s LENGTH 483 
&212> TYPE DNA 
Asp Asp Lieu 
Ser Val Asp 
Asp Asp Cys 
155 
Glu Phe Ala 
170 
His Leu Ala 
185 
Lieu Lys Arg 
Thr Gly Thr 
Asp Gly Pro 
235 
Thr Asp Glu 
250 
Lieu. Thir Asp 
265 
Lieu Lieu. Asp 
Asp Val Glu 
Phe Pro Thr 
315 
Ile Asn Ala 
330 
US 7,220,583 B2 
-continued 
Asn. Ile Gly Ile Val 
125 
Tyr Arg Lieu 
1 4 0 
Phe Ser Ala 
Gly Lieu Pro 
Ala Ala Thr 
19 O 
Val Val Gly 
2O5 
Lys Ser Val 
220 
Gly Met Val 
Leu Pro Pro 
27 O 
Asp Thr Lieu 
285 
Met His Leu 
3OO 
Ala Leu Ala 
Arg Met Glu 
<213> ORGANISM: Pseudomonas syringae pv. tomato DC3000 
<400 SEQUENCE: 17 
atgcaaac ct 
toctatggct 
agagtaggca 
atgctgatga 
ggttctittgc 
aaag.cgaagc 
attgaaaacc 
cittgaaccoa 
taa 
attatacccita 
cattc.gc.cca 
aagagctogc 
tittcc.gacitt 
taggaattac 
gaatcatcga 
citaaag caaa 
ttittgaagac 
<210> SEQ ID NO 18 
&2 11s LENGTH 160 
&212> TYPE PRT 
to caaaaaac 
tgaaaacgag 
tgatggtttc 
to cagoagag 
titcgcttggc 
agcaggttgt 
aattgaagtt 
aggtgactitt 
cctcccaccg 
attacctaaat 
gatgg.cgagg 
tacct attat 
gg tatttittc 
tatagotctt 
tat coagtga 
ttggtacagt 
cittgttgctoc 
titcatcatct 
aag catctgc 
ccitatggatc 
togtoagagt 
ggtotgaata 
aaacgtogto 
<213> ORGANISM: Pseudomonas syringae pv. tomato DC3000 
Ala Leu 
Ala Cys 
160 
Wall Ile 
175 
Telu Telu 
Thr Wall 
Arg Thr 
Gly Ala 
240 
Glu Pro 
255 
Ala Leu 
Glu Met 
Lieu Pro 
Arg Lys 
320 
Gly Arg 
335 
totgctgact 
cgacgctitta 
aggcgctctg 
tgctaagaaa 
tactggtgaa 
gagtggtgat 
ccagaagttc 
gtttitcc.gaa 
60 
120 
18O 
240 
360 
420 
480 
483 
162 

gtggg.cgatt 
actgacatgt 
alaccaccctg 
toaaatgcgt. 
atcaatgagg 
<400 
Met 
1 
Ser 
His 
Glin 
Teu 
65 
Glu 
Ser 
Teu 
Glu 
145 
Asn 
Glin 
Arg 
Thr 
Pro 
225 
Pro 
Pro 
Ala 
Ala 
Ser 
305 
cc.gcacct gc 
cggtag actt 
ataaaaac cq 
acaagattitt 
citggtaatag 
SEQ ID NO 20 
LENGTH 488 
TYPE 
ORGANISM: Pseudomonas 
PRT 
SEQUENCE: 20 
Ile Asn Lieu. Thir H 
Asp 
Ile 
Lys 
5 O 
Gly 
Wall 
Gly 
Telu 
130 
Ala 
Ser 
Pro 
Arg 
210 
Arg 
Glu 
Pro 
Glin 
Asn 
29 O 
Gly 
Ser 
Ala 
35 
Gly 
Ala 
Gly 
Wall 
Wall 
115 
Ala 
Thr 
Telu 
Asn 
Tyr 
195 
Pro 
Pro 
Thr 
Pro 
Glin 
275 
Ser 
Arg 
5 
Thr Lys P 
2O 
Gly Lys V 
165 
caagcc.gc.cc gtcaag.ccgt. 
atcc.gc.cgtt aaaaaggctt 
Cggcaa.cgag gcc gaggcgg 
gtocg accog gagttgcgca 
ggCatga 
is Ile 
ro Lys 
all Ala 
Leu Lleu. Asn. Glu 
Teu Ser G 
55 
ly Lys 
70 
Gly Arg Phe Asn 
85 
Trp Glu Arg Asp 
100 
Ser Asp S 
Asp Ala M 
er Lys 
et Ala 
135 
Asn Ala Arg His 
1 50 
Met Asn Asp Leu 
1.65 
Gly Asp Arg Val 
18O 
Gly Ala G ln Glin 
Glin Ala Asn. Ser 
Ala Ser G 
2 
215 
ly Arg 
30 
Pro Pro Arg Thr 
245 
Lys Ala G 
260 
lu Pro 
Glin Ala Arg Pro 
Thr Pro P 
Pro Asp G 
3 
rd Pro 
295 
ly Ala 
10 
US 7,220,583 B2 
-continued 
tgtacgagca 
acagagatgc 
cc.gagcqctt 
aag catacga 
syringae pv. tomato 
Ala 
Met 
Telu 
40 
Arg 
Glu 
Telu 
Gly 
120 
Ala 
Thr 
Arg 
Glin 
200 
Ala 
Pro 
Arg 
Arg 
Glu 
280 
Pro 
Glin 
Ser 
Glu 
25 
Glin 
Glin 
Pro 
Ala 
Ser 
105 
Lys 
Pro 
Tyr 
Arg 
185 
Ala 
Pro 
Asp 
Pro 
Pro 
265 
Thr 
Pro 
Glin 
Ser 
10 
Arg 
Wall 
Glin 
Wall 
Arg 
90 
Met 
Met 
Glu 
Phe 
Glin 
170 
Pro 
Arg 
Pro 
Gly 
Glin 
250 
Ala 
Pro 
Glin 
Teu 
Ala 
Thr 
Asn 
75 
Ala 
His 
Teu 
Pro 
Ser 
155 
Wall 
Met 
Pro 
Pro 
Ala 
235 
Ala 
Ser 
Pro 
Ala 
Ala 
315 
Ala 
Ile 
Ser 
Gly 
60 
Asn 
Ala 
Asn 
Phe 
Gly 
1 4 0 
Ser 
Phe 
Pro 
Glin 
Pro 
220 
Glin 
Asn 
Gly 
Arg 
Glu 
Arg 
DC3 OOO 
Arg 
Asn 
Ser 
45 
Teu 
Wall 
Phe 
Wall 
Ser 
125 
Asn 
Asn 
Glu 
Thr 
2O5 
Pro 
Glin 
Ser 
Arg 
Thr 
285 
Pro 
Pro 
Ala 
Wall 
Telu 
Ser 
Glu 
Asp 
Met 
110 
Telu 
Asp 
Telu 
Pro 
19 O 
Pro 
Glin 
Thr 
Pro 
27 O 
Arg 
Arg 
Glu 
cittgggcctic 
cgc gatgaag 
caaagtcatt 
caacggcc.gt 
Ala 
15 
Ala 
Telu 
Met 
Thr 
Wall 
95 
Ser 
Gly 
Asn 
Ile 
175 
Phe 
Pro 
Ala 
Ala 
Pro 
255 
Asp 
Pro 
Pro 
Thr 
Telu 
Ser 
Glu 
Ile 
His 
Ala 
Phe 
Ser 
Telu 
160 
Arg 
Trp 
Gly 
Glu 
Arg 
240 
Pro 
Gly 
Glin 
Ala 
Pro 
320 
1260 
1320 
1380 
1440 
1467 
166 
Pro Arg Thr 
Ala Glu Pro 
Ala Arg Pro 
355 
Pro Pro Pro 
370 
Ser Thr Ala 
385 
Val Gly Asp 
His Leu Gly 
Ala Tyr Arg 
435 
Asn Glu Ala 
450 
Lys Ile Lieu 
465 
Ile Asn. Glu 
167 
Arg Pro Glin Ala Asn 
325 
Arg Pro Ala Ser Gly 
340 
Glu Thr Pro Pro Arg 
360 
Pro Pro Lys Ala Glu 
375 
Arg Pro Asn. Asn. Thr 
390 
Ser Ala Pro Ala Lys 
405 
Leu Thir Asp Met Ser 
420 
Asp Ala Ala Met Lys 
4 40 
Glu Ala Ala Glu Arg 
455 
Ser Asp Pro Glu Lieu 
470 
Ala Gly Asn Arg Ala 
485 
<210> SEQ ID NO 21 
&2 11s LENGTH 864 
&212> TYPE DNA 
Ser Ala Pro 
330 
Arg Pro Asp 
345 
Thr Arg Pro 
Pro Ser Ala 
Ser Ala Ala 
395 
Pro Pro Wall 
410 
Val Asp Lieu 
425 
Asn His Pro 
Phe Lys Val 
Arg Lys Ala 
475 
US 7,220, 
-contin 
Pro Pro Pro 
Gly Thr Glin 
35 O 
Glin Ala Asn 
365 
Gly Gly Glu 
38O 
Asp Ala Ser 
Lys Pro Leu 
Ser Ala Wall 
43 O 
Asp Lys Asn 
4 45 
Ile Ser Asn 
460 
Tyr Asp Asn 
<213> ORGANISM: Pseudomonas syringae pv. tomato DC3000 
<400 SEQUENCE: 21 
atgaac atta 
aaaattitc.ca 
alaggtgcgta 
gagctogcct 
acgcto caac 
gtotatatgc 
acgacgacgt. 
ccitcgg.cggc 
caacgc.caca 
aacggggcaa. 
catcagacac 
agcatcaa.ca 
gccaaagaag 
gccatcCagg 
gccacgggca 
cgcc.gctoac 
titcc.ca actic 
gc gccatcag 
ccittgggcag 
citgtgttggc 
aggacagogC 
cgaatccatc 
citc.ccgcagg 
gtoctogcgc 
ggttcaatgc 
ccaatcctga 
gCatgc gaga 
citggcc.gtga 
toalactacca 
<210> SEQ ID NO 22 
&2 11s LENGTH 2.87 
&212> TYPE PRT 
cacgc.gcatg 
tgaccacatc 
caacatgttc 
gtttgaggct 
cggcaa.gcto 
agagcctgat 
citcggtgctg 
ggacaggtot 
caa.gcaaaca 
tittgcacagg 
gcago: aaaat 
togggaag CC 
agacitccacc 
gtga 
ggcaagggct 
atcaatgcc.g 
cgcaccagoa 
ggtgtc.ccgg 
gaccc caatc 
acticcictggg 
gcgcagagcg 
agtttgctogg 
gccalagggiac 
aa.gc.cga-cag 
caaaaag aga 
ggaatgcaac 
gacaagaaga 
cgtcc.gcaca 
cittcaatcaa. 
to gagaaagg 
citctittcago 
acg acctgaa 
accogacgc.c 
atacggcttic 
gcattgcgct 
gacCtggcc.g 
aggctgaagic 
cagotcaacg 
gcgc.cgalagg 
agcttctgga 
tdagogccac 
<213> ORGANISM: Pseudomonas syringae pv. tomato DC3000 
583 B2 
ued 
Pro Lys 
335 
Glin Glin 
Ser Ala 
Arg Pro 
Ala Arg 
400 
Tyr Glu 
415 
Arg Gly 
Ala Tyr 
Gly Arg 
480 
agg Cacagac 
gtggttgaat 
gaaactgttc 
gc gcc cctog 
ccittgtcagg 
caacg.cggto 
gtoatcatta 
ggatcacgc.g 
agaggagagg 
citacggtgat 
cgttgctgaa 
gottctoaga 
cgtgcto gag 
tgaaaagaac 
60 
120 
18O 
240 
360 
420 
480 
540 
600 
660 
720 
840 
864 
168 
<400 SEQUENCE: 22 
Met Asn. Ile 
1 
Gln Gly. Thr 
Ala Ala Ser 
35 
His Ile Arg 
5 O 
Leu Gly Ser 
65 
Thir Leu Glin 
Asn Lieu Wall 
Trp Asp Pro 
115 
Pro Asp Ala 
130 
Pro Ala Gly 
145 
Glin Arg His 
Arg Glu Glu 
Thr Glu Ala 
195 
His Arg Glin 
210 
Met Arg Glu 
225 
Ala Lys Glu 
Asp Wall Leu 
Lys Ile Ser 
275 
169 
Thr Pro Leu Thir Ser 
5 
Asp Lys Ile Ser Ile 
Ile Lys Trp Lieu. Asn 
40 
Thr Ser Ile Glu Lys 
55 
Asn Met Phe Gly Val 
70 
Pro Wall Leu Ala Phe 
85 
Arg Val Tyr Met Glin 
100 
Thr Pro Asn Ala Wall 
120 
Glin Ser Asp Thr Ala 
135 
Ser Wall Leu Ser Leu 
15 O 
Ser Pro Arg Ala Asp 
1.65 
Arg Asn Gly Ala Arg 
18O 
Glu Ala Tyr Gly Asp 
Lys Glu Thr 
200 
Glin 
: 
Gln Gln Asn Gly Met 
230 
Ala Leu Glin Ala Arg 
245 
Glu Ala Ile Glin Ala 
260 
Ala Thr Glu Lys Asn 
<210> SEQ ID NO 23 
&2 11s LENGTH 429 
&212> TYPE DNA 
280 
Ala Ala Gly 
10 
Pro Asn. Ser 
25 
Lys Val Arg 
Gly Lys Lieu 
Pro Ala Leu 
75 
Glu Ala Asp 
90 
Asp Ser Ala 
105 
Th Thir Thr 
Ser Ser Ser 
Leu Gly Ile 
155 
Arg Ser Ala 
170 
Phe Asn Ala 
185 
His Glin Thr 
Arg Val Ala 
Glin Arg Ala 
235 
Glu Ala Ala 
250 
Gly Arg Glu 
265 
Ala Thr Gly 
US 7,220,583 B2 
-contin 
Lys Gly Ser 
Thr Arg Met 
3O 
Ser Ala Ile 
45 
Phe Glu. Leu 
60 
Ser Ala Arg 
Pro Asn His 
Gly Lys Lieu 
110 
Ser Asn. Pro 
125 
Leu Pro Arg 
1 4 0 
Ala Lieu. Asp 
Lys Gln Thr 
19 O 
Pro Asn. Pro 
2O5 
Glu Ser Ile 
220 
Glu Gly Lieu 
Arg Lys Glin 
Asp Ser Thr 
27 O 
Ile Asn Tyr 
285 
<213> ORGANISM: Pseudomonas syringae pv. tomato DC3000 
<400 SEQUENCE: 23 
atgcgcacat 
togg cattgc 
gccagtctitc 
cgtgtc gatc 
cctgtccaca 
cgctacacco 
gcc.caag.cgc 
cgc.cgatag 
cc.gittaatgg 
aggccttgcg 
tggttcccitc 
cc.gagcacga 
Cgatgagcgc 
atgaccttgg 
ttgctogaa.ca 
totgcttgag 
Cgacgacggit 
tactgacggc 
cggacgtotg 
atgtatagoa 
Cgggaacggg 
gatcaagcag 
cacagoctoga 
tatttactgt 
gacgc.gctitt 
citggcgcttg 
cittgatgtcg 
gcagataccc 
gtaatcgaaa 
agaCCCtggg 
ggcaaggcaa. 
togctatotg 
cattgcacct 
agcaaaacac 
tgttgcttgc 
actittaggca 
ued 
Ser Ala 
15 
Ile Asn 
Ser Asp 
Ala Ser 
Pro Ser 
8O 
Asp Lieu 
95 
Thr Pro 
Ser Glu 
Arg Pro 
His Ala 
160 
Pro Gly 
175 
Lys Pro 
Asp Lieu 
Asn. Ser 
Leu Arg 
240 
Telu Telu 
255 
Asp Lys 
Glin 
citttgatact 
ggataag caa 
taccttgagc 
galacctgtct 
gttgttgttctt 
gctcqaaaac 
Cgatc aggga 
60 
120 
18O 
240 
360 
420 
429 
170 
171 
<210> SEQ ID NO 24 
<211& LENGTH: 142 
&212> TYPE PRT 
US 7,220,583 B2 
-continued 
<213> ORGANISM: Pseudomonas syringae pv. tomato 
<400 SEQUENCE: 24 
Met Arg Thr Ser Val Asn Gly Leu Leu Glu His 
1 5 10 
Gly Phe Asp Thir Ser Ala Leu Glin Ala Lieu Arg 
2O 25 
Leu Trp Glin Gly Lys Asp Lys Glin Ala Ser Lieu 
35 40 
Asp Gly Asp Ala Leu Phe Ala Ile Cys Thr Lieu 
5 O 55 
Glu His Asp Gly Arg Lieu Lleu Ala Lieu Ala Lieu 
65 70 75 
Pro Val His Thr Met Ser Ala Cys Ile Ala Leu 
85 90 
Thr Lieu. Cys Lieu Arg Tyr Thr His Asp Leu Gly 
100 105 
Thr Lieu Lleu Lieu Ala Leu Glu Asn Ala Glin Ala 
115 120 
Lys Glin Val Ile Glu Asn. Phe Arg His Asp Glin 
130 135 
<210> SEQ ID NO 25 
&2 11s LENGTH 474 
&212> TYPE DNA 
Ser 
Asp 
Teu 
Ser 
60 
His 
Asp 
Gly 
Teu 
Gly 
1 4 0 
<213> ORGANISM: Pseudomonas syringae pv. tomato 
<400 SEQUENCE: 25 
atgatcgc.gt togcaa.ccgg actgctagaa cacagotctga 
gcagatttgc aatcc.citt.cg g gatgaaggg tatttgctgt 
accagoctot toggtgc.ccgc tigctggcggg gatgcgctitt 
tacatc gatc ctdaac agga cqggcggctg. citggcgcttg 
ccagoccaca citctggg.cgc cagtatc.gcg citggatato.g 
cgttacacgc acg accitcac toggcacggc acagacaatt 
actcaggcac ttgcc.gagca gatcaagcag gtcatcgaaa 
cgc.ccgc.caa toccc.gc.cca cacago.ccga C ggccagatg 
<210> SEQ ID NO 26 
&2 11s LENGTH 157 
&212> TYPE PRT 
DC3 OOO 
Teu 
Asp 
Wall 
45 
Arg 
Teu 
Wall 
Asn 
Ala 
125 
Arg 
Gly 
Pro 
Wall 
Asn 
Glu 
Gly 
110 
Glu 
Arg 
DC3 OOO 
aacggcttgg 
ggCacgggaa 
ttgtcatcag 
cgctgcattt 
agcaaaatac 
cct tcc.gcag 
<213> ORGANISM: Pseudomonas syringae pv. tomato DC3000 
<400 SEQUENCE: 26 
Met Ile Ala Phe Ala Thr Gly Leu Leu Glu His 
1 5 10 
Gly Tyr Asp Ala Ala Asp Leu Glin Ser Lieu Arg 
2O 25 
Leu Trp His Gly Lys Asn Gly His Thr Ser Lieu 
35 40 
Gly Gly Asp Ala Leu Phe Val Ile Ser Thr Lieu 
5 O 55 
Ser 
Asp 
Teu 
Ser 
60 
Teu 
Glu 
Wall 
45 
Tyr 
Gly 
3O 
Pro 
Ile 
Thr 
15 
Tyr 
Ser 
Asp 
Telu 
Glin 
95 
Ala 
Glin 
atacgacgc.c 
aaacggtoac 
caccctgagc 
gaacttgtc.g 
cittgttgcctg 
gcttgaaag.c 
tgaattcgga 
ttag 
Arg 
15 
Tyr 
Ala 
Asp 
Telu 
Telu 
Thr 
Pro 
Ser 
Asn 
Asp 
Ile 
Telu 
Telu 
Ala 
Pro 
60 
120 
18O 
240 
360 
420 
474 
172 
Glu 
65 
Pro 
Thr 
Asn 
Pro 
145 
<400 
Glin 
Ala 
Telu 
Telu 
Glin 
130 
Ala 
Asp 
His 
Cys 
Ser 
115 
Wall 
His 
Gly Arg L. 
Thir Leu G 
173 
eu Lleu Ala 
70 
ly Ala Ser 
Leu Arg Tyr Thr His 
100 
Arg Ala L. eu Glu Ser 
120 
Ile Glu Thr Phe Arg 
135 
Thir Ala Arg Arg Pro 
1 
SEQ ID NO 27 
LENGTH 534 
TYPE 
ORGANISM: Pseudomonas syringae pv. tomato DC3000 
DNA 
SEQUENCE: 27 
gtgaaaaagt Ctggcgctgg 
togtogaagg 
aag actg.cgc 
gtogcc.gc.ca 
agtaacgtgc 
ccago.cgacg 
gact cactgg 
gCagaggatc 
gataccactt 
<400 
Wall 
1 
Ala 
Teu 
Ala 
Wall 
65 
Ser 
Asp 
Glu 
Ala 
Lys Lys Ser 
Thr 
Thr 
Wall 
5 O 
His 
Asn 
Glu 
Gly 
Wall 
130 
Gly 
Gly 
35 
Ser 
Gly 
Wall 
Gly 
Ala 
115 
Glin 
gc gttctaag 
ttcattcago 
gtgtgcatgg 
tgttcaatca 
aaatgttcag 
gtggcgagca 
citgcgcagtc 
caccitcaa.gc 
SEQ ID NO 28 
LENGTH 177 
TYPE 
ORGANISM: Pseudomonas syringae pv. tomato DC3000 
PRT 
SEQUENCE: 28 
5 
Ser Ser S 
2O 
50 
aactcaagcc 
taccattgcc 
aac agcc.gtt 
cittgtcggitt 
ggCactgg.cg 
gccttcactg 
actggctgtg 
citttgcgc.ga 
atcactitcait 
Gly Ala Gly Thr 
er Lys Gly 
Cys Phe Ala Pro Asn 
Tyr Glu L 
Leu Ser W 
40 
eu Lleu Pro 
55 
al Asp His 
70 
Leu Phe Asn Glin Ala 
85 
Ala Pro Ala Asp Glu 
100 
His Pro Arg Lieu Ala 
Thr Met G 
120 
lu Lys Gly 
135 
Leu Ala 
Ile Ala 
90 
Asp Lieu 
105 
Thr Glin 
Ser Glu 
Asp Ala 
Teu 
75 
Teu 
Thr 
Ala 
Phe 
Wall 
155 
tatgc gttgt 
agg caccitga 
togtatgagc 
gatcaccgcc 
citggacct gg 
aaacg.cgaag 
caaac catgg 
tgccattcat 
totgtgg.cga 
Glin Ala 
10 
Wall Leu 
25 
Lys Thr 
Gly Asn 
Arg Glin 
Leu Ala 
90 
Met Phe 
105 
Asp Ser 
Lieu Lys 
Tyr 
Ser 
Ala 
Tyr 
Pro 
75 
Teu 
Arg 
Teu 
Arg 
US 7,220,583 B2 
-continued 
His 
Asp 
Gly 
Teu 
Gly 
1 4 0 
Ala 
Teu 
Ile 
His 
Ala 
125 
Arg 
Teu 
Asn 
Glu 
Gly 
110 
Glu 
Pro 
togccitctg.c 
cgg gatgttt 
tattgcc.ggg 
agcc.ggcgct 
agc gttittga 
gtgcc catcc 
aga agggcct 
titttittacco 
gct catctgg 
Ala 
Thr 
Teu 
Ser 
60 
Ala 
Asp 
Pro 
Gly 
Teu 
1 4 0 
Teu 
Ile 
His 
45 
Wall 
Teu 
Teu 
Ser 
Gly 
125 
Ala 
Phe 
Ala 
Ser 
Ala 
Thr 
Glu 
Telu 
110 
Glu 
Glu 
Telu 
Glin 
95 
Thr 
Glin 
Pro 
gacgggaagic 
tgcacccaac 
caattattot 
gacacgactg 
C gaggg.cgc.g 
cc.gattggcc 
taaacggctg 
gatcagtagt 
citga 
Ala 
15 
Arg 
Ala 
Ala 
Arg 
Arg 
95 
Glin 
Asp 
Ser 
Asn 
Asp 
Ile 
Met 
Ser 
His 
Thr 
Ser 
Telu 
Phe 
Arg 
Telu 
Pro 
60 
120 
18O 
240 
360 
420 
480 
534 
174 

Ser Gly Val 
Asn Ala Ala 
115 
Lys Gly Thr 
130 
Leu Lleu Lys 
145 
Gly Gly Lieu 
Wal Met Ser 
Gly Lys Ala 
195 
Ser Ala Arg 
210 
Ser Ala Glin 
225 
Asp Leu Glin 
Pro Gly Ser 
Ile Ala Gly 
275 
Phe Leu Ala 
29 O 
Asn Lieu Lys 
305 
Asp Ser His 
Gly Met Pro 
Asn Ser Ile 
355 
Glin Wal Wall 
370 
177 
Leu Ser Pro Arg Phe 
100 
Ala Ile Arg Ala Thr 
120 
Leu Phe Thr Asn Lieu 
135 
Arg Val Val Asn Asp 
15 O 
Asp Lieu. Asn Tyr Lieu 
1.65 
Gly Trp Ala Ala Arg 
18O 
Arg Tyr Glu Thr Ala 
200 
Glu Lieu Ala Phe His 
215 
Thr Lys Val Gly Phe 
230 
Wall Leu Arg Gly His 
245 
Asp Phe Ala Lys Arg 
260 
Pro Ser Gly Thr Ala 
280 
Pro Ala Cys Lieu Lys 
295 
Glu Lieu Val Arg Tyr 
310 
His Ser Met Leu Glu 
325 
Glu Gln Trp Asp Asp 
340 
Lys Gly Arg Gly Phe 
360 
Arg Glin Ala Ala Glin 
<210> SEQ ID NO 31 
&2 11s LENGTH 1173 
&212> TYPE 
<213> ORGANISM: Pseudomonas 
DNA 
<400 SEQUENCE: 31 
atgcggtttg 
ttacgtttgc 
gctgacgtga 
agacitctt.cg 
agatacccag 
cago atc.gct 
ggtgcacata 
gttcccitcag 
aa.cattcatt 
atgctg.ccc.g 
gag.cgatago 
atcagoctoc 
ttaaactgat 
gtgattitcgc 
cgagcgtolac 
titccaaaaga 
gCgtgg Cagg 
to gaga.gc.ca 
375 
aggCC agaag 
aggtgcatg 
acctgctgat 
ggtaggaact 
gaaggatc.cg 
acatcttgaa 
cagtgcgtgt 
gCagtggaac 
to C gg cacag 
Asp Val Met 
105 
Ser Arg Val 
Met Leu Ser 
Pro Ala Leu 
155 
Lys Ala Cys 
170 
Ala Ser Glu 
185 
Ser Asn Lieu 
Arg His Asn 
Asp Lys Gly 
235 
Gly Ser Ser 
250 
Ala Glu Wall 
265 
Ser Arg Met 
Ser Lieu Gly 
Ala Cys Tyr 
315 
Wall Asn Lieu 
330 
Thr Leu Tyr 
345 
Gly Ile Asp 
Lys Ser 
cc caaag.ccc 
cc.cagtgaag 
gttcgtocag 
citggcgctdt 
ggagg cagtg 
caaggcaata 
ttcaaagcto 
CaCaaaa.. CCC 
gtogc.cggac 
US 7,220,583 B2 
-contin 
Gly Ser Val 
110 
Gly Thr Leu 
125 
Asn Asn. Phe 
1 4 0 
Glin Gln Lys 
Glu Gly Asp 
Ser Arg Glu 
19 O 
Ser Glin Thr 
2O5 
Pro Wall Asn 
220 
Leu Pro Glu 
Val Trp Ser 
Ser Gly Lys 
27 O 
Wall Ala Wall 
285 
Ile Glu Ser 
3OO 
Ala Tyr Phe 
Gly Val Ala 
Asn Glu Pro 
35 O 
Asn Lieu Ala 
365 
syringae pv. tomato DC3000 
citatggatgc 
aag Caggaac 
aaatgggtot 
C gaCaggagt 
tatgggcago 
agacggttct 
gc gctgacgt. 
aacgggtaaa 
atgagttcat 
ued 
Gly Trp 
Arg Glu 
Lys His 
Lieu. Asp 
160 
Leu Tyr 
175 
Glin Ile 
Lieu. Ile 
His Pro 
Glu Ser 
240 
Wall Lys 
255 
Pro Ile 
Ala Arg 
Glu Glin 
Gly Glin 
320 
Ser His 
335 
Phe Ser 
His Arg 
accgtcatca 
gactgcacct 
aggtoctdtg 
cc.gttittgca 
aatcaatctg 
tgagc gtttc 
cacacac gat 
actgaaccot 
acactgttac 
60 
120 
18O 
240 
360 
420 
480 
540 
178 
acgcatcc to 
gggttgacga. 
ttggcaaagg 
gcCagg cqaa 
gatgacCagg 
toacgtatta 
gcc.gagtgtt 
aattatctg.c 
Caggcgcaag 
to acct gacc 
cactggaaaa 
agtttgtcga 
citcgtttgac 
atc.ccitat.ca 
togaagacga 
citattagtga 
CC gagaggga 
acgtaggtgc 
tacctgitatt 
Cggaaaaaag 
tgaag accoa 
aagttattoc 
<210> SEQ ID NO 32 
&2 11s LENGTH 390 
&212> TYPE 
<213> ORGANISM: Pseudomonas 
PRT 
<400 SEQUENCE: 32 
Met Arg Phe 
1 
Ala Pro Ser 
Glu Glu Ala 
35 
Ala Asp Wal 
5 O 
Lys Lieu Met 
65 
Arg Tyr Pro 
Ala Ile Asn 
Asn Lys Thr 
115 
Ala Cys Phe 
130 
Val Ala Gly 
145 
Asn. Ile His 
Ile His Cys 
Pro His Trp 
195 
Lys Lieu Pro 
210 
Pro Tyr His 
225 
Ala Arg Arg 
179 
acgc.catata 
agagaaactg 
tggtttcaag 
agttggcgaa 
agtagctaaa 
gttgttatcaa 
tittgctcaaa 
tagctattoa 
totaaaag.cgg 
gag actggca 
ggatagaaag 
Asp Ala Ala Arg Gly 
5 
Ser Leu Arg Lieu Arg 
Gly. Thir Thr Ala Pro 
40 
Arg Pro Glu Met Gly 
55 
Val Gly. Thir Leu Ala 
70 
Gly Asp Phe Ala Lys 
85 
Leu Gln His Arg Ser 
100 
Val Leu Glu Arg Phe 
120 
Lys Ala Arg Ala Asp 
135 
Gln Trp Asn His Lys 
15 O 
Phe Glu Ser His Pro 
1.65 
Tyr Thr His Pro Glu 
18O 
Lys Ala Lieu. Asn. Glu 
200 
Asp Pro Lys Arg Lieu 
215 
Gly Phe Lys Lieu Ser 
230 
Ile Glu Asp Glu Val 
245 
aaa.catcc.gc 
cca gacccta 
citgtccaccg 
gatgttgttgt 
gcc.gctgcto 
gCggg cagoa 
aacggtoaga 
gatataagcc 
atgggaattg 
cittgg catgc 
taa 
Gln Lys Pro 
10 
Ala Ile Ala 
25 
Ala Asp Wall 
Val Gly Pro 
Leu Ser Thr 
75 
Asp Pro Gly 
90 
Ser Wall Thr 
105 
Gly Ala His 
Wall Thr His 
Thr Glin Arg 
155 
Ala Glin Wall 
170 
Phe Wall Glu 
185 
Gly Leu Thr 
Leu Pro Ile 
Thr Gly Asp 
235 
Gly Glu Asp 
250 
US 7,220, 
-contin 
actggaaag.c 
ag.cgtctott 
ggg acto citg 
tgaaag.cgtt 
agatctaccc 
tgcgtggagg 
aactgcctda 
citggtoacgc 
tgttctgatac 
tacgggagga 
syringae pv. tomato DC3000 
Lys Ala Pro 
Gly Gly Met 
3O 
Asn Glin Pro 
45 
Val Arg Lieu 
60 
Gly Val Arg 
Gly Ser Val 
His Leu Glu 
110 
Ile Pro Lys 
125 
Asp Val Pro 
1 4 0 
Wall Lys Lieu 
Ala Gly His 
Arg His Ile 
19 O 
Thr Arg Lieu 
2O5 
Pro Leu Ala 
220 
Ser Trp Pro 
Wall Leu Lieu 
583 B2 
ued 
cctgaac gala 
gcc cattccc 
gcc.ggatgcg 
citttggcggc 
caagattgcc 
acaac agctg 
cagttttacg 
gaaaaaaata 
ag.cgttttitt 
cctgctgatg 
Met Asp 
15 
Pro Ser 
Pro Pro 
Phe Wall 
Phe Ala 
8O 
Trp Ala 
95 
Glin Gly 
Asp Ser 
Ser Gly 
Asn. Pro 
160 
Glu Phe 
175 
Lys His 
Thr Glu 
Asp Ala 
240 
Lys Ala 
255 
600 
660 
720 
840 
9 OO 
96.O 
1020 
1080 
1140 
1173 
180 
Phe Phe Gly 
Ala Glin Ile 
275 
Tyr Glin Ala 
29 O 
Val Gly Ala 
305 
Asn Tyr Lieu 
Ala Lys Lys 
Ile Wall Phe 
355 
Leu Ala Leu 
370 
Wall Ile Pro 
385 
181 
Gly Asp Asp Glin Ala 
260 
Tyr Pro Lys Ile Ala 
Gly Ser M 
280 
et Arg Gly 
295 
Lieu Lleu Lys Asn Gly 
3 
Leu Pro W 
325 
10 
al Phe Ser 
Ile Glin Ala Glin Ala 
340 
Asp Thr Ala Phe Phe 
Gly Met L 
360 
eu Arg Glu 
375 
Asp Arg Lys 
3 
<210 SEQ ID NO 33 
&2 11s LENGTH 474 
&212> TYPE DNA 
90 
Ile Ser Glu 
265 
Ser Arg Ile 
Gly Glin Glin 
Gln Lys Lieu 
315 
Tyr Ser Asp 
330 
Glu Lys Ser 
345 
Ser Pro Asp 
Asp Leu Lieu 
US 7,220,583 B2 
-contin 
Val Ala Lys 
27 O 
Thr Glu Arg 
285 
Leu Ala Glu 
3OO 
Pro Asp Ser 
Ile Ser Pro 
Glin Lys Arg 
35 O 
Leu Lys Thr 
365 
Met His Trp 
38O 
<213> ORGANISM: Pseudomonas syringae pv. tomato DC3000 
<400 SEQUENCE: 33 
atgaac aggc 
atgg cagota 
ggitatctata 
cacaagaaac 
Cagaagggag 
gatcttgagt 
galaggtoagc 
acaaagttcag 
ttcacaagac 
acgcto atgc 
togcgc.cgga 
actic cattaa. 
galacattgac 
atcgaaaatc 
acaattggat 
catctgagtg 
<210> SEQ ID NO 34 
&2 11s LENGTH 157 
&212> TYPE 
<213> ORGANISM: Pseudomonas 
PRT 
<400 SEQUENCE: 34 
Met Asn Arg 
1 
Ser Pro Cys 
Pro Glin Ser 
35 
Phe Ala Gly 
5 O 
Ser Ile Lys 
65 
Glin Lys Gly 
Asn Gly Val 
Cagtctgctg 
tatgagttgt 
aacgtttgct 
agagtttitcc 
taact gtagt 
aggaaatgag 
taaagagcigt 
tdagttctgtt 
Leu. His Lys Thr Ser 
5 
Ile Met Ala Ala Asn 
Val Lys Tyr Val Asn 
Trp Glu G 
Glu Phe S 
Gly. Thir L 
85 
Ile Asp L. 
100 
40 
ly Asn Trp 
55 
er Thr Ala 
70 
eu. Thir Asn 
eu Glu Tyr 
gcq gotatat 
cctgtc.ccgc 
ggttgggagg 
actgcttitat 
tattoactaa 
aatagacitaa 
ggcgcggttg 
Leu Lleu Ala 
10 
Ala His Ala 
25 
Gly Ile Tyr 
Wal Ser Glin 
Leu Tyr Lieu 
75 
Arg Lys Ser 
105 
tgaccgcatc 
aaag.cgtgaa 
ggalactgggit 
atctittcagt 
gCggagataa 
agacactitat 
gaattcaagg 
taaacgagga 
syringae pv. tomato DC3000 
Ala Ile Leu 
Met Ser Cys 
3O 
Ile Ala Pro 
45 
Pro His Lys 
60 
Ser Val Asp 
Ser Leu Ser 
Gly Asn. Glu 
110 
ued 
Ala Ala 
Glu Lieu 
Phe Thr 
320 
Gly His 
335 
Met Gly 
Glin Arg 
ccc.ctgcatt 
gtacgittaat 
ttcticalacca 
ggataaaagt 
tgg.cgtaata 
cgttitccatt 
atatgaatgt 
citga 
Thr Ala 
15 
Pro Wall 
Glu Thr 
Lys His 
Lys Ser 
8O 
Gly Asp 
95 
Asn Arg 
60 
120 
18O 
240 
360 
420 
474 
182 




































































































